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Myxomatous mitral valve disease (MMVD) is the single most common acquired 
cardiac disease of dogs, and is a disease of significant veterinary importance. It also 
bears close similarities to mitral valve prolapse in humans and therefore is a disease 
of emerging comparative interest. Realising the importance of collagen fibres in 
mitral heart valves and considering the paramount significance of myxomatous 
mitral valve disease, a better understanding of the pathogenesis of MMVD is 
essential. Thus, this study was designed to investigate the changes in collagen 
molecules, including fibril structure, fibril orientation, d-spacing, collagen density, 
collagen content, thermal stability, and the status of mature and immature cross-
links. A combination of biophysical and biochemical tools such as x-ray diffraction, 
neutron diffraction, HPLC were utilised in order to fulfil the objectives. Biochemical 
assay of hydroxyproline revealed a 10% depletion of collagen in mildly affacted 
(grade I and II) leaflets, while a  20% depletion of fibrillar collagen was revealed by 
mapping the collagen fibrils onto the anatomy of cardiac leaflets using x-ray data. 
Differential scanning calorimetry showed that there were no significant differences 
in the onset temperature of denaturation of collagen between the healthy and affected 
leaflets. However, in affected areas of leaflets, the enthalpy of denaturation 
significantly dropped by 20%.  In the affected regions, neutron diffraction results 
showed an increase in the immature reducible cross-links though the low number of 
the samples can be considered a limiting factor in this regard. However, the HPLC 
results showed a 25% decrease in the number of mature cross-links. Additionally, the 
recently introduced imaging technologies to biology and medicine such as 
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differential enhancing imaging (DEI) and coherent anti-Stokes Raman scattering 
spectroscopy (CARS) were, to the author’s best knowledge, applied for the first time 
to this disease. In doing so, this thesis furthers our understanding of the pathogenesis 
of MMVD, especially in relation to the collagen. The thesis provides new findings 
about MMVD and demonstrates the potential of biophysical tools for studying 
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Myxomatous mitral valve disease (MMVD) is the most common heart disease in 
dogs, and accounts for 75% of their cardiovascular problems. MMVD in dogs 
describes myxomatous degeneration of leaflets and it seems that the diseases is sex, 
age, body weight and build and breed dependent.  It is also recognised by different 
names in veterinary literature, including endocardiosis, chronic valvular disease, 
chronic valvular fibrosis, mitral regurgitation (MR), acquired mitral insufficiency 
and mitral valve prolapse. However, none of these terms gives a complete 
description. Chronic valvular disease is a non-specific term and can embrace a vast 
array of abnormalities and diseases. Acquired mitral insufficiency implies that the 
condition does not have a congenital aspect, but the role of mitral valve dysplasia in 
the condition is unknown. Mitral valve prolapse focuses on only one feature of the 
disease: protrusion of one or both mitral leaflets towards the left atrium during 
systole (Kittleson, 1998; Pedersen, 2000; Olsen et al., 2003a; Hyun, 2005). 
In general, MMVD is a benign condition, which takes several years to progress from 
a clinically silent condition to severe heart failure. Some dogs may not develop 
clinical signs at all, while others may need a range of medical treatment and/or in the 
end die or are euthanized. Moreover, MMVD may further complicate other medical 
and surgical conditions (Pedersen, 2000; Häggstrom et al., 2005).  Despite the fact 
that a considerable amount of advances have occurred in the understanding of the 
disease, the true nature of the disease especially in terms of aetiopathogenesis, 
16 
 
remains widely unknown.  I will review several aspect of MMVD in detail in 
subsequent sections. 
Influence of gender, age, body weight and build and breed 
Age and breed 
Although in most cases the major changes associated with MMVD occur in middle 
age, as the dogs get older the severity of the condition also worsens. The severe 
forms of MMVD in dogs are rarely seen before middle age. Besides, compared to 
human mitral valve prolapse, it seems that the severity of the disease in human 
increases with much more intensity to dogs. However, this may only be related to the 
longer life span of human, longer follow-up periods and the difference in the 
underlying cause of the two diseases. In the study by Kittleson (1998) on dogs aged 
between 5 and 8 years and dogs aged between 9 and 12 years, clinical evidence of 
MMVD was demonstrated in 10% and 25% of dogs, respectively.  
Echocardiographic screening in the cavalier King Charles spaniel (CKCS) has shown 
early signs of the disease at an early age and that the severity of the disease 
progresses as the dogs approach its senescence. However, this finding may be 
strongly breed-dependent. Häggstrom et al. (1992) have shown that 7-10 year old 
CKCSs had a higher risk of mortality or euthanasia due to heart failure than those of 
the same age group of dachshunds.  In fact, 10% of CKCS developed a grade 3 or 4 
murmur, while a much smaller number of dachshunds was found to have murmurs. 
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The breed predisposition to MMVD is well recognised and commonly quoted breeds, 
include the poodle (miniature and toy), miniature schnauzer, cocker spaniel, 
chihuahua, cavalier King Charles spaniel, fox terrier, beagle, Pekinese, dachshund 
and Boston terrier. Of these, the CKCS is of greater importance since it has a unique 
susceptibility and is a very popular breed. The prevalence of MMVD in this breed is 
50% at 4 years and 100% at the age of 10 (Häggstrom et al., 1992; Beardow and 
Buchanan, 1993; Van Vleet and Ferrans, 2001). However, only 10 – 15% of affected 
CKCS develop severe MR leading to death or euthanasia before the age of 10 
(Häggstrom, 1996). 
Influence of gender  
The exact influence of gender on MMVD incidence is not obvious and is a 
contentious matter. Echocardiographic data from dachshunds and CKCSs has shown 
that the gender does not have any significant difference in the incidence of MMVD 
among the young dogs. A study based on necropsy findings of 550 dogs has revealed 
the same degree of prevalence between two sexes (Das and Tashjian, 1965). 
However, other studies suggest that males are up to twice as likely as females to 
developing MMVD. Nevertheless, whether there is a difference in the gender 
prevalence of the MMVD at the early stages, male dogs often display more severe 
complications, and are more likely to develop heart failure than female dogs 
(Pederson, 2000). A study has found that the development of congestive heart failure 
due to myxomatous mitral valve in male cocker spaniels was 4.5 times greater than 
in females (Detweiler and Patterson, 1965). The latter is in good agreement with the 
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study byOlson et al. (1999) in which they showed that the severity of MMVD in 
male dachshunds above the age of two increased at a faster rate compared to females. 
Influence of body shape 
As MMVD has a propensity to occur in small breeds, it is interesting to speculate on 
the relationship between body size, weight and disease incidence. A study of 153 
cocker spaniels showed that there was a negative correlation between the severity of 
the disease and body weight (Buchanan, 1977; Pederson et al., 1999). Similar studies 
in different small breeds substantiate the concept of negative correlation between 
body weight and disease severity (Olsen et al., 1999). Furthermore, a negative 
correlation has also been found between the circumference of the thoracic cage and 
severity of disease. However, it seems that narrow-chested breeds (i.e. cocker spaniel 
and chihuahua) are more inclined to being affected than breeds with a more rounded 
and broad chest, such as beagle and Cairn terrier.In comparable studies in humans, it 
has been shown that there is a negative correlation between weight and the severity 
of mitral valve prolapse and that this is not a function of height. Additionally, which 
might be comparable to dogs, the low anteroposterior chest diameter has been related 
to mitral valve prolapse in human patients. The suggested explanation for this 
relationship is that the heart is trapped in the chest cavity, small for the surrounding 




Developmental anatomy of the heart  
Development of a mammal embryo can be divided into 5 stages including, 
gametogenesis, fertilization, cleavage, gastrulation and organogenesis. The heart is 
the first organ to be formed and differentiated in the embryo, in order to deliver the 
demands of a highly growing embryo. Initial signs of cardiac development appear in 
the splanchic mesoderm, leading to the formation of the cardiogenic plate and then 
the endocardial tube (Figure 1.1). Peristaltic movement in the endocardial tube can 
be observed as early as 18-19 days of gestation (Noden and de Lahunta, 1985). 
 
 
Figure 1.1: Five primitive regions in the endocardial tube, namely truncus arteriosus 
(presumptive aorta and pulmonary trunk), bulbus cordis (presumptive right ventricle), 
ventricle (presumptive left ventricle), atrium (presumptive right and left auricles) and sinus 
venosus (presumptive coronary sinus and wall of right atrium) (Fletcher and Weber, 2004). 
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As the embryo grows the region between bulboventricle and atrium become more 
constricted and the proliferation of mesoderm in the canal results in a crest-like tissue 
protruding into the tube. These protrusions join together, forming the atrioventricular 
endocardial cushion, which is responsible for creating two separate atrioventricular 
orifices. Subsequently, dilation, hypertrophy and trabeculation occur in the 
ventricular walls, which allow the mesenchymal strands of the atrioventricular 
endocardial cushion to form the cusps of the A-V valves and chordae tendineae 
(Noden and de Lahunta, 1985). 
Anatomy and histology of mitral valve 
The mitral valve, like its counterpart in the right heart is a one-way valve that allows 
blood to flow from the left atrium to the left ventricle during diastole and prevents 
the backflow of the blood during systole.!The mitral valve is located immediately 
adjacent to the aortic valve; contrary to the tricuspid valve, which is separated from 
the pulmonic valve by myocardium. The name “mitral” is thought to have been 
suggested by Andreas Vesalius for its similarity to the plane view of a bishop’s mitre 
(hat).  Mitral valve leaflets along with the annulus of the mitral valve, chordae 
tendinae and left papillary muscle are the parts of the mitral valve apparatus. 
The leaflets and cusps are embraced by a fibrous ring called the mitral annulus that is 
located between the atrium and the ventricle. The mitral annulus is a D-shaped, cord 
like and fibrous structure that maintains the attachment of the leaflets. The straight 
border is a continuation of the aortic root and the anterior leaflet. The fibrous annulus 
tissue is thickened at both ends, forming the left and right fibrous trigonum. The 
21 
 
annulus provides a firm origin for the leaflets and is involved in a dynamic process 
called delayed contraction during systole. However, as the fibrous ring cannot 
contract by itself; it is thought that the atrial musculature present in the proximal part 
of the posterior leaflet provides the necessary contraction. 
The mitral valve of a dog is composed of a large septal or aortic (anterior) leaflet and 
a medium sized mural (parietal or posterior) leaflet (Figure 1.2). 
 
Figure 1.2: A normal canine mitral valve spread open by cutting through the mural leaflet. 
 The two leaflets receive chordae tendineae from both papillary muscles equally. The 
spaces between chordae tendineae (interchordal) provide a vital path for blood flow. 
Furthermore, between leaflets there are small commissural cusps, which only attach 
to one papillary muscle. Chordae tendineae themselves are divided into marginal 
(first order) and basal (second order) depending upon whether they attach to the free 
edge or ventricular aspect of the leaflet, respectively. The atrial surface of the leaflets 
is smooth. However, the ventricular surface is a combination of rough (where the 




There are two papillary muscles, namely the anterolateral and the posteromedial 
papillary muscle. Half of the anterior and posterior leaflets are supported by one or 




Figure 1.3: Schematic atrial view of mitral valve. The connections for anterolateral and 
posteromedial papillary muscles are identified with the numerals 1 and 2, respectively.  T1= 
left trigone, T2 = trigone, C1 = anterolateral commissure , C2 = posteromedial commissure , 
A1 and A2 = anterior leaflet , P1 and P2 = posterior leaflet lateral scallops and PM1 and PM2 
= anterolateral and posteromedial segments of posterior leaflet (Degandt  et al., 2007). 
The geometry of the mitral valve complex is also vital to its anatomy. The important 
criteria in this regard are the left ventricular diameter at the level of papillary 
muscles, the annular diameter and the annulo-papillary length. Moreover, recent data 
show that contrary to the long-held belief that the lengths of the two leaflets are equal 
to the diameter of the annulus, there is a small overlap between the leaflets. It is 
assumed that this overlap is necessary to prevent of production of a regurgitant jet 
during systole (Espino et al.,  2007). 
Histologically (Figure 1.4), the atrioventricular valves have 4 layers: atrialis, 
spongiosa, fibrosa and ventricularis. The atrialis and ventricularis layers are 
continuous with the endothelial layer of the heart. The fibrosa layer is the main 
component of the leaflet and is mostly composed of well-structured and packed 
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collagen fibres which continue with the collagen fibres of tendinous cords where 
they attach. Between the atrialis and the fibrosa, there is a thin layer of spongiosa, 
which contains loose collagen fibres, smooth muscle, fibroblasts and elastic fibres in 
a mucopolysaccharide-rich stroma (Kittleson, 1998; Banks, 1993; Dellmann and 
Eurell, 1998). 
 
Figure 1.4: four discreet layers of mammalian mitral valve leaflet upon light microscope 
examination. Atrialis and Ventricularis are lined with the endothelium. Spongiosa is consisted 
of loosely arranged collagen fibrils, proteoglycans and some elastic fibrils. Fibrosa is mainly 
composed of well structured collagen fibrils type I and III with proportions of about 70% and 






Human mitral valve prolapse: an analogous of MMVD? 
It was about 40 years ago when John Brereton Barlow described the origin of late-
systolic murmur and the associated clicks in relation to the mitral valve (Barlow et 
al., 1963). Later on, Barlow and his colleagues chose the term  “billowing mitral 
leaflet syndrome” and attributed it to leaflet, chordeal or myocardial pathology, 
although Criley preferred using the term  “mitral valve prolapse” to describe the 
condition (Criley et al., 1966; Pocock and Barlow, 1970). Since then, there have 
been many developments in the understanding of the disease. Mitral valve prolapse 
in humans is a heterogeneous disease with different clinical and pathological 
manifestations. Previously, it was believed that the young females were affected 
more than the males; in other words 2.1% prevalence in males and 2.7% in females. 
However, epidemiological studies based on the Framingham Heart Study, and 
application of the current criteria for long axis 2-dimensinal echocardiography, have 
shown that the prevalence of disease is around 2-3%, with no disparity between men 
and women (it is estimated that between 7  and 144 million individuals are affected 
by MVP worldwide). The age distribution of the patients with MVP is similar in both 
genders with onset around the third decade of their lives (Freed et al., 1999; Hayek et 
al., 2005). 
The potential causes of mitral valve prolapse make an extensive list, including 
connective tissue disorders (e.g. Marfan syndrome, Ehlers Danlos syndrome, 
osteogenesis imperfecta, adult polycystic kidney disease and pseudoxanthoma 
elasticum), congenital heart disease (e.g. pectus excavatum), genetic abnormality, 
haematologic disturbances, neuroendocrine disorders (e.g. angiotensin II type 1 
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receptor involvement), sequel to acute rheumatic fever, ischemic heart disease, 
metabolic abnormalities (e.g. magnesium deficiency) and other diverse disorders. 
However, all of theses causes may also be categorised into primary mitral valve 
prolapse (idiopathic in otherwise healthy people) and secondary mitral valve 
prolapse (in association with other disorders) (Stefanadis and Toutouzas, 2000; 
Szombathy et al., 2000; Benjamin, 2001; Braunwald, 2001; Pschirrer et al., 2002; 
Jouan et al., 2004; Kitlinski et al., 2004; Weyman and Scherrer-Crosbie, 2004). 
It seems that genetics plays an important role in the development of nonsyndromic 
MVP. However, the condition is heterogeneous. Primary MVP may be familial or 
sporadic.  An autosomal inheritance mode has been recognised in familial cases with 
different degree of expressivity and MMVP1 and MMVP2 genes have been mapped 
to chromosomes 16p11.2-p12.1 and 11p15.4, respectively with age-dependent 
penetrance. A third chromosomal locus for MVP has also been mapped to 
chromosome 13q31.3-q32.1. Furthermore, a rare form of X-linked MVP was 
identified over three decade ago. It is linked to chromosome Xq28. Many 
experiments have been done on genes encoding collagen in the valve leaflets, but to 
date, no involvement of these genes has been observed. The existence of marked 
abnormalities in collagen fibres in the affected leaflets combined with other evidence 
suggest that the defective collagen fibres might be the result of post-translational 
changes rather than gene sequences (Braunwald, 2001; Chou et al., 2004; Weyman 
and Scherrer-Crosbie, 2004; Hayek et al., 2005). 
The symptoms of MVP include late systolic murmurs, mid-systolic clicks, fatigue, 
palpitations, atypical chest pain (nonretrosternal), dyspnoea, dizziness, postural 
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orthostasis, syncope or presyncope, neuropsychiatric symptoms, infective 
endocarditic, severe mitral regurgitation needing surgical intervention, heart failure, 
cerebral and coronary embolic events, arrhythmias and even sudden death 
(Stefanadis and Toutouzas, 2000; Hayek and Griffin, 2002). Another interesting 
feature of MVP is the established association between MVP and low blood pressure, 
high heart rate and increased levels of catecholamines. An increased level of 
catecholamines in normal individuals often leads to increased blood pressure through 
stimulation of !1 receptors. Stimulation of !2 postsynaptic receptors nevertheless 
causes an arteriolar vasodilatation and could lower the blood pressure. Additionally, 
in the patients with MVP it has been shown that while !2 receptors show an 
exaggerated response to the agonist isoprotrenelol causing more blood pressure drop, 
treating the patients with a non-selective ! blocker such as propranolol results in an 
increase in blood pressure. It seems that supercoupling and preponderance of !2 
receptor are responsible for this phenomenon observed in MVP patients (da Silva et 
al., 2007). No similar study has so far carried out in affected dogs to see whether 
there is a corresponding alteration in the receptors. 
The large numbers of the studies on mitral valve prolapse have also included the 
psychiatric studies. The similarities of some of the clinical symptoms of MVP to 
those of panic disorder, such as palpitation, chest pain and fatigue, have probably 
been the main driving forces behind this. So far, several studies have been carried 
out. Nevertheless, they have produced very different results that have failed to 
establish any strong association between these two conditions. Differences in the 
methodological approaches and biased sampling might explain the discrepancies in 
28 
 
the results. Moreover, even if there is a association between the panic disorder and 
MVP, it appears that the connection is weak and non-specific and is comparable to 
those of seen in generalised anxiety disorder and social phobia (Filho et al., 2008). 
However, more than half the people with MVP might be asymptomatic during their 
life span (Jonkaitiene et al., 2005). In general, when there is no apparent sign, no 
treatment is suggested. However, symptomatic patients might receive a range of 
medications, including anxiolytics, antibiotic prophylaxis, beta blockers, calcium 
channel blockers, and antiarrhythmic agents (Scordo, 2005). Surgical intervention 
might also be needed in patients with MVP in whom the disease progresses towards 
severe valve regurgitation. It is estimated that 85,000 heart valve replacement 
operations are performed annually in the USA, and 275,000 worldwide, of which 
mitral valve procedures accounts for the majority of them (Schoen, 2005; Schoen and 
Levy, 2005). 
Aetiopathogenesis of MMVD (MVP) 
MMVD or mitral valve prolapse in dog is also likely to be the result of a variety of 
causes, and in that respect bear some similarities with the human condition and 
allowing careful extrapolation of existing data between these two conditions may 
prove useful (Pedersen and Häggstrom, 2000). What the exact relationship is 
between MVP and MMVD in both humans and dogs is not clearly understood, and 
while the conditions may be one and the same, this might also not be the case. 
Overall, little is known about the underlying cause of MVP and MMVD. For the 
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purpose of this thesis MMVD and MVP will be presumed to be part of the same 
disease process. 
The response to injury theory for MMVD is one that suggests changes are due to the 
effects of continuous impact on the leaflets. During a normal lifespan of a dog the 
mitral leaflets open and close more than 1 billion times. Every time, they must 
withstand the pressure of contractions and of the blood itself. However, there must be 
some other contributory factors explaining why the condition occurs in some breeds 
more than others. The fact that certain breeds, like the cavalier King Charles spaniel 
have the propensity to develop the disease suggests that the condition has a 
hereditary component. In small breeds, MMVD is thought to be a polygenic 
threshold trait. In due course, with full characterisation of the canine genome, we 
may be able to identify a series of genes, which are responsible for MMVD 
(Kittleson, 1998), but one consideration is that differences in cardiac geometry 
between breeds might also support the response to injury theory, and this question 
may be answered with the development of 3-D echocardiography. 
The endothelium of the leaflets has also been suggested to have a role in initiating 
the series of events that lead to progression and aggravation of the disease. It has 
been shown that the damaged endothelium is responsible for the production and 
secretion of a number of mediators such as endothelin-1 (Mow and Pedersen, 1999). 
Endothelin-1 (composed of three similar 21 amino acid polypeptides) is known 
originally to be a pressor and vasoconstrictor in the cardiopulmonary system, but is 
also a mitogen that promotes the proliferation of smooth muscle cells and fibroblasts. 
In addition, an increase of collagen production and, conversely, the breakdown of 
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collagen are triggered by endothelin-1. The biological functions of endothelin-1 are 
mediated through two cell surface receptors ETA (mainly in vascular smooth 
muscle) and ETB (mainly in endothelial cells). Following binding to the receptor, the 
signal is transduced by a series of second messengers, including Ca2+, 1,2-
diacylglycerol (DAG), inositol triphosphate (IP3), cyclic adenosine 3$,5$-
monophosphate (cAMP) and arachidonic acid. The synthesis of collagen occurs 
when the protein kinase C becomes active. Apart from these effects of endothelin-1, 
it has recently been shown that it also reduces the expression of a tissue inhibitor of 
matrix metalloproteinase-1 (TIMP-1) and induces matrix metalloproteinase-2 (MMP-
2). This might lead to degradation of extracellular matrix (ECM) and collagen. 
Besides, endothelin-1 is capable of modulating the release of cytokines such as 
tumour growth factor !1 (TGF- !1), tumour necrosis factor # (TNF- #), platelet-
derived growth factor (PDGF) and basic fibroblast growth factor (bFGF) (Droge, 
2002; Khatib et al., 2002; Horstmeyer et al., 2005; Mishra et al., 2006). Mow and 
Pedersen have demonstrated that there is a significant correlation between the density 
of endothelin-1 receptor and the severity of MMVD in dogs (Mow and Pedersen, 
1999). Although the endothelin-1 receptor antagonists contradict the effect of 
endothelin-1, extensive clinical trials are needed to prove their efficacy in preventing 
or treatment of MMVD (Corcoran et al., 2004). 
Nitric oxide (NO), its regulatory balance with endothelin and its extracellular matrix 
functions have been the subject of many recent studies. Nitric oxide is produced from 
L-arginine in the presence of NADPH and O2 (Figure 1.5). This reaction is catalyzed 
by nitric oxide synthase (NOS). Nitric oxide synthase is found in three forms, 
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neuronal (nNOS, type I), inducible (iNOS, type II) and endothelial (eNOS, type III). 
While two of these enzymes, namely nNOS and eNOS are constitutively expressed 
in mammalian cells and the increase of calcium levels is responsible for their 
activation, iNOS is expressed in immunologically active cells and works 
independently of the calcium levels (Myers and Tanner, 1998; Droge, 2002). 
Moreover, eNOS has the unique feature of increasing production of NO in response 
to sheer stress. This can have a significant importance in MMVD where abnormal 
closure of mitral valve places an extra strain on the leaflets. Although the synthesis 
of NO is stimulated by endothelin, NO per se inhibits the synthesis and effects of 
endothelin (Stricklett et al., 2005). By measuring NADPH diaphorase, it has been 
shown that there is a strong correlation between NOS expression and mitral leaflets 
affected with myxomatous degeneration that even corresponds to the severity of the 
disease (Olsen et al., 2003b). Apart from its interaction with endothelin in 
extracellular matrix, NO triggers some direct effects on collagen via a paracrine 
mechanism. Inhibition of NO production in a co-culture system (porcine coronary 
endothelium + vascular smooth muscle cells) has caused an increase in collagen, 




Figure 1.5: Nitric oxide synthase produces NO from L-arginine in the presence of NADPH 
and O2 (diagram courtesy of Phil Dash, St George’s, University of London). 
Neuroendocrine abnormalities also occur in MMVD and may play a role in the 
aetiopathogenesis of the disease. Of these, norepinephrine and epinephrine system 
and renin-aldosterone regulation abnormalities have been extensively investigated. In 
one study, a higher plasma rennin activity (PRA) and a lower plasma aldosterone 
concentration (PAC) were found in murmur-free cavalier King Charles spaniel dogs, 
but not in an age and sex-matched control group (Pedersen et al., 1995). In another 
study in men, it was shown that there was a significant increase in PRA in patients 
with MVP after upright activity, compared to supine, and also compared to controls. 
However, the concentration of aldosterone was considerably increased in the control 
group after upright activity while it remained unchanged in patients with MVP 
(Zdrojewski et al., 1995). In this connection, Pedersen has shown that although there 
is no strong association between PRA and mitral regurgitation in dogs, a significant 
correlation exists between increased renin release and the severity of mitral valve 
prolapse (Pedersen et al., 1998).  It should be noted that an increase in renin release 
largely corresponds with the sympathetic activity in patients with mitral valve 
prolapse. It is also well recognised that any depletion of blood volume which reduces 
the ventricular volume can lead to ventricular-valvular disproportion causing more 
stress on the leaflets. Whatever the cause of activation of the sympathetic system, a 
sustained sympathetic activity leads to various adverse consequences, including 
apoptosis and matrix remodelling. These in turn might have a deleterious effect on 
the diseased mitral valve (Tallaj et al., 2003). In this respect, the impact of the rich 
innervations of mitral valves is worth taking into account. A recent study shows that 
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mitral valve action is not merely a mechanical response involving opening and 
closing in response to the pressure of blood. Rather, there is a profuse network of 
motor and sensory nerves. Calcitonin gene-related peptide (CGRP), norepinephrine 
(NE), neuropeptide Y (NPY) and some contributions from postganglionic autonomic 
nerves are just a part of the dense innervations of mitral valve (Williams and Jew, 
2004). However, recent work from our group has shown a decrease in valve 
innervation with age but no change associated with MMVD (according to Geoff 
Culshaw, personal communication, November 6, 2008). 
 
Pathology and histopathology  
Whatever the underlying cause might be there is a clear pattern of change to the 
leaflet morphology which by itself contributes to the leaflets mechanical failure. The 
following section will concentrate mainly on the complexity of collagen synthesis 
and production (see later) as investigation of changes in the biology of collagen will 
be the main theme of the thesis.  
Microscopically and macroscopically, there are similarities in the pathology of 
myxomatous mitral valve disease in dogs and primary human mitral valve prolapse. 
In the dog the disease begins with the appearance of small and discrete nodules at the 
free margins of the leaflets. As the disease progress these small nodules coalesce, 
forming bigger nodules. The affected areas, in contrast with other regions, are thick, 
and opaque, but there is no sign of inflammation of any kind. In 30% of cases the 
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tricuspid valve is also involved. Some studies suggest that leaflets start to shrink, but 
the evidence is the leaflets begin to enlarge in size. However, these can easily be 
overlooked, since they mostly present themselves as interchordal hooding (rolled up 
edges). The concept of shrunken leaflets may derive from the fact that the 
compensatory enlargement of the left heart makes the leaflets appears relatively 
small. Nevertheless, in the very advanced stages of the disease some shrinkage due to 
secondary fibrosis might occur. In MMVD, when the valves become incompetent, it 
is not because the so-called shrunken leaflets cannot span the annulus but rather 
because redundant leaflets cannot coapt properly. 
Grossly, on the basis of the Whitney classification (Whitney, 1974), myxomatous 
valves can be categorized into three grades. In grade I there are very small and 
separate nodules along the leaflet edges. The presence of larger nodules, 
accompanied with irregular and more thickened areas on the free edges, is seen in 
grade II disease. Grade III is recognised as considerable thickening in the entire 
leaflet, dilatation of the mitral annulus and redundant and flail leaflets. However, it is 
not possible to judge the extent of the disease solely on the basis of the thickening of 
the leaflets, since a degree of thickening might be a normal phenomenon both in 
humans and dogs as they age.  A gross pathological assessment is necessary when a 
heart is dissected and before detachment of the mitral valve from its surrounding 
tissues. In addition to the mitral valve changes, other changes, including  rupture of 
the chordae , dilation of the left atrium, eccentric hypertrophy of the left ventricle, 
atrial jet lesions and a full thickness tear of the atrium or ventricle might also be 
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present (Kittleson, 1998; Schoen, 1999;Van Vleet and Ferrans, 2001; Häggstrom et 
al.,  2005). 
Histopathological studies of MMVD have shown that changes to the endothelium on 
the atrial side of the leaflets are one of the first changes that occur. Subsequently, the 
size of the spongiosa layer increases noticeably. Valve interstitial cells have been 
shown to trans-differentiate from quiescent fibroblasts to activated myofibroblasts 
and trans-locate towards the damaged the endothelium (Disatian et al., 2008; Han et 
al., 2008,) and production of extracellular matrix intensifies, mainly composed of 
proteoglycans. Proteoglycans are macromolecules of glycosaminoglycans (GAGs) 
covalently bound to a core protein. Proteoglycans and hyaluronate tend to associate 
with water molecules, so occupy large volumes, called domains. Proteoglycans 
filaments, except in bone, run orthogonal to the collagen fibrils with a separation 
interval about 60 nm. In bone their orientation is in between or mostly in parallel 
with collagen fibrils. It has been suggested that they often bind to collagen fibrils 
through the gap regions of collagen molecules. Therefore, it seems that by the 
interaction with collagen they could determine the fibrils layout, forming cross-links, 
and affecting mechanical properties and fibrils diameters. Proteoglycans have also 
been suggested to down-regulate the collagen fibrillogenesis (Weber et al., 1996; 
Raspanti et al., 2008). The type of proteoglycans is also important in determining the 
extracellular matrix structure. For example, dermatan sulphate (DS) is found in those 
tissues with a plentiful oxygen supply while keratin sulphate is a substitute for the 
connective tissues where there is less oxygen supply (Scott, 1991). It is not clear 
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whether a change in oxygen could actually switch the synthesis of one type PG to 
another. 
While the total elastin content of affected leaflets increases, there are some signs of 
fragmentation in elastin fibres, which bear some similarities to that of digestion 
processes mediated by elastase. Nevertheless, no cellular source of elastase has yet 
been found in leaflets. It has also been suggested that the increased amount of elastin 
is the result of production by either abnormal or immature elastin (Whittaker et al., 
1987; Kittleson, 1998; Tamura et al., 1995; Akhtar et al., 1999; Grande-Allen et al., 
2004). What is interesting about elastin is its high tensile strength compared to 
collagen and so it could contribute more per unit weight to the valves mechanical 
integrity.  
Overall, the changes in the fibrosa (collagen mainly) are characterised by a thinning 
and degenerative processes. Under the microscope, collagen bundles appear 
disrupted, swirled, fragmented and attenuated. As the disease progresses and 
especially when it leads to congestive heart failure (CHF), fibrosis in the leaflets, at 
least in human, becomes apparent which might be an adaptational response to the 
growing stress on the leaflets (Grande-Allen et al., 2005). 
Although of the pathology the disease in dog and human bear close resemblance to 
each other, one major difference is the development of bacterial endocarditis in 
humans. In elderly male patients bacterial endocarditis is a common complication of 
MVP and is found in surgical intervention for mitral regurgitation in 10% of patients, 
but is rarely identified in canine patients (Agozzino, 1992). 
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Collagen biosynthesis  
Collagens are a major protein of all vertebrates, accounting for 30% of the proteins in 
mammals. At least, 30 distinct types of polypeptides are implicated in producing 
about 27 different types of collagen. However, here only fibrillar collagen (types I, 
II, III, V and XI) will be discussed. The following is a brief account of fibrillar 
collagen biosynthesis and a more detailed review can be found elsewhere (Bornstein, 
1974; Kivirikko and Myllylä, 1984). All fibrillar collagens are all about 300nm in 
length. They are formed from three separate polypeptides, called alpha chains, each a 
left-handed helix. The whole molecule itself, however, is a right-handed superhelix. 
This triplet structure could be homotrimeric or heterotrimeric depending on the 
collagen type. The sequence of amino acids in each chain is a regular repeating of a 
tripeptide, Glycine-X-Y where X is often proline and Y is often 4-hydroxyproline. 
Proline and hydroxyproline impart rigidity to the molecule whereas glycine, because 
of its small size, plays an important role at points where three chains are in close 
contact with each other. Collagen type I is a major component of fibrils in tendon, 
skin, bone and mitral valve, whereas in cartilage the collagen is mostly made of type 
II. Collagen fibrils may also be hetrotypic if they contain different types of fibrillar 
collagen. For example, collagen type III is also found in collagen fibrils in mitral 
valve alongside collagen type I. This is also true for type II and XI collagen in the 
cartilage. Collagen fibrils can also differ in length at various stages of their 
development, ranging from 20 nm to 500 nm, exceeding the size of the fibroblasts 
from which they have been secreted. Small-diameter collagen fibrils are found in a 




Collagen biosynthesis takes place in several stages, and though it resembles other 
proteins, some co-translational and post-translational modifications are unique to 
collagen. As different tissues express different # chains molecules, it appears that 
they have various genes for these chains. The locations of some of these genes have 
already been determined. For example, in humans, genes for #1 (I), #2 (I) and #1 
(III) are located on chromosome 17, 7 and 2, respectively (Huerre et al., 1982). The 
size of these genes is ten times bigger than corresponding translated mRNAs, 
because the coding information is located in more than 50 exons (varying between 51 
and 54 in fibril forming collagen), which intermittently are interrupted by introns 
(non-coding regions). While the exons sizes are homologous in these genes, the sizes 
of the introns vary widely. The structures of these complex genes have been 
categorized into 3 groups namely: collagen helix, C-propeptide protein region and N-
propeptide protein region. The helical domain of collagen is composed of 44 exons 
(between exon number 6 and 49) each containing 54 bp (base pairs) coding for 6 
Gly-X-Y repeats. However, it is also possible to find exons with 45, 99, 108, and 162 
bp. The finding that most of the exons coding for helical regions have 54 bp suggests 
that current collagen genes are the result of the duplication or multiplication of an 
original single unit containing 54 bp. Each individual exon in the helical region of a 
given collagen gene begins with a codon for glycine and ends with a codon Y which 
would precede glycine residue of the next exon. The N and C terminals of the triple 
helix are coded by the junctional exons 6 and 49, respectively, which are also 
responsible for coding of the non-helical region of # chains and part of the 
propeptide. Possessing three different structural domains in one exon and not 
interrupted by any exons might be related to a specific functional attribute such as 
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procollagen protease activity which plays an essential part in collagen biosynthesis. 
The size of exons coding for the C-propeptide, namely part of exon 49 and (50-52) 
are much bigger compared to exons destined for triple helix and also very conserved 
compared to the exons responsible for coding N-propeptide (from exon 1 to part of 
exon 6). 
The mRNA for the pro # chain is produced in the same way as most other proteins in 
eukaryotes. The primary transcript mRNA is consisted of both exons and introns and 
is very large. This mRNA undergoes multiple steps of excision and splicing in order 
to produce a translatable cytoplasmic mRNA.  Like other secreted proteins, as 
collagen products are being synthesized on free ribosomes, the N-terminal signal 
sequence of the protein is recognized by signal recognition particle (SRP)  and the 
translation is paused until this complex binds to the SRP receptor on the endoplasmic 
reticulum (ER). This attachment causes the nascent polypeptide chain to cross the 
membrane, and translation resumes upon this attachment. As preprocollagen emerges 
into lumen of the RE, the signal peptide is removed enzymatically and the new 
molecule is called procollagen. 
Post-translational modification 
Hydroxyproline and hydroxylysine are almost exclusively found in collagen. Their 
formation is catalyzed in a series of post-translational events by the following three 
enzymes: peptidyl proline 4-hydroxlyase, peptidyl proline 3-hydroxlyase and 
peptidyl lysine hydroxlyase. All three enzymes are located in the cisternae of 
endoplasmic reticulum and hydroxylate proline and lysine on the nascent polypeptide 
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while it is growing on the ribosomes. However, hydroxylation continues even after 
the translation has been completed, until the formation of the triple helix prevents 
any further hydroxylation. These enzymes require Fe2+, 2-oxoglutarate, O2 and 
ascorbate for their proper biological activities. The minimum sequence requirements 
for peptidyl proline 4-hydroxlyase and peptidyl lysine hydroxlyase are -X-Pro-Gly-   
and    -X-Lys-Gly-, respectively. However, there are reports that both of the enzymes 
are also capable of acting upon some other triplets. Peptidyl proline 3-hydroxlyase 
would also need its own specific sequence for hydroxylation, which is -Pro-4Hyp-
Gly-. The function of 4-hydroxyproline is essential for the stability of the triple helix 
at physiological temperature and even for the stability of a given collagen molecule 
at 37ºC, the complete hydroxylation of Y in Gly-X-Y is necessary. However, the 
exact role of 3-hydroxyproline remains unknown. The extent of methyl 
hydroxylation varies in terms of different species and it seems the animals that do 
live at lower temperatures (for example, Arctic fish) show the lower degrees of 
methyl hydroxylation. Nonetheless, the 50% of proline in fibril forming collagens is 
4-hydroxylated. Two functions have been demonstrated so far for hydroxylysine. 
Firstly, it serves as a site for the attachment of carbohydrate units and, secondly, it is 
essential for intermolecular cross-links. The extent of hydroxylation of lysine varies 
between different tissues and types of collagen.  The importance of peptidyl lysine 
hydroxlyase is very well documented in a variant of Ehlers-Danlos syndrome, in 
which the affected people have a genetic deficiency of the enzyme leading to 
malfunction of certain connective tissues. 
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Although the catalytic action of peptidyl proline 4-hydroxlyase and peptidyl lysine 
hydroxlyase is similar, their primary sequences and subunit structure show 
considerable differences. Peptidyl proline 4-hydroxlyase is a tetramer comprised of 
two # and two ! subunits, both of which are necessary for the enzyme activity. On 
the other hand, peptidyl lysine hydroxlyase is a dimer consisting of only one type 
subunit. 
Glycosylation of hydroxylysine residues 
The addition of carbohydrates to hydroxylysine residues is catalyzed by two specific 
enzymes. Peptidyl hydroxylysine galactosyltransferase (GT) is responsible for 
adding galactose from UDP-galactose to certain hydroxylysine residues. 
Subsequently, the transfer of glucose from UDP-glucose to galactosylhydroxylsine is 
catalyzed by peptidyl galactosylhydroxylsine glucosyltransferase (GGT). The free %-
amino group of hydroxylysine has been shown to play a very important role in 
carbohydrate transfer in both enzymes, as N-acetylation or deamination completely 
inhibits the reactions. In addition, it seems that the longer the polypeptide chain is, 
the greater the tendency for the efficient interaction with the enzymes. Furthermore, 
the two glycosylation events are also affected by the amino acid sequence of the 
peptide. The number of -X-Hyl-Gly- sequences in the nascent collagen polypeptide 
has been recognised as a determinant factor in the degree of carbohydrate attachment 
to hydroxylysine residues, whereas the amino acid sequence in the proximity of 
hydroxylysine does not seem to have a very important role in this process. As 
mentioned before the carbohydrate donor for the glycosylation is UDP (uridine 
diphosphate) and both reactions need a bivalent cation, preferably Mn2+ for catalytic 
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action. Nonetheless, it has been shown that Fe2+ and Co2+ could also activate GTT in 
a low concentration, though in higher concentration, they display an inhibitory 
function (Myllylä et al., 1979). Corresponding information for GT is not still 
available though several other cations are documented to inhibit both transferases.  






Figure 1.6: Before binding to UDP-glucose, GGT binds successively to two Mn2+ and as the 
dissociation constant for Mn2+ for second site in vivo situation is high, it is not firmly bound to 
the enzyme so has not been shown above. During each catalytic cycle Mn2+ often does bind 
not the enzyme. GGT: galactosylhydroxylysyl glucosyltransferase; UDPglc: UDP-glucose; 
Glc-pept: glucosylated peptide (Kivirikko and Myllylä, 1984). 
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Only carbohydrate attachment to mammalian mature collagen exists either as 
monosaccharide galactose or as disaccharide glucosylgalactose. Like hydroxylation, 
the glycosylation occurs while the polypeptide chain is being translated and 
continues after the complete pro # chain is released, until before it is hindered by the 
formation of triple helix. The precise function of combined hydroxylysine and 
carbohydrate has not been completely resolved. However, it is thought that they have 
the following functions: 
1.  As they constitute quite large molecules on the collagen molecules, they 
might influence the biological properties of collagen by altering the lateral 
packing of molecules within fibrils (Grynpas et al., 1980).  
2.  The sensitivity of collagen molecules to mammalian collagenases might be 
affected by the extent of glycosylation. 
3.  In some collagen molecules such as type IV, these hydroxylysine-linked 
carbohydrates might serve as an attachment site for some cells. 
Glycosylation of asparagine residues in propeptide  
Unlike collagen molecules, the propeptides of procollagen molecules have 
asparagine-linked carbohydrates which, in the case of procollagen types I and III, are 
almost always found in the C-terminal of the propeptide, whereas in procollagen type 
II both ends of the propeptide, including the N-terminal, is known to contain the 
same asparagine-linked carbohydrate. As most other proteins, the asparagine linked 
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carbohydrate is first synthesized on a lipid carrier. Then, the preformed 
oligosaccharide is transported to a conserved sequence of -Asn-X-Ser/Thr in a 
nascent polypeptide chain to attach to asparagine residue. In the case of human pro 
#1(I) and pro #2(I) chains and chick’s pro #2(I) and pro #1(III), this sequence is -
Asn-Ile-Thr while in chick’s pro #1(I) this sequence is -Asn-Val-Thr. The transfer 
occurs in the lumen of the ER and is catalyzed by an enzyme called oligosaccharyl 
transferase. Following the transfer, the oligosaccharide undergoes some further 
changes and additional reactions occur, resulting in the production of mannose-rich 
complex oligosaccharide structures.  
The function of the asparagine-linked carbohydrates remains unknown. There have 
been suggestions that these mannose oligosaccharides play a role in normal secretion 
of procollagen from the cell. There are also reports that the clearance of C-propeptide 
from the circulation by liver endothelial cells is mediated through mannose-receptor 
endocytosis (Nelson and Cox, 2005; Sellaro, 2003). 
Procollagen assembly and helix formation  
The propeptides of procollagen contain both interchain and intrachain disulfide 
bonds. While interchain bonds in type I and type II procollagen are only found 
between C-terminal propeptides, in type III procollagen, both N- and C-terminals of 
the propeptides are attached by disulphide bonds. In a complete type III collagen 
molecule, two interchain disulfide bonds are also found in the C-terminal of the triple 
helix. Regarding the interchain disulphide bonds, it seems that they are not formed 
until the translation completes or in other words the polypeptide is released from 
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ribosomes. Formation of these bonds starts while procollagen molecules approach 
together in a process called “registration” which plays a role in proper alignment of 
the molecule (Murray et al., 2000; Diegelmann, 2001).  It has been shown that 
preventing formation of triple helix does not have any effect on the formation of 
interchain C-terminal disulphide bonds in the propeptide. However, the inhibition of 
formation of triple helix would prevent the formation of interchain N-terminal 
disulphide bonds. This clearly indicates that interchain disulphide bonds in the C-
terminal of the propeptide are synthesized earlier than those of N-terminal bonds. 
Additionally, the formation of a triple helix is a requirement for the latter. Protein 
Disulphide Isomerase (PDI) is an enzyme responsible for catalyzing disulphide 
bonds in vivo. Interestingly, PDI itself is the ! subunit of peptidyl proline 4-
hydroxlyase enzyme. However, the role of PDI in peptidyl proline 4-hydroxlyase is 
not related to its isomerase activity. It seems that PDI functions to keep the insoluble 
# subunits in proline 4-hydroxylase in the catalytical and non-aggregated state. Two 
conditions are required for in vivo triple helix formation, namely the complete 4-
hydroxylation of the Y position in the Gly-X-Y sequence and the formation of 
interchain disulphide bonds in the C-terminal of the propeptide. However, cis-trans 
isomerisation of the prolyl peptide bond poses an important rate-limiting step in 
triple helix formation. It has been documented that this isomerisation process is 
facilitated by enzymes with peptidyl prolyl cis-trans isomerase (PPI) activity. In 
vitro studies have shown that the drug cyclosporine A, by inhibiting PPI, slows down 
the folding of procollagen I and III in cultured human fibroblasts. The triple helix of 
procollagen of fibrillar collagen folds from C-terminal to N-terminal at a rate which 
is consistent with cis-trans isomerisation of prolyl peptide bonds. The main task for 
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interchain disulphide bonds in terms of procollagen folding has been demonstrated 
by virtue of fast formation of triple helix in type I and II procollagen, compared to 
the lengthy process in type  IV procollagen which lacks these interchain disulphide 
binding) and type V procollagen (which only some chains are connected by disulfide 
bonds) formation. The presence of these disulphide bonds might account for up to 
one hour difference in folding time in different types of procollagens. 
Another quality control mechanism which ensures that only the properly folded 
procollagen molecules are secreted is the peptidyl proline 4-hydroxlyase enzyme. It 
has been shown that the peptidyl proline 4-hydroxlyase enzyme interacts 
continuously with collagen chains in the presence of enzyme inhibitors. In one study, 
peptidyl proline 4-hydroxlyase was inhibited by #, #$-dipyridyl, and it was observed 
that peptidyl proline 4-hydroxlyase formed a stable bond with un-hydroxylated and 
non-helical pro #1 (III) chains. Additionally, upon the removing of the inhibition (by 
the addition of excess iron) hydroxylation and helix formation resumed. 
Interestingly, a low affinity of peptidyl proline 4-hydroxlyase for substrate is seen 
when collagen is fully hydroxylated or helix structure is achieved. This characteristic 
of peptidyl proline 4-hydroxlyase enables it to retain malformed or immature 
collagen. For example, in an osteogenesis imperfecta (OI) patient with a 180 deleted 
amino acids in triple helix, complete intracellular retention of mutant molecules has 
been reported. These molecules then could be digested by a mixture of enzymes such 
as trypsin and chymotrypsin. 
BiP (Binding Protein) is a 78 kD-ER resident enzyme, which was originally 
identified as the immunoglobulin heavy chain binding protein or glucose regulated 
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protein (Grp 78). It is constitutively synthesised inside cells and is presumed to have 
a general role in the assembly of newly synthesised polypeptides, including collagen. 
It often recognizes the unfolded polypeptides and by preventing them from inter- and 
intra-chain aggregation, prepares them for proper folding. However, it has been 
shown that its production is increased in the presence of mis-folded and under-
glycosylated polypeptide. Moreover, it is further induced under stress conditions, 
which often leads to the accumulation of intracellular incorrectly folded proteins. As 
some studies have shown, BiP could only act on the C-terminal propeptide of  
procollagen and in normal conditions, transiently binds to it. Nonetheless, in the case 
of some abnormalities in the C-terminal propeptide of procollagen, BiP binds stably 
to this part of polypeptide and subsequent assembly of procollagen is slowed or 
completely blocked (Gething, 1999; Koide and Nagata, 2005) 
HSP47 (or colligin) is a collagen specific binding molecule with 47 kDa molecular 
weight, which is classified as a heat shock protein. It has been shown that, following 
exposure of chicken embryo fibroblasts to 45° C, there is a 10 fold increase of the 
HSP47 transcription. Nevertheless, normal transcription is resumed very quickly if 
the temperature returns to 37°C. The protein is primary a resident of the ER of 
vertebrates. The cDNAs for HSP47 have been cloned for human, rat, mouse and 
chicken. HSP47 bears some resemblance to the serpin family of serine proteinase 
inhibitors though in in vitro assays it does not show any proteinase activity. The 
expression of HSP47 is closely linked to that of collagen and some in vitro studies 
have shown that HSP47 cannot display any binding distinction between unfolded 
chains and mature folded collagen molecules. However, the binding is pH dependent 
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and stops below pH 6.3, due to conformational changes. The specific sequence, 
which is recognised by HSP47, has not been fully identified. Some researchers have 
suggested that HSP47 recognises the amino acid sequence of -Arg-Gly-Asp- 
(RGDs). However, it seems that other determinants must be involved as HSP47 only 
recognises collagen RGDs motifs and does not recognise RGDs sequences found in 
other molecules such as fibronectin (Nagata, 2003; Koide and Nagata, 2005). 
HSP47 binds to the polypeptide chain as translation starts and this binding continues 
through the chain association and triple helix folding. It disassociates itself from the 
triple helix only when the triple helix enters the Golgi. There are some possible roles 
for HSP47. Firstly, after triple helix formation occurs in the ER, it might still need 
some more modification, but at this stage other chaperones are no longer able to 
recognise the polypeptide. Thus, continuous binding to HSP47 would ensure that this 
modification will happen. Secondly, binding of HSP47 to the polypeptide protects 
the newly synthesised triple helix from intracellular degradation that might otherwise 
take place as a result of prolonged retention in the ER, resulting in a haphazard 
aggregation of polypeptide. Ishida et al. (2006) recently demonstrated that Hsp47-/- 
fibroblasts produced low levels of type I collagen, which was very thin and 
frequently branched. They also showed that this low production was due to the 
accumulation of indiscriminate aggregate of new synthesized polypeptide in ER in 
the absence HSP47. Thirdly, by covering the reactive groups that are responsible for 
assembling higher order structures of collagen, HSP47 could guarantee that this does 
not happen inside the ER. A final suggested role for HSP47 is that this protein 
provides thermal stability for helical region of procollagen. Thus, by binding to the 
50 
 
helix, HSP47 ensures that thermal disturbances such as heat shocks do not micro-
unfold the helix. After the successful formation of fully hydroxylated triple helix, the 
procollagen-HSP47 complex is transported to the cis-Golgi or the ER-Golgi 
intermediate compartment (ERGIC) via vesicle transport. 
The disassociation of HSP47 from procollagen might be caused through a pH 
change. In vitro disassociation occurs below pH 6.3 and the low pH of in the Golgi 
apparatus (estimated 5.7) may therefore result in disassociation. However, to validate 
this mechanism, the exact pH inside of Golgi apparatus should be confirmed. The 
procollagen triple helices then form some lateral bundles through a mechanism called 
“cisternae maturation” (Bonfanti et al., 1998). Interestingly, the lateral bundling of 
type one procollagen is inhibited in the presence HSP47, suggesting the contrary 
function of HSP47 and necessity of its absence inside Golgi apparatus. Figure 1.7 




Figure 1.7: HSP47 of action in vivo: Normal cell (left) and HSP47-knockout cell (right). In the 




Procollagen trafficking from the ER to the Golgi 
The newly synthesized proteins destined for secretion are transported from the ER to 
the cis face of Golgi. They exit fully processed from the trans face of Golgi and then 
are carried towards plasma membrane (PM). However, the mechanism involved in 
this transportation has been the centre of heated debate for about 40 years. It is 
generally accepted that the route from the ER towards the Golgi involves budding of 
vesicles 60-80 nm of diameter from the ER membrane. The vesicles are coated with 
a special molecule called COPII (coat protein complex II). COPII is made of 5 
different proteins and is thought to play an important role in the structure of the 
vesicles. Moreover, it has been shown that different populations of COPII provide 
specific determinants for different protein cargos. COPI is another protein which 
facilitates the retrograde transport of ER-resident proteins back to the ER. In 
addition, it also plays a role in later stages of protein transportation (see below). 
Newly synthesized procollagen proteins are about 300 nm long and are rather rigid, 
so the conventional 60-80 nm vesicles are unable to contain these molecules. Further 
research has demonstrated that procollagen molecules exit the ER in a saccular 
structure called VTC (vesicular tubular cluster) which, interestingly, lacks COPII. 
However, the process of exit is yet again COPII dependent and COPII is found in the 
proximity of procollagen exit site. It is thought that COPII might be necessary for 
increasing the concentration of procollagen or other unknown factors near to the exit 
site. VTCs move along microtubules towards Golgi apparatus and in later stages 
might be also called the ERGIC (the ER-Golgi intermediate compartment). In 
addition, it has been shown that in the same later stages there is a close association 
between ERGIC and COPI. 
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Upon reaching the Golgi, procollagen molecules start to undergo some post-
translational modification. For example, the processing of N-linked oligosaccharides 
in the Golgi is very well recognised. Nonetheless, the process of traversing of 
molecules from cis to trans cisternae while they are being modified is rather 
controversial. The conventional approach considers the Golgi as a structure with 
different cisternae layers and the proteins are transported between these layers via the 
“vesicle shuttle model”, which involves budding off from one layer and merging 
with another layer. The second approach, which is also called the “cisternae 
maturation model” and is favoured for procollagen transport, suggests that proteins 
move across the layers of the Golgi layers without even leaving the lumen of the 
Golgi apparatus (Bonfanti et al., 1998). In this model, after receiving of the given 
protein, cis-cisternae transform into medial-cisternae and subsequently into trans-
cisternae (Figure 1.8). The role of COPI vesicles lies at the heart of the controversy. 
The former model suggests that these type of vesicles are in involved both in 
anterograde (forward) and retrograde movement of proteins and Golgi-resident 
enzymes, respectively. In the latter model, COPI is not necessary for anterograde 
trafficking of proteins and it has been shown in yeast that some protein could be 




Figure 1.8: Two suggested routes of protein transport in the Golgi: (a) “cisternae maturation 
model”, in which destined proteins never leave the lumen of the Golgi and (b) “vesicle 
shuttle”, in which anterograde movement happens via vesicles. It seems that collagen 
traverses using the cisternae maturation model (Malhotra and Mayor, 2006). 
Furthermore, two other intermediate models have also been proposed. The first one, 
the “hybrid model” suggests a possible combination of vesicular transport and 
cisternae maturation and the second one, the “intersectional connection model”, 
proposes a theory of tubules which connect cisternae in the Golgi making it possible 
for forward and backward movement of cargo proteins and Golgi-resident enzyme. 
At the present time, a single working model, which is in agreement with all studies 
and explains the exact role for COPI coated vesicles, seems elusive. 
From the Golgi apparatus to secretion 
Proteins are finally committed to their different destinations in the trans Golgi, as a 
result of different carriers in various cells.  Using confocal and internal reflection 
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microscopy with fluorescently tagged proteins has proved that these carriers are 
heterogeneous in terms of their size and shape. Their transport is microtubule 
dependent. As with collagen, an electron microscopy study of fibroblasts has 
revealed some electron-dense vacuoles separating from trans Golgi. These vacuoles 
contain bundles of procollagen, and may be as large as 500 nm. At the early stage of 
deposition of connective tissue, the PM of fibroblasts become very convoluted and 
studies have shown that collagen fibrils are present in the recesses of convoluted PM 
and secreted through this structures (Birk and Trelstad, 1984; Ploetz et al., 1991). 
Producing a solution of collagen molecules using cold or weak acidic buffers, and 
subsequently warming and neutralizing the solutions, leads to the spontaneous self-
assembly of  collagen molecules into fibrils with the characteristic 67 nm axial D-
periodicity. However, these reconstituted fibrils show no preferred orientation. Canty 
et al. (2004) describe a novel protrusion in embryonic tendon as a fibril depositor or 
“fibripositors”. They further suggest that the conversion of procollagen to collagen 
molecules, and some degree of fibril formation, occur in vacuoles or GPCs (Golgi 
Plasma Membrane Carriers), while procollagen molecules are being transported for 
secretion. They have shown collagen fibrils as large as 28 nm in diameter inside 
GPCs. Moreover, the fibripositors always orient in along the tendon axis. This 
finding might establish a link between intracellular transport of collagen and the 
orientation of fibrils in the ECM. An interesting finding in this study was that they 
failed to see any fibripositors in the later stages of the life. It seems that they are only 
found for a narrow span of embryonic life and act as nucleolus for proper orientation 




An important step in the biosynthesis of collagen is the removal of N- and C-
propeptides from procollagen molecules by procollagen N- and C-proteinases, giving 
rise to a collagen molecule 3000 Å long and 15 Å thick that is able to self-assemble 
into a fibril (Nelson and Cox, 2005). This cleavage does not just happen outside of 
the cell, but as Canty et al. (2004) showed, it can also happen inside GPCs. This 
proves the theory that production and transport of these proteinases is concomitant 
with procollagen molecules. Perhaps the Lapiere et al. work (1971) is a vivid 
example of the importance of these enzymes, they showed that cattle fragile skin 
associated with dermatosparaxis was the result of a defect in the cleavage of N-
propeptide in the pro # chain of type I procollagen. Although Lapiere et al. (1971) 
proved the existence of this enzyme, they were unable to isolate it. However, later 
research led to the isolation and preparation of N-proteinase and showed that various 
types of the enzyme only act on certain types of intact procollagen molecules and 
cannot cleave the N-propeptide of heat-denatured procollagen. Furthermore, it has 
been shown that recognition of the native conformation of procollagen by this 
enzyme is a function of temperature, and is related to the thermal transition of the 
helix. For example, a difference of 2 or 3°C between the unfolding temperatures of 
human type I and chick embryo procollagen seems to play an important role in the 
activity of the N-proteinase.  It could also be said that this sensitivity to the substrate 
conformation acts as a checkpoint ensuring that all N-terminals have the correct 
conformation, therefore guaranteeing their later packing (Prockop et al., 1998). The 
members of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin 
57 
 
motifs) family, namely ADAMTS-2, ADAMTS-3 and ADAMTS-14, are responsible 
for N-proteinase activity.  
In terms of C-proteinase, the members of the tolloid family of zinc 
metalloproteinases including BMP-1 (bone morphogeneic protein 1), mammalian 
tolloid (mTLD) and tolloid like 1(TLL-1) are involved in cleaving of the C-
propeptides. Although it was said that the N-proteinase activity is important for 
proper packing of collagen, the C-proteinase activity is significant as a form of rate-
limiting step for fibrillogenesis, as it has been shown that the retained C-propeptides 
are never incorporated in fibril formation (Canty and Kadler, 2005; Ge et al., 2006). 
Furthermore, the cleavage of these propeptides from soluble procollagens (which is 
essential for intracellular trafficking) produces insoluble collagen molecules. Figure 




Figure 1.9: A simplified overview of production of collagen. Three procollagen ! chains 
approach together from their carboxy-terminal ends to form a trimer. The folding of these 
three chains continues towards the amino terminus before the formation of the triple helix. 
The cleavage of carboxy and amino-termini happens after the procollagen has been 
transported across the Golgi apparatus, thereby allowing their self-assembly into collagen 
fibrils (see the text for more detail) (Hendershot and Bulleid, 2000). 
Collagen suprastructure 
The self-assembly of collagen molecules into fibrils is an entropy driven 
phenomenon which also occurs in other proteins like microtubules and actin 
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filaments in order to reach a stable situation. During the assembly, solvent molecules 
are lost from the surface of the molecules minimizing the surface area/volume ratio 
of the final assembly and decreasing its free energy.  The molecules of collagen align 
parallel to each other, in quarter stagger pattern. If every molecule is considered to be 
4.4D long, then the stagger between adjacent molecules is 1D. The gap between the 
head of one and the tail of the next molecule is 0.6D. This structure makes a rope-
like pattern possessing repeats of gap and overlapping in which each repeat is 1D 
(between 64 and 67nm depending on the tissue) (Figure 1.10). Additionally this 
structure is responsible for the characteristic striation pattern observed under electron 
microscopy. 
Figure 1.10: Total length the collagen molecules is 300 nM or 4.4 D, where D is the length of 
striation. In the negative stained methods, dark and light patterns of the fibrils are 
representing the gap and overlapping areas (Modified from Millard, 2007).  
Another study (Holmes et al., 1992) has shown that the primary fibrils have a near 
paraboloidal pointed tip and a blunt end. The growth of the fibril occurs exclusively 
from the pointed end. However, as growth continues the blunt end becomes pointed 
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and growth then continues in the other direction as well. The final result is a fibril 
having two pointed tips with collagen molecules orientated with their N-termini 
towards either end of the fibril. Thus, these fibrils are N-N bipolar and it seems that a 
switch in molecular orientation occurs somewhere along the fibril (Figure 1.11) 
 
 
Figure 1.11:  Collagen molecules are forming fibrils in N-N bipolar manner where the both 
end of the fibrils end in N-termini. Although the growth of the fibrils only happens from N-
termini end. It seems that there is a switch area in the middle of the fibrils (Kadler et al., 
1996). 
 
However, this type of orientation seems not to be the case in all fibrils. For example, 
in 18-day chicken embryo about half of the early fibrils are bipolar and half are 
unipolar (polarity of the molecules is unchanged throughout the fibril) so the fibril 
posses both N- and C- termini. Fusion of these bipolar and unipolar fibrils is also 
matter of the scientific interest. Unipolar fibrils could fuse in a different way that is 
inconsistent with in-vivo and in-vitro studies. Two unipolar fibrils both possess the 
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orientation of N- to C- from left to right could fuse side-by-side or end-on-end in 
order to elongate or thicken the size of fibrils, respectively. Two oppositely 
orientated unipolar fibrils could also fuse end-on-end giving rise to a long bipolar 
fibril. However, the following scenarios are disallowed: The side-by-side fusion of 
two oppositely orientated unipolar fibrils and side-by-side or end-on-end fusion of 
two bipolar fibrils. The question remains, however, what would be the function for 
bipolar fibrils. One might suggest that they could play a role in controlling of 
diameter of collagen fibrils in certain tissues (Kadler et al., 1996).  
The collagen fibril formation in cell culture is dependent on the integration of 
fibronectin into the emerging fibrils. Fibronectin is a ubiquitous extracellular matrix 
protein secreted as a soluble dimer and then assembled into multimeric fibrils at the 
cell surface. An in vitro study has shown that directing an antibody to the collagen 
binding fragment of fibronectin would inhibit both the assembly of fibronectin and 
collagen. It has also been shown that certain integrin molecules do not just potentiate 
the action of fibronectin, but they also directly interact with collagen molecules. 
These studies demonstrate that fibril formation begins from the cell surface and in 
interaction with other molecules such as integrin and fibronectin in a way that 
assembly of collagen is almost downstream to that of fibronectin. Further 
investigation is needed to examine whether these events would exactly occur in-vivo. 
There are other molecules, which could bind to the collagen molecules and modulate 
the fibril diameter. In vitro studies have revealed that small leucine-rich repeat 
proteoglycans (SLRPs) such as decorin, fibromodulin and lumican have an effect on 
the diameter of collagen fibrils. Keene et al. (2000) have demonstrated that decorin 
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binds to the C-terminus of procollagen type I inducing a delayed fibril assembly and 
a subsequent reduction in the average fibril diameter, which is essential in some 
connective tissue, such as cornea to maintain its transparency. Unpublished proteome 
data have shown differential expression of several of these SLRPs in canine MMVD 
(according to Richard Han, personal communication, November 6, 2008). 
Cross-links and lysyl oxidase 
Both collagens and elastin proteins contain lysine or hydroxylysine-derived covalent 
cross-links. An enzyme that belongs to the family of lysyl oxidase enzymes is 
responsible for catalyzing these cross-links. The locations of these cross-links depend 
on the amino acid sequence and the quaternary structures, but they may also be quite 
flexible. Lysyl oxidase oxidatively de-aminates certain lysine and hydroxylysine 
residues leading to the corresponding #-aminoadipic-&-semialdehydes, usually 
referred to by allysine and hydroxyallysine (Figure 1.12). Thus, there could be two 
pathways in fibrillar collagen, namely allysine (lysine-derived aldehyde) and 
hydroxyallysine (hydroxylysine–derived aldehyde). The allysine pathway 
predominates in skin while hydroxyallysine is the dominant pathway in internal 
connective tissues like bone, cartilage, ligaments, and tendons, but much less 
frequent in the skin. However, this is not always true as rat–tail tendon, for example, 
contains allysine derived cross-links. Generally, hydroxyallysine pathway is 
abundant in the tissues that bear mechanical loads. 
When lysine- and hydroxylysine-derived aldehydes react with corresponding 
aldehydes on adjacent polypeptide chains or with intact lysine and hydroxylysine 
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residues initial condensation products form leading to bifunctional cross-links (cross-
links that connect two molecules of collagen together).  As these bifunctional cross-
links posses Schiff base double bonds (-N=CH-), they can be reduced by reagents 
like sodium borohydride (NaBH4). Furthermore, as these reducible collagen 
syntheses occur transiently in connective tissues, they are also called intermediate or 
immature cross-links. Of these, dehydrolysinonorleucine (reduced form: lysinonor-
leucine,LN), dehydrohydroxylysinonorleucine (reduced form: hydroxy-
lysinonorleucine, HLN), dehydrohydroxylysinohydroxynor-leucine (reduced form: 
dihydroxylysinonorleucine, DHLN) have been identified and studied extensively 
(Figure 1.13) (Saito et al., 1997).  
During the maturation of the tissue, the intermediate reducible divalent cross-links 
transform into tri-functional and even tetra-functional cross-links namely, 
hydroxylysyl pyridinoline (HP or pyridinoline Pyr), lysyl pyridinoline (LP or 
Deoxypyridinoline- D-Pyr) and histidine adducts. 
In the fibrillar collagens (types I and III), four cross-linking sites have been 
identified. Two sites occur toward the amino terminus, one in the telopeptide region, 
the other in the helical region. A second pair of sites occurs toward the carboxyl 
terminus, one in the helical region, and the other in the telopeptide region. However, 
the hydroxylation of lysine in telopeptide seems to be a very crucial step in 
determining which cross-links pathway the collagen molecules would follow. It 
appears the hydroxylation is regulated by an enzymatic system. The enzyme is 
known to be telopeptide lysyl hydroxylase (TLH). A direct involvement of this 
enzyme has been recently confirmed in a type of osteogenesis imperfecta called 
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Bruck syndrome. In this condition, a lack of hydroxyallysine-derived cross-links 
leads to the fragility of bone despite the presence of allysine-derived cross-links. This 
shows the different properties of mature cross-links in terms of rendering strength, 
flexibility and loading-bearing to various tissues. Different variants of TLH have 
been recognised and it seems that they are tissue-specific. Further investigation of the 
TLH may reveal different spectrum of cross-link patterns in various tissues. 
Lysyl oxidase (LO) belongs to a multi-gene family consisting of five members, 
namely LOX, LOXL, LOXL2, LOXL3 and LOXL4. However, in this family, lysyl 
oxidase is the enzyme that has been studied most intensively. Lysyl oxidase was 
initially detected in embryonic chick epiphyseal cartilage with elastin substrates 
prepared from 16-day chick embryo aortas labelled with [6-5H] lysine in organ 
culture in the presence of the lathyrogen, !-aminopropionitrile (!-APN) to inhibit 
aldehyde formation. From the time of its discovery in 1968 by Pinnel and Martin, 
plenty of work has been carried out in relation to specificity, purification, physical-
chemical properties, expression under different condition and catalytic mechanism. 
Originally, the investigation of this enzyme was hampered due to the enzyme 
insolubility and rapid aggregation of the enzyme. A major advance occurred when 
the enzyme was solubilised using buffers containing 4-6M urea. Full activity was 
recovered when the urea was removed. Lysyl oxidase has been now isolated from a 
range of different sources including, human, pig, avian, rodent and bovine. The 
approximate molecular weight of isolated enzymes is 32 kDa. In vitro studies of the 
translational product of lysyl oxidase have shown that the enzyme is synthesized as a 
pro-proenzyme product with a molecular weight of 46 kDa. Subsequent signal 
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peptide cleavage and N-glycosylation result in a 50 kDa proenzyme. The 50kDa 
proenzyme has been detected both in the cell medium and intracellular fraction. 
Procollagen C-proteinase, which can be inhibited by EDTA, then cleaves this 
proenzyme between Gly-168 and Asp-169 (human sequence) to produce a mature 
and non-glycosylated 32 kDa enzyme, ready to operate (Kagan, 1986; Mäki, 2002; 
Kagan and Li, 2003). It has also been found that other extra-cellular enzymes 
including talloid and talloid-like protease are able to cleave the 50kDa proenzyme to 
its active form at a lower efficiency. It is worth noting that procollagen C-proteinase 
and procollagen N-proteinase are also responsible for the removal of N- and C- 
procollagen peptide, respectively. This removal is essential for spontaneous 
aggregation of collagen molecules into mature microfibrils. Thus, procollagen C-
proteinase plays a dual role in collagen cross-links by producing a suitable collagen 
substrate for lysyl oxidase and also by converting lysyl oxidase proenzyme into a 




Figure 1.12: Lysyl oxidase oxidatively deaminates a peptidyl lysine to generate a peptidyl !-
aminoadipic-"-semialdehyde (allysine), which spontaneously reacts with corresponding 




Figure 1.13: A schematic overview of two major pathways in collagen cross-links, allysine 
and hydroxyallysine and their relevant subsequent reactions leading to bifunctional, 
trifuctional and tetrafunctional cross-links (Mäki, 2002). 
The previous section covered enzymatic cross-links. However, there is another type 
of cross-links called non-enzymatic glycation cross-links. Generally, non-enzymatic 
glycation or Maillard reaction occurs between reducing sugars and proteins. In this 
reaction the reducing sugars react with the free amino groups of proteins, leading to 
the production of unstable Schiff bases, which themselves then undergo an Amadori 
rearrangement producing stable fluorophore or chromophore compounds known 
collectively as advanced glycation end products (AGEs) (Figure 1.14). The 
formation of AGEs depends on the reactivity of specific amino groups, sugar 
concentration (glucose, fructose or dicarbonyl compounds) and the half-life of the 
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given protein. Over the time the concentration of AGEs increases not only because of 
the persistent glycation but also because of the reduced turn-over of protein 
associated with the aging. Thus, it seems that proteins with rather long half-life such 
as collagen and elastin are more vulnerable than others. The accumulation of the 
AGEs, over the time, has also been attributed to their resistant to proteolytic 
digestion (Wautier and Schmidt, 2004; Atanasova et al.,2008)  Increased production 
of these AGEs has also been studied in a variety of pathological conditions such as 
diabetes, atherosclerosis and neurodegenerative diseases (Monnier, 1989; Grillo and 
Colombatto, 2008; Monnier et al., 2008) . In the case of collagen, advanced 
glycation products derived from glycated lysine and hydroxylysine. In vitro studies 
show that fructose and pentose react much more rapidly with collagen than glucose 
(Reiser, 1998). These non-enzymatic cross-links lack the proper qualities of 
enzymatic cross-links and lead to functional impairment of the given tissue. Besides, 





Figure 1.14: Mechanism of formation of the advanced glycation end products (AGEs); 
pentosidine, carboxymethyllysine (CML) and methyl glyoxal-lysine (MOLD) (Schmid et al., 
2002). 
 
Catalytic properties and cofactors of lysyl oxidase 
LOX enzyme is categorized as an oxidation-reduction enzyme. Redox enzymes 
possess the capacity to remove electrons from atomic targets within the substrate 
(oxidation) and render it to a final acceptor of electrons (reduction) in order to restore 
the activity of the enzyme. Many enzymes use cofactors like nicotinamide adenine 
dinucleotide (NAD+) and flavin adenine mononucleotide (FMN) or dinucleotides 
(FADs) as electron sinks accepting the electrons that have been removed from the 
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substrates. However, some enzymes including LOX seem to have chosen another 
path. LOX possesses two almost unique cofactors: a tightly bound copper Cu (II) and 
a unique covalently-bound distinct cofactor known as lysine tyrosylquinone (LTQ) 
(Lucero and Kagan, 2006). The copper cofactor is bound in a tetragonally distorted, 
octahedrally coordinated ligand field (Gacheru et al. 1990). LTQ is catalysed in a 
newly synthesised LOX by firstly oxidation of a tyrosine residue (Tyr 349 in rat 
enzyme) by the help of a copper bound enzyme. This produces an intermediate 
product called peptidyl dihydroxypheyalanine quinone. This is followed by covalent 
addition of the quinone ring to the %-amino group of the lysine residue (Lys 314 in rat 
enzyme). The first stage in catalytic activity of the enzyme takes place when an %-
amino group of substrate lysine residue binds to one of the carbonyl groups of LTQ. 
The resulting Schiff base formation then undergoes rate-limiting general base-
facilitated abstraction, permitting the transfer of two electrons into LTO. This flow of 
electrons has now produced the reduced form of cofactor known as lysine tyrosyl 
aminoquinol. Hydrolysis of this intermediate imine leads to the formation of reactive 
aldehydes ready to form cross-links. After releasing the aldehydes, the molecular 
oxygen re-oxidizes the cofactor by the help of Cu (II), producing hydrogen peroxide 
and ammonia. Now the catalytic activity of the enzyme is complete and it is ready 




Figure 1.15: An overview of lysyl oxidase (LOX) catalytic activity (Lucero and Kagan, 2006). 
Inhibitors of LOX 
!-aminopropionitrile (!-APN) is a potent irreversible inhibitor of LOX. Its ability to 
inhibit formation of cross-links in collagen was recognized before the recognition of 
in-vitro activity of LOX enzyme itself. A disease called lathyrism can be induced 
experimentally if !-aminopropionitrile is administered to a growing animal. The 
disease is characterised by fragility of different connective tissues and an increased 
solubility of collagen fibrils, all due to failed cross-links. Other irreversible inhibitors 
of LOX are vicinal diamines like cis-1, 2-diaminocyclohexane and ethylenediamine. 
Furthermore, heparin, N-aziridine, trans-2-phenylcyclopropyamine and 
homocysteine thiolacetone can act as LOX inhibitors. 
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D-pencillamine can also inhibit lysyl-oxidase activity in standard doses (0.5 g/daily). 
It binds to aldehydes, especially in soft tissues, where most of the aldehydes come 
from lysine. It has also been shown that at higher doses, it makes copper unavailable 
to the enzyme, further interfering with the production of cross-links. It also worth 
mentioning here that copper deficiency in animals and humans results in several 
abnormalities including impaired cross-links and although it diminishes the activity 
of the enzyme, it does not have any significant effect on the level of LOX mRNA 
indicating that biosynthesis of the enzyme is not markedly affected by copper 
availability of copper, which may happen in the copper deficient diet. The detail of 
copper role in catalytic activity of lysyl oxidase can also be found elsewhere 
(Gacheru et al., 1990)  
Substrate specificity to LOX 
The dramatic difference in primary and three-dimensional structure of the substrate 
lysine in collagen and tropoelastin suggests that there must be some kind of 
flexibility for LOX in terms of its substrate specificity. Moreover, the sequence 
region in LTQ where the tyrosine progenitor is found, and where the Lys314 forms 
part of LTQ, is abundant with anionic residues. Thus, in a functional LOX, LTQ 
provides a rich, negatively-charged active site making the enzyme well-suited to 
cationic protein substrates. In case of tropoelastin, the susceptible lysine is a cationic 
molecule and suitably matched for LOX. However, the substrate lysines in collagen 
are found in a hydrophilic region containing anionic residues and seemingly not 
suitable for the active site of LOX. Interestingly, the lysine residue within Asp-Glu-
Lys-Ser, which is normally the sequence of the N-terminal of the #1(I) chain of 
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mature type I collagen, is a perfect in vivo substrate for LOX. On the contrary, LOX 
is unable to react in vitro with the same sequence in a synthetic collagen-like peptide. 
However, replacing the Asp residue with Gly makes the reaction possible. The 
question is, how can the unfavourable negative charges contributed by Asp residues 
in a naturally occurring collagen be overcome? It is hypothesised that the 
condensation of collagen molecules and cationic sites in neighbouring collagen 
molecules within the quarter-staggered microfibril permits the oxidation by LOX. 
This proposal is supported by molecular modelling studies of the microfibrillar array. 
In addition, collagen and tropoelastin molecules are not the only biological targets of 
this enzyme. Evidence has shown that several other basic globular proteins with pI ' 
8 such as H1 histone can be oxidised by LOX (Smith-Mungo and Kagan, 1998; 
Lucero and Kagan, 2006) 
Other biological roles of LOX 
It has already been shown that decrease expression of LOX is implicated in a number 
of in extra-cellular matrix diseases, including cutis laxa, Menkes’ syndrome and 
spontaneous coronary artery dissection, scleroderma, atherosclerosis, liver cirrhosis 
and senile plaque formation in Alzheimer and non-Alzheimer dementia. However, 
recent evidence suggests that more functions may be attributed to LOX, including 
induction of motility and migration in monocytes, vascular smooth muscle cells and 
fibroblasts. Moreover, the observance of LOX activity in the cytoplasm and 
nucleolus has lead to discovery of its involvement in cell signalling and 
transcriptional gene regulation, probably through binding to histone substrates as 
noted above. Even more recent studies have shown that non-catalytic domains of 
74 
 
LOX can bind to various proteins such as fibronectin and placental lactogen. 
Considering the paramount importance of LOX in gene regulation and signal 
transduction, it is expected that aberrant expression of the enzyme might lead to 
some types of malignancies. Paradoxically, in some cancers the up-regulation of 
LOX has been shown to act as a tumour suppressor, whereas in other cancers the up-
regulation of LOX has been considered to be a metastasis-promoting factor. The full 
details of versatile biological functions of LOX are beyond the scope of this 
dissertation and can be found elsewhere (Smith-Mungo and Kagan, 1998; Szauter et 
al., 2005; Erler et al., 2006). 
Collagen turn-over and degradation 
The traditional view of collagen turn-over favours a fast turnover during the growing 
period of an animal and very slow rate in adult animals, except in the uterus during 
pregnancy, wound healing area and some pathological conditions (Sodek, 1976). 
However, recent studies have shown that collagen turnover in the adult can indeed be 
fast (Humphrey, 2002). Prior to formation of covalent cross-links, collagen 
molecules are highly susceptible to degradation, but the degradation susceptibility of 
mature molecules seems to be independent of the time of their synthesis. Generally, 
there are two main degradation pathways for collagen, namely intracellular (or 
degradation of procollagen molecules) and extracellular pathways. Bienkowski et al. 
(1978) studied intracellular degradation and showed that, in some cases, as much as 
one third of newly synthesised collagen (procollagen) was degraded even before its 
secretion. The study of the kinetics of this process in different tissues in rats has 
revealed a very wide range of discrepancy. For example, the amount of degradation 
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through this process in the skin and heart is about 10% and 60%, respectively. 
However, whether this degradation occurs inside the cisternae of Golgi or lysosomes 
is not clear. However, the suggestion is in the case of over-load by faulty 
procollagens the cisternae of Golgi are that the primary site of degradation (Laurent, 
1987). 
In the extracellular pathway, collagen is broken down, either before or after 
formation of the fibrils, mostly by the means of a group of collagenases belonging to 
a family of enzymes called matrix metalloproteinases or MMPs (Grande-Allen et al., 
2005; Diegelmann, 2001). These MMPs are tissue specific. For example, in mitral 
valves of adult humans and pigs, it seems that MMP-13 and MMP-1 play an 
important role in collagen degradation. These enzymes are produced by fibroblast-
like cells, which constitute the major cell population of connective tissues. 
Furthermore, there is a population of smooth muscle cells and myofibroblasts that 
have ability to secret collagenases. It should be borne in mind that these cells are also 
capable of producing collagen, elastin and proteoglycans. The MMPs cleave covalent 
bonds in collagen at quite unique and specific positions, namely between a glycine 
residue and a leucine or an isoleucine residue. It is interesting to note that the 
catalytic site of MMPs is 8 Å  long, while the diameter of a collagen molecule is 1.5 
Å . Apart from the size incompatibility, the scissile bond for collagen degradation is 
buried inside the molecule and is practically inaccessible for the enzyme. Thus, the 
exact mechanism of the enzyme is still unknown, though some theories have been 
suggested. The “molecular tectonic” theory states that the MMPs undergo some 
conformational changes and actively unwind collagen molecules just before acting 
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upon them. The problem with this theory is that the conformational changes in 
MMPs would need an energy input while the degradation of collagen molecules 
require any energy input. There is evidence that collagen in physiological conditions 
in vivo is not as rigid and inflexible as originally thought. It seems that they 
experience very subtle conformational fluctuations that are also necessary if they are 
to perform their function. This idea has been confirmed by molecular dynamic 
simulations that suggest that the MMPs recognise and subsequently bind to cleavage 
sites that are already partially unfolded. The implications arising from this study are 
that some surface molecules that bind to the native collagen triple-helix could 
increase its stability, thereby rending the collagen more resistant to conformational 
fluctuation and subsequently to MMPs (Salsas-Escat and Stultz, 2007).  
Another group of enzymes that could act on collagen, both in extracellular matrix 
and inside the cell, are cathepsins. They belong to papain-cyctein proteinase family, 
the members of which have collagenolytic and elastinolytic activities. Several 
cathepsins have been identified; including cathepsin K, S, B, L and G. Cathepsin K is 
probably the most widely studied, with a number of studies focussing on its role in 
osteoclast-mediated bone resorption and joint diseases. The collagenolytic activity of 
cathepsin K is unique in that type I and type III collagen are cleaved at the end and at 
the multiple sites, irrespective of its conformation within native triple helix, whereas 
other cathepsins cleave the collagen molecules only in telopeptide regions, 
generating monomers of the collagen molecules. Cathepsin K is produced in 
fibroblasts or osteoclasts in an inactive form of a proenzyme. After autoproteolysis 
happens, it stays inside lysosomes or is secreted into the extracellular matrix. 
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Extracellular matrix is an acidic microenvironment and the enzyme is fully 
functional at the acidic pH of 5.5. In bone, this milieu is provided by osteoclasts in 
the bone resorption lacunae. The weak expression of cathepsin K in the steady state 
of other tissues like lungs and skin in the normal tissues has also been demonstrated. 
However, the over-expression of cathepsin K in diseased conditions suggests that the 
enzyme plays an important role in remodelling, homeostasis and matrix re-
deposition. Nonetheless, the necessary acidic micro-environment for the activity of 
the enzyme has not been seen in these tissues. It has been suggested that in these 
tissues collagen binds to specific cell surface proteins such as !1 integrins and 
urokinase plasminogen activator receptor associated protein (uPARAP), followed by 
uptake by the cells and delivery to lysosomes where  cathepsin K could act 
effectively in acidic conditions (Garnero et al., 1998;  Rünger et al., 2006). 
Although these enzymes are produced mainly by transformed fibroblasts of any 
given tissue, they could also be produced by other inflammatory cells such as 
neutrophils. Additionally, it has been shown that a range of cytokines could affect 
collagen turnover. The involvement of Interleukin-1beta (IL-1 !) and tumour 
necrosis factor (TNF) in myxomatous mitral valves, in the tissue of periodontitis 
patients and in synovial fluid has been demonstrated, and it was shown that these 
cytokines can stimulate and increase the activity of both matrix metalloproteinases 
(MMPs) and cathepsins (Hou et al., 2001; Rabkin et al, 2001; Cox et al., 2006). 
In addition, these cytokines are not only involved in degradation of collagen 
molecules, but they also affect the collagen synthesis. A study has compared the 
ability of human dermal fibroblasts to synthesise types I and III collagen, using 
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recombinant IL-1 and TNF#. The study showed that there was a decrease in the 
synthesis of collagen type I in both cases. However, while TNF# acts through the 
reduction of the amount of procollagen mRNA level, the level of procollagen mRNA 
in the presence of IL-1 was surprisingly high (Mauviel et al., 1991). This result for 
IL-1 is in disagreement with some studies which showed that IL-1 could increase 
collagen synthesis. It suggests that some post-transcriptional interventions might be 
the cause of the reduction of collagen synthesis. Although differences in the 
experimental conditions used might explain the observed discrepancy, it could also 
be related to the status of fibroblasts in terms of whether they are already activated or 
not. The author also envisages another explanation whether or not it is definitely 
proved that IL-1 reduces collagen synthesis in vivo. The excessive synthesis of 
procollagen might put a real burden on the collagen biosynthesis pathways leading to 
the production of many faulty molecules destined for intracellular digestion before 
secretion. 
Prostaglandins also seem to play a key role in metabolism and turnover of collagen. 
Prostaglandins are synthesised from arachidonic acid via the cyclooxygense pathway 
and have capacity to affect a vast majorities of regulatory, differentiative and 
inflammatory processes. PGE2 is of a particular interest in terms of its regulatory 
effect on collagen turnover. PGE2 achieves this through four different E prostanoid 
receptors, namely EP1-EP4. These receptors belong to a family of G protein coupled 
receptors. EP1 activation causes a raise in the level of Ca2+.  EP2 and EP4 lead to an 
increase of cAMP. EP3 activation, however, decreases the level of cAMP. Although 
it is generally accepted that PGE2 is able to suppress collagen synthesis, the effect of 
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PGE2 on differentiation and proliferation of fibroblasts in different cell lines has 
revealed a discrepancy. This heterogeneity might reflect the expression of different 
receptors in different tissues. This discrepancy in different cell lines obligated studies 
on primary cells. A study carried out by Huang et al. (2007) using histologically 
normal fibroblasts from adult human lung parenchyma, has shown that PGE2 both 
suppresses collagen expression and fibroblast proliferation by increasing the cAMP. 
This was mediated mostly by EP2 receptors and to a lesser degree by EP4 receptors. 
Thus, as has also been demonstrated in other studies,  agents such as !-adrenergic 
agonists (e.g. isoproterenol), phenylbutyrate (a weak and non-toxic histone 
deacetylase inhibitor) and forskolin which can raise the level of cAMP, can affect 
and suppress collagen expression as well (Saltzman et al.,1982; Rishikof  et al., 
2004). Although there is a simultaneous increase in PGE2 levels in cells treated with 
IL-1, it seems that IL-1 realises its function independently from PGE2 as treating the 
cells with indomethacin does not affect the ability of IL-1 to reduce  collagen 
production  (Mauviel et al., 1991).  
 Not only can indigenous cells in a given tissue play a role in the turnover and 
metabolism of collagen, but cells from other sources could also have effects. A study 
on myxomatous mitral valve in humans has revealed an increase in the population of 
CD34+ fibrocytes in the affected leaflets. These fibrocytes are presumed to derive 
from circulatory CD14+ and are different from those of mitral valves. Although 
CD34+ fibrocytes could synthesis type I and III collagen, they are thought to be the 
main source of MMP9 which is considered one of the important factors in 
pathogenesis of myxomatous mitral valve in humans (Barth et al., 2005). The reason 
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why these circulatory cells migrate, transform and dwell in mitral leaflets remains to 
be elucidated. In unpublished observations in the dog, there is little evidence of 
accumulation of CD34+ cells in canine MMVD (according to Richard Han, personal 
communication, November 6, 2008). 
In summary, it can be understood that there are delicate and rather complex 
mechanisms which influence collagen synthesis and turnover in different tissues. For 
example, while the fractional turnover of collagen (an amount of collagen equivalent 
of the total collagen mass in a given tissue) in the heart tissue of an adult rat is about 
5% per day, the value for that of lung is about 8% per day (Laurent, 1987). From 
this, the necessity for further research to clarify the subtlety of collagen homeostasis 
in various tissues ca be appreciated, both at different stages of development and in 
disease, not least in the mitral valve.   
Clinical signs and diagnosis 
Most dogs with mild and moderate disease do not present any obvious clinical signs 
and the disease is usually detected through auscultation during routine physical 
examination. However, the course of the events at this stage might vary from an 
insidious condition taking years to a rapidly progressing heart failure. Although the 
disease mostly occurs among the small breeds, it seems that the deterioration of 
clinical signs is much more dramatic in some large dogs. In the severe cases which 
might be accompanied by mitral regurgitation, there is a wide range of clinical 
manifestation, which results from the compromised heart function. Coughing is 
caused by pulmonary oedema, the pressure on the left main stem of bronchus or the 
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combination of both. The cough becomes exacerbated especially at night when the 
dog lies laterally. Weakness and decreased stamina due to failed left and right 
ventricular forward flow might also exist. Right-sided heart failure could also lead to 
ascites. In addition, syncope and sudden death are seen in some dogs (Pedersen, 
2000; Häggstrom et al., 2005). 
Diagnosis is made on the basis of criteria that include medical history, physical 
examination, echocardiography and thoracic radiographs.  A murmur may be 
identified in early stages of the disease. This murmur is associated with early systole. 
Nevertheless, as the disease progresses it incorporates the whole of the systole 
(holosystolic) and its intensity also increases. Mid-systolic click may be found in the 
affected dogs. However, detection of these abnormal sounds depends on the 
experience of the observer, the state of the mind of the animal and concurrent 
complications such as pleural effusions and cardiac tamponade (Pedersen, 2000; 
Pedersen and Häggstrom, 2000). 
 
Electrocardiography 
Most abnormalities found in electrocardiographic examination of the myxomatous 
mitral valve result from the accentuation of a normal ECG. In different cases of 
MMV, different patterns of ECG ranging from normal to complexities in rhythm, 
rate and configuration have been noticed. However, it has been documented that both 
dogs and humans reveal severe sinus arrhythmia in their ECG compared to that of 
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control groups. Additionally, in cases of compensatory left atrial and left ventricle 
enlargement, prolongation of P wave and QRS wave would be seen, respectively. 
The mean electrical axis in the frontal plane often remains unchanged throughout the 
course of disease (Häggstrom et al., 2005).  
Diagnostic imaging 
Echocardiography is an extremely useful method for screening, diagnosis and 
prognosis of myxomatous mitral valve disease. The diagnosis is made when there is 
at least 2 mm displacement of one or two mitral leaflets above the annulus plan 
towards to the atrium during the systole, in either right parasternal or apical long axis 
two dimensional view (Hayek and Griffin, 2002; Hansson, 2004; Häggstrom et al., 
2005). Measurement of the average protrusion of anterior leaflet, posterior leaflet and 
coaption points between the two leaflets is another method that is also used by some 
researchers (Olsen et al., 2003a). As the mitral valve annulus is saddle shaped, in 
normal hearts a four-chamber view echocardiography may show some signs of 
prolapse which in fact is not the case. It is also important to realize that there is a 
correlation between the severity of the disease and the degree of the protrusion. In 
echocardiograms, the lesions, including thickening, usually appear more prominently 
in the anterior leaflets. In humans, if the thickening is greater than 5mm the condition 
is called “classic prolapse”, otherwise it is considered as “non-classic prolapse”. In 
severe cases, the entire leaflet might protrude into the atrium (flail leaflet) raising the 
suspicion of chordae rupture. However, the echocardiographic features in MMV can 
be mistaken for the lesions caused by bacterial endocarditis which bear some 
similarities to that of myxomatous leaflets although in the case of former condition 
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the lesions are more or less solitary and echodense. Moreover, the signalment of the 
disease which is febrile and often seen in large dogs could be a clue to differentiate it 
from MMV disease (Kittleson, 1998). Three-dimensional echocardiography has 
recently been used to access the anatomical lesions in the myxomatous valves in 
humans and is of particular value in timing of surgical intervention in order to repair 
the affected valve (Macnab et al., 2004). 
In mild forms of the disease there are no apparent changes in the size of left atrium 
and right ventricle either in echocardiograms or radiographs. Nevertheless, as the 
disease progresses, there would generally be signs of left atrium enlargement 
followed by an increase in diameter of left ventricle. However, the wall thickness of 
the left ventricle usually remains within the normal range (Kittleson, 1998). 
Aim, scope and hypothesis 
Realising the importance of collagen fibres in mitral heart valves and considering the 
paramount significance of myxomatous mitral valve disease, a better understanding 
of pathogenesis of MMVD is essential. It can be hypothesised that there are 
differences in various characteristics of collagen when comparing healthy leaflets 
with MMVD leaflets. The hypothesis of this study is that there are changes in fibril 
structure, fibril orientation, d-spacing, collagen density, collagen content, thermal 
stability, and the status of mature and immature cross-links in diseased valves. This 
study was designed to investigate this hypothesis using a combination of biophysical 
and biochemical tools, such as x-ray diffraction, neutron scattering, differential 
scanning calorimetry (DSC) and high performance liquid chromatography (HPLC). 
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Additionally, the recently introduced imaging technologies to biology and medicine, 
such as differential enhancing imaging (DEI) and coherent anti-Stokes Raman 
scattering spectroscopy (CARS) were applied to investigating this disease. The 
hoped outcome of this study was furtherance of our understanding of the 
pathogenesis of MMVD. The study provides new findings about MMVD and 





X-ray diffraction in the 
evaluation of connective tissue 




Without doubt, the name of Wilhelm Conrad Rontgen and x-ray are inseparable. On 
November 8, 1895 he realized that a paper plate covered on the one side with barium 
platinocyanide located as far away as two meters from a sealed and covered 
discharged tube became fluorescent. Later on, he exposed his wife’s hand against the 
newly discovered rays and first x-ray image in history was recorded, showing 
shadows of his wife’s hand bones and that of the ring she was wearing. For this 
discovery, Röntgen was awarded the first Nobel Prize in physics in 1901 (Franks, 
1996). 
X -rays are produced by the stoppage of cathode rays or electrons when they strike a 
metal target. When they hit the target two phenomena occur simultaneously. First, 
when electrons approach to the nuclei of the target material all their kinetic energy 
converts to the rays called “continuous” or “white” x-ray radiation. In the second 
event, electrons which strike the different orbits of the atoms in the metal target 
remove the electrons from their original orbits or shells. When other electrons 
transfer to occupy the vacant positions, x-rays are produced. Taking into account that 
the latter type of x-rays originate from different orbits with various characteristic 
energies, they are called “spectrum x-rays”. The energy of continuous or white x-
rays does not depend on the target material, while spectrum x-rays are specific to the 
target (Michette, 1993; Franks, 1996). 
X-rays are now produced by different methods across the world, but for research 
purposes, one of the common used sources is the synchrotron radiation source (SRS). 
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In SRSs, electrons are accelerated up to the speed of light within an evacuated 
polygonal ring. Their movement is maintained by huge external magnets. The 
bending movement of the electrons at the corners of the polygon produces radiation 
ranging from infra-red to short wavelength x-rays. The radiation is emitted 
tangentially from the orbit and is channelled through side gates to different 
experimental instruments. The high intensity and wide spectrum of x-rays renders the 
synchrotron radiation an invaluable tool for a variety of scientific applications 
(Munro, 1996). 
X-ray diffraction 
Diffraction is defined as the deviation of a wave from its natural direction of 
propagation when it encounters an object or a medium. When a wave hits an atom it 
is scattered in a certain direction. The scattering pattern from a single atom is so 
weak that it cannot be observed. However, if there is an ordered structure with a 
regular repeat distance between scattering structure, the scattered rays interact with 
each other to give rise to a special pattern of constructive and destructive 
interference. This diffraction pattern can be detected by a suitable detector. As the 
wavelengths of x-rays (0.01-0.1nm) are so close to the inter-atomic distances, they 
are capable of producing the best diffraction pattern from molecules. In 1912, Max 
von Laue for the first time discovered the diffraction of x-rays by crystals and 
showed that x-rays behaved like waves rather than particles. However, the 
development of x-ray diffraction into a reproducible and calculable technique is 
thanks to a unique father and son team, namely Sir William Henry Bragg and his son, 
William Laurence Bragg, who proposed Bragg’s Law: 
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 n( = 2dsin)         (2.1)   
Where n is an integer, ( is the wavelength of the rays, d is spacing between layers of 
atoms and ) is the angle between the incident ray and the scattering or diffracting 
planes. The following example provides a better explanation of the Law. It can be 
imagined that two rays strike a regular repeating structure molecule where the 
distance between the atomic planes is a given d (Figure 2.1). The first ray scatters 
from the first layer at an angle ). This phenomenon equally occurs in the case of the 
second ray at the same angle of ). However, the distance which the second ray 
travels is farther than the first ray, namely 2a. If 2a is equal to an integral number of 
wavelengths (n(), both rays, while they exit from the molecule, will be in phase. This 
kind of interaction between different rays where they reinforce each other is also 





Figure 2.1: The diagram depicting the Bragg’s Law. In this drawing the second ray travels 
2a farther than the first ray. If this path length is a whole number of wavelength, then the 
constructive interference will occur. From trigonometry   a = d sin # or 2a = 2 d sin #   thus, 
n$ = 2d sin # (Nelson, 2008). 
X-ray diffraction in biological research 
X-ray diffraction has played a paramount role in the development of biology. 
Generally, in terms of its application, it can be categorized into two major various 
areas: crystallography and non-crystalline diffraction (i.e. mainly fibre diffraction). 
Many biological molecules including many proteins, viruses and vitamins can be 
persuaded to form crystals, whereby they are arranged in an ordered lattice (the 
orderly, regular three-dimensional arrangement of atoms in a crystal). In addition, 
there are also a number of biological molecules, such as collagen fibres, filamentous 
viruses, amyloids and DNA molecules, which are not able to form crystals, but 
which still posses a degree of special spatial ordering. The difference between fibres 
and crystals is that in fibres the molecules are parallel to each other although 
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randomly oriented about the fibre axis, so the diffraction pattern is cylindrically 
averaged. Additionally, compared to crystals, fibres are often more stable and better 
able to withstand changes in the surrounding environment, including temperature and 
humidity. Consequently, fibre diffraction is an ideal tool for study of these structures 
(Lewis, 1997; Miller et al., 1999; Stubbs, 1999). 
Aim 
Reflecting its importance in MMVD, collagen structure has been the subject of a 
number of studies using conventional and electron microscopy (Chapter 1). X-ray 
diffraction has the advantage over electron microscopy that the tissue is maintained 
in physiological conditions during the x-ray exposure, and prior chemical processing 
of the tissue is eliminated. Additionally, EM can only examine a localized volume of 
tissue, so is unable to give information about the whole tissue density. X-rays pass 
through the entire sample thickness and the results thus represent averages 
throughout the tissue. X-ray diffraction techniques also have the ability to 
differentiate the tissue density in terms of collagenous and non-collagenous tissue. 
They can also distinguish between fibrillous from non-fibrillous collagen while 
mapping the preferred orientation of the fibrils. So, the purpose of this study was to 
determine the changes in collagen fibril organization, including tissue density, fibril 
orientation, fibril density, degree of fibril alignment and d-spacing between diseased 




Materials and methods 
Mitral valve leaflets were collected from five affected dogs and one healthy control 
(table 2.1). They were from both sexes and their average age was about 7 years. The 
pathological status of the samples was confirmed by gross examination at the time of 
collection. All tissue samples were snap-frozen using dried ice within 10 min of 
collection and then stored in between -60 and -70 °C freezer until their use. In 
addition to the control sample, since diseased and normal areas coexist in one leaflet, 
each valve could also be used as its own control. The Royal (Dick) School of 
Veterinary Studies School (RDSVS) ethics guidelines on the use of clinical material 
were satisfied for all samples throughout the study.  
Breed Age Sex 
cross-bred Terrier  11 years old female 
cross-bred Collie 7 years old male 
CKCS 9 years old male 
CKCS 6 years old male 
Beagle 5 years old female 
cross-bred German Shepherd (control) 3 years old male 
Table 2.1: The details of the animals used in the experiment in order to study tissue 




The major requirements for a an x-ray specimen holder are a) to keep the sample in a 
fixed position relative to that of the incident beam, b) to keep the sample humid and 
prevent it from drying during the course of the runs, and c) exerting a certain amount 
of pressure in order to maintain the collagen fibres in a stretched condition. The 
specimen, soaked in normal saline, was sandwiched, flattened and sealed between 
two sheets of mica. Keeping samples humid maintains the crystallinity of the 
collagen fibrils and prevents “helicoidal effect” which can produce molecular tilting 
and changes in the d-spacing (Cameron et al., 2000). The reason for the stretching of 
the samples by a small amount is that in the relaxed state, collagen fibrils possess a 
periodic crimp along their length. Thus, it is advised that in order to produce a 
diffraction pattern free from the splitting of reflections that such a crimp can 
produce, the fibres should be stretched approximately an additional 10% of their total 
length (Bradshaw, 1985). Stretching of a sample should be done by clamps evenly 
pushing the tissue from all directions. In our case, the samples were not treated like 
this; however, flattening the samples seemed to be enough for the purpose of our 
experiment.  
X-ray diffraction measurements  
Collagen molecules lie almost parallel to the fibril axis and diffract x-rays from the 
670 Å repeating pattern of gap and overlap regions. The intensity of diffraction is 
related to the amount of collagen, and the alignment of the diffraction pattern reflects 
the alignment of the fibres. Therefore, diffraction patterns can be used to probe the 
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alignment of the collagen fibrils that produced that diffraction. The technique can 
also be used to determine total tissue content (collagenous and non-collagenous) by 
quantitative analysis of total x-ray scattering at any point (Miller et al., 1985; Meek 
and Quantock, 2001; Aghamohammadzadeh et al., 2004). X-ray diffraction 
measurements were performed with synchrotron radiation (Experimental Station 2.1, 
Synchrotron Radiation Source, the Council for the Central Laboratory of the 
Research Councils (CCLRC), Daresbury, UK) using a method developed from that 
of Aghamohammadzadeh and co-workers (2004). The specimens were mounted in a 
specially-designed sample cell, attached to a movable sample stage. The stage was 
programmed to translate in a raster of 1-mm steps, horizontally and vertically, while 
a finely focused (0.1 mm vertical * 1 mm horizontal) beam of 1.54 Å wavelength x-
rays recorded the fibre diffraction pattern for 45 seconds at each point. Each sample 
was typically measured at 300 points, in a grid of 20 * 15 pixels. A multiwire two-
dimensional area detector, placed 4 m from the sample, collected the diffraction data. 
The collection of diffraction data and movement of the sample relative to the beam 
were coordinated by a computer running a Python (www.python.org) script file. 
Calibration measurements included the detector response, in which the efficiency of 
each pixel was determined by a long exposure to a randomly decaying radioactive 
source, and detector calibration, which used the well-characterized diffraction pattern 
of wet rat tail collagen. 
Data analysis 
The diffraction pattern of a fibrous material, such as collagen, contains information 
in the meridional plane, describing structure along the axis of the fibre, and in the 
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equatorial plane, describing lateral structure. For this study, Bragg reflections of the 
meridional diffraction pattern were recorded and analyzed to provide information 
about the collagen content and the degree and prevailing angle of alignment of the 
fibrils. The level of background scattering was also determined to give an indication 
of the amount of non-collagen tissue. Data analysis was performed using the program 
FiberFix (Collaborative Computational Project for Fibre Diffraction and Solution 
Scattering, CCP13). A ring was defined, centred on the middle of the diffraction 
pattern and wide enough to encompass the third, fourth, and fifth orders of 
meridional diffraction (Figure 2.2). This region was chosen because it was 
sufficiently clear of any x-ray scattering from the backstop but included strongly 
diffracting Bragg peaks. The third and fifth orders of diffraction are characteristically 
very bright for type I collagen and have excellent signal/noise ratios, thereby 
simplifying the tasks of background subtraction and peak shape analysis. PeakFit 
(Version 4, AISN Software) was used to fit Gaussian peaks to the annular 
distribution of scattering intensity (Figure 3.3). The Gaussians were then analyzed in 
terms of peak area (total diffracted intensity of the selected area of the diffraction 
pattern, related to the amount of collagen), peak centre (angle of preferred fibril 
orientation), peak width (degree of fibril alignment), and mean background level 
(related to the amount of non-ordered material). These values were then plotted to 
produce maps of each parameter across each valve leaflet. 
The numerical diffraction values of total the tissue density, collagen fibril density, 
and degree of collagen alignment were analyzed separately for each leaflet using a 
two-sample un-paired t-test to compare affected and lesion-free areas. Significant 
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differences were taken at P < 0.05. Analysis of regression was carried out to 
determine whether there was any relationship between amount of collagen and total 
tissue density in diseased and lesion-free areas. 
Results 
A typical small-angle x-ray diffraction pattern from a dog mitral valve leaflet is 
shown in Figure 2.2. The x-ray beam passed through the sample perpendicular to the 
plane of the leaflet. Because collagen fibrils can occur in all possible orientations 
within this plane, the diffraction pattern may appear as a series of concentric circles. 
The anisotropic distribution of intensity in this example reveals a preferred angle of 





Figure 2.2: X-ray diffraction pattern from canine mitral valve collagen. The pattern is 
dominated by a series of meridional Bragg reflections, arising from constructive diffraction of 
X-rays by the regularly repeating 670 Å axial structure of collagen fibrils. The superimposed 
circles define a ring encompassing the third, fourth and fifth Bragg peaks of meridional 
diffraction. Circular integration of diffracted intensity in this region was used to provide 






Figure 2.3: The annular distribution of diffracted intensity from canine mitral valve collagen. 
The data result from circular integration Figure 2.2 (see the text). Horizontal axis, angle; 
vertical axis, intensity (arbitrary units). Also shown is a pair of fitted Gaussian distributions 
centred at 88.96°! and 268.1°. Note that the peak area, the peak width (full width half 
maximum) and the peak centre were used to calculate the amount of collagen, the degree of 
alignment and the orientation of the collagen fibrils, respectively. 
Estimation of total tissue 
Highly ordered material, such as collagen, produces a well-defined diffraction 
pattern, which overlays an anisotropic background of x-ray scattering by any 
disordered material that the x-ray beam strikes. A sensitive measure of the amount of 
tissue (collagenous and non-collagenous) at any one point on the leaflet is provided 
by the quantitative analysis of this non-coherent scattering of x-rays. Absorption of 
the x-ray beam by the sample can also be estimated by comparing the current 
measured at ion chambers before and behind the sample. A regression analysis of the 
two methods for one of our samples showed that they are closely related (>95% 
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significance), thereby validating our approach. Total tissue density differed 
significantly (P < 0.05) between affected and lesion-free areas. The contour maps of 
the diseased samples also revealed a considerable variation in total tissue content 
distribution among diseased and unaffected areas that was not consistent with a 
specific pattern (Figure 2.4 A). 
Collagen fibril orientation 
Figure 2.4B shows a map of collagen fibril orientation across a single leaflet. In the 
visibly normal areas of the mid-zone of the leaflets, the collagen fibrils run parallel to 
the free edge, meaning they take up a transverse course between two commissures. 
However, when they approach the edge of leaflets close to the annulus, they become 
oriented more vertically, such that they are orthogonal to the adjacent areas. In 
diseased areas, which are mostly located on the free margins of the leaflets, the 
orientations of fibrils are haphazard. This contrasts with healthy regions and healthy 
valve (Figure 2.4 E), where the direction of fibrils is more or less continuous with the 
fibrils in neighbouring chordae tendineae and there is an ordered pattern of collagen 
fibrils across the valve. 
Collagen fibril density 
Figure 2.4C is a representative plot of collagen fibril density, determined on the basis 
of the strength of diffraction by the collagen at each point. These plots were derived 
from two different fibril populations: those with a preferred orientation and those 
without. This plot therefore shows the total diffraction irrespective of fibril 
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orientation and so represents directly the relative amount of collagen fibres in the 
path of the x-ray beam. In all samples, the total diffraction, and therefore the amount 
of collagen significantly increased (P < 0.05) from the diseased free edge of the 
leaflet to the unaffected base of the valves.  
Degree of collagen alignment 
Plots were drawn to map the degree of preferred alignment of the collagen fibrils. All 
the diseased leaflets showed non-uniform distribution of collagen alignment, with 
clear differences in the degree of preferential alignment between the diseased and 
healthy areas. These differences were consistent in all samples, and, as illustrated by 
Figure 2.4 D, it was clear that the maximally aligned collagen is located toward the 
lesion-free periphery of the leaflets (P < 0.05). A comparison of these affected 
regions with the same areas in apparently healthy leaflets is a clear indication of the 







Figure 2.4: Contour maps showing an area of 20 ! 15 mm of a single canine mitral valve 
which also contains free edges of leaflets. A and E total (non-collagenous) tissue density of 
diseased and control sample, determined from the background (incoherent) x-ray scattering 
in a ring centred on the middle of the diffraction pattern and enclosing the third, fourth, and 
fifth meridional Bragg peaks. The background was measured in a region of reciprocal space 
that contained no diffraction features from collagen fibrils. Preferred orientation of collagen 
fibrils in diseased (B) and apparently healthy (F) mitral valve leaflets, determined by fitting 
Gaussian distributions to the Bragg peaks and determining the angular position of the peak 
centre. The major difference between normal and diseased valves is in the free margins of 
the leaflets, where the disordered collagen fibrils of the diseased valve contrast starkly with 
the well-aligned fibrils of normal tissue. Collagen fibril density in diseased (C) and apparently 
healthy valve leaflets (G), determined from the total area under the Bragg peaks (total 
diffracted intensity). Degree of alignment of collagen fibrils in diseased (D) and apparently 
healthy (H) valve leaflets, determined from the width of the fitted Gaussian distributions. For 
ease of comparison with the other plots, the data are expressed as 180° % W, where W is 
the full width at half height (in degrees) of the Gaussian distribution. Note that free edges of 
the leaflets are the locations where lesions are usually found. The figures G and H display a 
higher amount of collagen density and the degree of alignment towards free margins, 
respectively compared to the affected leaflet (units are arbitrary). 
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d-spacing measurement  
The x-ray diffraction patterns of connective tissues rich in collagen fibrils possess 
features that arise from the interaction of x-rays with the molecular spacing. Of these, 
the most obvious and perhaps most important is the d-spacing. The highly ordered 
axial arrangement of molecules, in which neighbouring molecules are staggered by 
about 670 Å, is responsible for this pattern. This repeating periodic function of 670 Å 
acts as a main diffraction grating and the final image results from Bragg reflections 
which corresponds to the d-spacing and integral fractions of this spacing such as 670 
Å , 670/2 Å ….670/n Å where n is an integer. These frequencies can also be 
identified as first-order, second-order etc. The strongest diffraction arises from the 
axial spacing along the fibril, thus the pattern is referred as the meridional pattern. 
Using the Bragg equation (n( = 2dsin)), it is possible to calculate the d-spacing. The 
third order of the diffraction was used to calculate the d-spacing, as it was very clear. 
Data for this calculation was obtained from 4 leaflets obtained from 2 dogs with 
grade I and II mitral valve invovlment (table 2.2). The results showed that there was 
no difference between the diseased and healthy areas of the leaflets with a measured 
d-spacing of 660.0 Å.   
Breed Age sex 
cross-bred Terrier  11 years old female 
cross-bred Collie 7 years old male 




The study has shown that small-angle x-ray diffraction may be used to study the 
different characteristics of the axially projected structure of collagen fibrils in 
myxomatous mitral valves. This technique has been applied to determine the various 
attributes of collagen fibrils in the diseased canine mitral valves and develop detailed 
maps of collagen fibril orientation, collagen density, the degree of alignment of the 
fibrils, and the relative amount of tissue density. This allows better understanding of 
the spatial arrangements of collagen within diseased valves. Any changes that affect 
the quality, quantity, or organization of collagen could lead to the mechanical failure 
and dysfunction of mitral valves. The identification of collagen fibril orientation is 
one of the most striking findings of this study and shows that the mass of 
preferentially aligned collagen runs differently in different regions. In the main 
lesion-free body of the leaflets, collagen has a transverse course between the 
commissures. Near the free edge, it is almost a continuation of the collagen fibrils in 
the chordae tendineae. Because fibre orientation is the most effective way to 
optimize strength without increasing weight, fibre direction tends to reflect the 
prevalent tensile forces acting on a tissue (Sellaro, 2003). Therefore, knowledge of 
pattern of fibril alignment would have important implications for mechanical, 
bioprosthetic, and tissue-engineered valves and may inform the design of mitral 
valve substitutes. In contrast, diseased areas showed no distinct preferred orientation, 
and the collagen fibrils were disorganized with a haphazard and irregular 
arrangement. This confirmed what was previously suspected from histopathological 
and transmission electron microscopy studies (Tamura et al., 1995). In other tissue 
types dynamic changes in collagen alignment can occur in response to continuous 
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mechanical force, but the short time frame of valve leaflet movement is unlikely to 
allow collagen fibrils to rearrange in response to changes in force alone. In MMVD, 
which is an age-related disease, the alignment of fibrils declines, whereas in aged 
specimens of other tissues, collagen tends to have the best defined patterns, which 
indicates a greater degree of regularity from increased cross-linking of the collagen 
molecules. This suggests that the collagen changes that occur with MMVD are not 
simply an aging process. The quantity of collagen was also greatly reduced in the 
affected areas compared to non-affected areas. Since the tensile strength of collagen 
fibrils is directly proportional to the mass of the fibrils, it can be assumed that the 
affected areas will be less capable of resisting the load and strain imposed by 
ventricular systole. The free edge of normal leaflets is the thickest part of the leaflet 
(Ho, 2002), and in healthy valves, collagen content is related to tissue thickness. The 
plots of baseline scattering in this study showed notable variation across the leaflets, 
which did not correspond to diseased areas. Regression analysis of the amount of 
collagen compared to the total tissue content at each pixel (P + 0.01, n = 120 points) 
revealed that there was a significant relationship between these two parameters in 
lesion-free areas. However, this relationship did not hold true in affected areas, 
where depletion of collagen is not reflected in a parallel decline in total tissue 
content. One possible explanation is that MMVD involves increased production and 
deposition of glycosaminoglycans (GAGs). The different types of GAGs have 
diverse properties for absorbance and for destructive and constructive interference 
(Kittleson, 1998), and although some of them could produce a clear and ordered 
diffraction pattern, others would only contribute to tissue density. It is also believed 
that GAGs in the right proportions do play a role to maintain collagen fibrils in 
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specific spatial order. Thus, the increasing amount of the GAGs would not only 
disturb that spatial order but, by reducing the physical space, might also encourage 
the process of collagen depletion. Determining the exact types of involved GAGs 
would be useful in furthering understanding of the disease. An additional 
confounding factor is that the type of collagen present in connective tissues is linked 
to the type and quantity of related GAGs. Type III collagen tends to be associated 
with more GAGs, although there are conflicting reports on the changes in Type III 
collagen content in human myxomatous mitral valve disease (Hammer et al., 1979; 
James et al., 1991), and the exact makeup of collagen types in canine MMVD still 
needs to be determined. 
The d-spacing measurement has also been the focus of several studies.  In a study of 
one kind of muscular dystrophy in mouse it has been shown that there were no 
differences between the d-spacing of collagen between the affected and healthy mice 
though there was some abnormality in collagen organization in muscular tissue. On 
the other hand, the d-spacing of collagen is not a constant value in all the tissues of 
the same species. For example, in the same study the d-spacing for the muscular 
collagen and rat tail collagen was 657 Å and 670 Å, respectively (Kurg et al., 1982). 
Lewis et al., (2000) found differences of the d-spacing comparing malignant, benign 
and normal human breast tissue. Another study on arterial collagen has also shown 
that there is a relationship between the fibrillar stretch and the d-spacing and spacing 
does not remain constant throughout the nonlinear stress-strain of the tissue 
(Holzapfel, 2008). It seems that in determining the d-spacing not only is the type of 
collagen an important factor, but the interaction of collagen molecules with different 
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glycosaminoglycans can also play a role. This variability may also depend upon 
physiologic conditions. The condition of the sample is also important, whether is 
wet, dried or fixed. In the current study, no differences were found in the d-spacing 
between the diseased and healthy leaflets. This corresponds to the result of another 
study that showed the d-spacing did not change significantly among the myxomatous 
and healthy leaflets in human patients (James et al., 1991). The same study showed 
that the there was a slight decrease in the d-spacing with aging. The reason for this 
decrease has not been fully explained, but it maybe related to the formation of non-
reducible rigid cross-links. This finding supports the idea that although MMVD 
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Diffraction enhancing imaging (DEI) 
Diffraction enhancing imaging (DEI) is a method that produces high-contrast images 
based on absorption, refraction and scatter rejection in soft tissues. In conventional x-
ray photography, the final image results from differential absorption of x-ray energy. 
This may be sufficient for hard or calcified tissues such as bone, but it has very 
limited use for the study of soft tissues. In DEI the x-rays which pass through the 
tissue are more important than those absorbed. These rays are scattered and 
diffracted in very subtly different ways to each other.  
A brief description is presented here and detailed accounts of this method have been 
provided by others (Chapman et al., 1997; Menk et al., 2005). The most important 
feature of the DEI instrument is the analyzer crystal (Figure 3.1). X-rays from a 
synchrotron light source pass through a monochromator. The mono-energetic x-rays 
traverse the sample, undergo diffraction by the analyzer crystal and are finally 
recorded by the detector. When the x-rays traverse the sample they are refracted by 
very small angles due to tiny variations in refractive index. The analyzer crystal 
almost completely eliminates the x-rays which have been scattered to a large angle 
by the sample. The x-rays emerging from the sample and hitting the analyzer crystal 
will meet the conditions for Bragg diffraction only for a very narrow range of 
incident angles. If the x-rays that have been refracted by the sample are within the 
angular acceptance range of the analyzer, they will be diffracted onto the detector. 
On the contrary, if the x-rays that have been scattered by the sample fall outside this 
angular approval range, they will not be diffracted at all. As the angular deviations 
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due to the refraction are very small, it is necessary to use a perfect crystal, thereby 
limiting the choice of crystal to silicon (Si), germanium (Ge) and quartz. A variation 
in the intensity of diffracted x-rays can be observed when the crystal is rotated in an 
axis parallel to the lattice and perpendicular to the incident beam. This intensity 
variation is called as the “rocking curve” (Lewis et al., 2003; Li et al., 2003; 
Muehleman et al., 2004). 
    
 
Figure 3.1: a schematic layout of diffraction enhancing imaging (DEI) set-up at the SYRMEP 
beamline at Elettra. 
Aim 
MMVD is known to involve structural changes in the matrix of the leaflets (Chapters 
1 & 2). In order to characterise these changes further, the following experiment was 
designed to see what kind of changes (if any) were detectable using the DEI 
technique, and whether the findings could confirm or enhance the current available 
information about MMVD.  
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Materials and methods 
The diffraction enhanced images were collected at the 6.1 bending magnet beamline 
‘SYRMEP’ at Elettra, a third generation synchrotron light source operating in Trieste 
(Italy). The synchrotron can run at 2.0 or 2.4 GeV with a maximum ring current of 
320 or 140 mA.  In the present work the monochromator consisted of a double flat Si 
[111] crystal located in the vacuum 18 m away from the bending magnet source. This 
makes it possible to select energies within the range 8.5 to 35 keV. An aluminium 
filter, just before the instrument, was used to reduce the beam intensity and the shape 
of the laminar beam was defined by micrometric tungsten slits. In the experimental 
hutch, which was about 25 m away from the source, the sample and the detector were 
placed in vertical micrometric translators. Thus, the acquisition of a 2D image was 
possible by vertical scanning of the sample by a laminar beam. The analyzer was a 
single flat perfect crystal of Si [111] with the dimensions 10 mm thick, 130 mm wide 
and 80 mm long. There were also two ionisation chambers placed upstream and 
downstream of the sample. The upstream chamber was used as a flux monitor for 
evaluating the entrance dose in the sample. The downstream chamber was used to 
calculate the experimental rocking curve. In other words, the ratio between the 
downstream and upstream signals was assessed for precise positioning of the 
analyzer crystal. The sample cell was a cuvette-like chamber (made of transparent 
plastic) with a narrow bottom part to accommodate the leaflet. It was filled with 
phosphate buffer saline (PBS) in order to prevent the sample from drying. The 
camera was a 2048 & 2024 pixel CCD detector (Photonic Science Ltd, Roberts-
bridge, UK). Each pixel was of 14 & 14 ,m2. The energy of the x-rays was about 20 
keV.  The distances from the specimen holder to analyzer crystal and from analyzer 
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crystal to detector were 60 and 32 centimetre respectively. A curve for intensity of 
transmitted energy (rocking curve) was drawn by rocking the analyzer crystal around 
the Bragg angle (Chapman et al., 1997). The narrow rocking curve of the analyser 
crystal makes it possible to record a tiny deviation of the incident beam by a camera 
as intensity modulations. Each final image from a given point in the sample was 
interpreted in terms of 3 areas of a related rocking curve. The images acquired at the 
top of the curve (peak) are not only the result of conventional x-ray absorption but 
also represent the extinction contrast caused by the rejection of small angle 
scattering. On the other hand, the images produced by the slope of the rocking (at 
FWHM) are entirely attributed to the refraction effects. After collection, the images 
were studied using software ImageJ (Images Processing and Analysis in Java, 
version 1.40). Four freshly thawed samples (grade I or II) from two dogs were run 
altogether (Table 3.1) 
Breed Age Sex 
Labrodor  8 years old Female 
Mixed breed Terrier  10 years old Female  




At the peak of the rocking curve the samples were hardly visible as there is little 
information about the refraction. However, images of the leaflets were quite apparent 
from the slopes of the rocking curve where the refraction was at its maximum Figure 
3.2 shows two of the DEI images. The healthy regions of the leaflets showed a 
smooth pattern with no apparent differences in contrast or refraction indices. On the 
other hand, the diseased areas revealed a distinct pattern which was distinguishable 
from the surrounding healthy tissue. The chordae tendineae were also recognisable, 





Figure 3.2: Diffraction enhanced image from of the parts (5 mm X 10 mm) of two mitral valve 
leaflets. Note the increased contrast and number of lines in the diseased areas (arrows A) 
compared to that of healthy areas (arrows B). Air bubbles can also be seen as an artefact 




Synchrotron radiation sources make it possible to produce a high intensity, 
collimated and tunable x-ray beam for use in the diffraction enhancing imaging 
technique. In the present study, this method was used to detect architectural 
distortions in diseased areas of MMVD valve leaflets, compared to healthy zones in 
the same valve. The detection of collagen fibrils assumes that the material filling the 
gaps between the collagen bundles has a density that is less than the firm bundles of 
collagen. In the healthy areas of the leaflets, collagen fibrils run in very close 
proximity to each other, occupying most extra-cellular spaces. Obviously, this can 
not give rise to strong DEI signals. However, as other studies and the x-ray data have 
shown (chapter 2), the collagen in the disease area becomes fragmented, depleted 
and its orientation becomes disordered. Besides, the increased amount of specific 
classes of proteoglycans, which is a common finding in MMVD (Gupta et al., 2008), 
can substitute for the depleted collagen fibrils, resulting in increased contrast and 
material disparity compared to its periphery. These factors may explain the results 
obtained from the lesion areas of the leaflet compared to the healthy areas. It should 
be born in mind that, all the differences observed in the leaflet were obtained from a 
completely soft tissue that otherwise would be invisible with conventional x-ray 
images. 
The DEI result is also consistent with the x-ray diffraction finding (chapter 2) where 
it was shown that the collagen fibrils were disrupted in the lesion areas. Furthermore, 
this DEI result is in very good agreement, even in terms of DEI images, with a study 
performed by Pisano et al., (2000). They studied infiltrating lobular breast carcinoma 
and confirmed spiculation and architectural distortion in the affected areas compared 
115 
 
to normal ones. Although MMVD and breast carcinoma are totally different 
pathologies, the architectural distortions appear very similar in the two conditions. 
Since the introduction of DEI to biology and medicine in the late 80s, its potential 
has been tested in different conditions and tissues such as lungs, heart, liver and 
limbs in mouse; and human articular cartilage (Lewis et al. 2003; Muehlemant et al. 
2004).  The high resolution and quality of the images in DEI renders it as an option 
which can be applied successfully for studying abnormalities in soft tissues. The 
ability of the technique in depicting strong edge enhancement is another advantage, a 
property that is lacking in conventional x-ray imaging. This provides strong 
boundaries, even between soft tissues, and gives them a three dimensional 
appearances. Further development of the technique will make it possible to obtain 
images in a fraction of a second, making it easier to image live tissues in humans and 
animals that would otherwise be blurred because of their motion. One major 
drawback for DEI is the need for a synchrotron radiation source and its expensive 
set-up. Additionally, it should be remembered that, DEI is not a useful tool for 
studying tissues at a molecular level. In summary, the current study demonstrates the 
successful application of DEI as a useful tool in detecting the structural changes in 
MMVD. The qualitative DEI results showed structural changes of the matrix in 
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Hydroxyproline and proline each have a single hydrogen atom attached to the 
nitrogen atom of their pyrrolidine ring and are therefore referred to as imino acids 
(Figure 4.1). Hydroxyproline differs from proline by having a hydroxyl group (OH) 
attached to the "-carbon atom.  In the extracellular amino acid pool L-proline is one 
of the major constituents and many features have been attributed to it. Proline acts as 
an inhibitory neuromodulator and also serves as a precursor for glutamate synthesis 
in the synapse network of the central nervous system (CNS). Additionally, it has 
been shown that a gene (PRODH1) involved in encoding of proline oxidase (POX) is 
inducible by P53, a well-known tumour suppressor. Hydroxy-L-proline is, however, 
primarily found as an oligopeptide in the body. The major form of hydroxyproline in 
mammals is 4-hydroxy-L-proline with the origin of endogenous and dietary collagen. 
3-hydroxy-L-proline from collagen in basement membrane is found in much smaller 
quantities (Phang et al., 2001; Hu et al., 2008). 
 
Figure 4.1:  The structure of hydroxyproline. Note that in proline and hydroxyproline the side 
chains are bonded to the backbone nitrogen as well as to the !-carbon. The ring plays an 
important role in restricting the geometry of any protein where it is present.      
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Although nonessential amino acids can be synthesized via endogenous pathways, 
these pathways are not often used when there is a good supply of dietary proteins. 
However, some endogenous pathways are essential as they provide precursors for 
other metabolic pathways. Pyrodoxal-5-phosphate coenzyme catalyzed 
decarboxylation and transamination reactions are necessary for amino acid 
metabolism. Interestingly, since proline does not have any primary amino group it is 
excluded from this pathway. The study of proline metabolism is gaining increased 
interest. A role for proline has been identified in interactions such as defense against 
osmotic challenge in prokaryotes and plants, as a redox shuttle in insects, and as a 
mediator of parasite-induced pathophysiology in mammalian hosts (Phang et al., 
2001) 
Proline and hydroxyproline metabolism 
Orinithine and glutamate are the main precursors of proline, with pyrroline-5-
carboxylate (P5C) or glutamic-"-semialdehyde as the intermediates. Ornithine-"-
aminotransferase (OAT) is an enzyme responsible for the conversion of orinithine to 
P5C. The mitochondrial matrix of cells from all tissues accommodates this enzyme. 
It can also be found in red blood cells. Additionally, P5C synthase, which is an ATP 
and NADPH-dependent enzyme, can also be found in the mitochondrial inner 
membrane. P5C synthase catalyzes the production of P5C from glutamate. In 
mammals, a high activity of P5C synthase has been observed in small intestinal 
mucosa, colon, pancreas and brain. Conversion of P5C into proline is mediated by 
P5C reductase with the help of cofactors such as NADH or NADPH. Proline 
degradation starts by conversion of proline into P5C by an enzyme called proline 
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oxidase, which is located in the inner membrane of mitochondria. Then, P5C 
dehydrogenase catalyzes the conversion of P5C into glutamate. 
The principle route of biosynthesis of hydroxyproline or 4-hydroxy-L-proline is the 
post-translational hydroxylation of proline in a newly synthesized collagen. Peptidyl-
proline hydroxlyase catalyzes this hydroxylation and requires O2, ferrous iron and #-
ketoglutarate. 3-hydroxyproline, unlike 4-hydroxyproline occurs only in interstitial 
collagen. The ratio of 3-hydroxlyproline to 4-hydroxlyproline is often used in 
experiments to determine the amount of basement collagen to that of total collagen. 
The formation of 3-hydroxyproline occurs in the same manner as 4-hydroxyproline 
except that it is catalysed by a different prolyl hydroxlyase. The degradation of 4-
hydroxy-L-proline starts with steps similar to those of proline degradation, though 
with the distinct enzyme. However, there is one exception where one single enzyme 
catalyzes dehydrogenation of both P5C and pyrroline-3-hydroxy-5-carboxylate.This 
enzyme common to both pathways may be a linking point between the metabolism of 
proline and hydroxyproline. The degradation of hydroxyproline starts with an 
oxidation reaction leading to --pyrroline-3-hydroxy-5-carboxylate, similar to that of 
proline oxidation. Then NAD+-dependent dehydrogenase catalyzes the conversion of 
the pyrroline product into 4-erythro-hydroxy-L-glutamte followed by transamination 
of hydroxyglutamte to form 3-hydroxy-2-oxoglutarate. After this point, however, the 
similarities between two pathways end. Hydroxyoxoglutarate is sliced into two 
products, namely glyoxylate and pyruvate. Knowledge about the degradation of 3-
hydroxyproline is limited, but its urinary excretion can be used as a marker for 
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basement membrane turnover. Figure 4.2 shows the main degradation pathways of 4-
hydroxyproline in the mammalian tissues. 
 
Figure 4.2:  The major pathway of 4-hydroxyproline in mammals’ tissue. In the major 
pathway the enzymes are (1) hydroxy-L-proline oxidase (2) '-pyrroline-3-hydroxy-5-
carboxylate dehydrogenase (3) glutamic-oxaloacetate amino transferase (4) 4-hydroxy-2-
oxoglutarate lyase. In the minor pathway, the enzyme is (5) L-amino acid oxidase and the 
reaction (6) is spontaneous (Phang et al., 2001). 
Free hydroxyproline in plasma forms less than 25 percent of the total hydroxyproline 
of plasma, and this percentage may vary between children and adults. The remainder 
of the imino acid is incorporated into proteins by peptide bonds. There have been 
numerous studies performed on urinary excretion of proline and hydroxyproline 
(Bates, 1977; Hasselbalch, 1987). 
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The ratio of total proline excretion in urine to that of total hydroxyproline in humans 
rises from childhood to adulthood. Moreover, excretion of the peptide bound form of 
hydroxyproline increases from childhood to adolescence, proving a greater turn-over 
of collagen during the growth period. However at the same time there is no increase 
in urinary excretion of free hydroxyproline as renal re-absorption of imino acids 
dramatically increases from infancy and childhood to adulthood. 
Hydroxyproline is restricted to collagen and therefore it can be used for measuring 
collagen turn-over or determining the collagen content of a given tissue. It may also 
provide useful information for some physiological and pathological conditions such 
as growth, aging and malignancies. 
Aim 
Collagen depletion has long been suspected in MMVD and has been demonstrated 
by conventional and electron microscopy (Chapter 1). X-ray diffraction studies 
(Chapter 2) showed depletion of fibrillar collagen in the diseased areas. However, 
there are no previous reports that have quantified the changes (increase or depletion) 
of collagen in canine MMVD. Collagen composition in human myxomatous mitral 
valves is also a matter of controversy (Cole et al., 1984; James et al., 1991). This 
experiment was designed to determine the amount of collagen (irrespective of spatial 
arrangement) in the diseased and healthy regions. The results would determine 
whether there is a consistent relationship between the collagen depletion and severity 
of disease (MMVD grade I in current study). Furthermore, as non-fibrillous collagen 
molecules also play a role in the pathophysiology of MMVD, this experiment would 
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complement the results of the differential scanning calorimetry experiment (Chapter 
5) in determining the extent of the relation between the whole collagen content to 
that of fibrillous collagen in MMVD.  
Materials and methods 
The samples were obtained from 3 dogs with grades I and II myxomatous mitral 
valve disease (Table 4.1). They were cut to produce three 3 * 3 mm specimens from 
affected and healthy regions of the leaflets., Their wet weight was also measured. 
Additional samples were prepared from dog tail tendon. An adapted form of the 
Bergman and Loxley method was used to determine the hydroxyproline content of 
the tissues used (Hurtig et al., 2001). Since hydroxyproline is exclusively found in 
collagen, where it comprises 13.4% of the protein, the total concentration of collagen 
can be determined by multiplying the hydroxyproline value by 7.46. The tissues were 
dehydrated in 1 mL acetone (60 minutes) and degreased in 2 mL petroleum ether 
(120 minutes). The fragments were dried in an incubator at 100°C for 30 minutes. 
Drying continued in a freeze-dryer for 6 hours. The samples were re-weighed again 
(dry weight). 100 ,L of 6 N HCl was added to each test tube and they were sealed 
under vacuum. The sealed tubes were incubated at 110°C for 12 hours. The 
hydrolysates were then dried, resuspended in 1 mL HCl (1 mM) and transferred into 
1.5 mL Eppendorf tubes. They were centrifuged at 10000 rpm for 15 minutes. The 
supernatants were used for the next step of the protocol. This preparation was carried 
out in triplicate for each sample. To 100 ,L of supernatant in each test tube, the 
following reagents were added in order: 400 ,L HCl (1mM); 1 mL isopropanol; and 
500 ,L of an oxidant solution. The oxidant solution contained 1 mL of 7% 
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chloramine-T made in distilled water added to 4 mL of acetate/citrate buffer, pH 6 
(14.3 mg sodium acetate trihydrate, 9.4 g trisodium citrate dihydrate and 1.4 g citric 
acid monohydrate were dissolved in 96 mL isopropanol and made up to 250 mL with 
distilled water). Standard hydroxyproline solutions of 1.5, 1, 1/2, 1/4, 1/8, 1/16, 1/32, 
1/64, 1/128 mg/mL were made from L-4-hydroxyproline (Fluka Biochemika) and 
treated in the same way.  A blank control was made by adding 500 ,L 1 mM HCl 
instead of the supernatant or standard solution.  The tubes were vortexed and left at 
room temperature for 4 minutes. 500 ,L freshly prepared Ehrlish’s reagent solution, 
containing 3 mL of Ehrlish’s reagent (10 g paradimethylaminobenzaldehyde in 11 
mL 70% perchloric acid) mixed with 16 mL isopropanol, was added to all tubes. The 
tubes were vortexed again and incubated in a water bath at 37°C for 2 hours. The 
absorbance was read at 550 nm (Varian Cary 50 Scan spectrophotometer) for all the 
samples and concentration of hydroxyproline was calculated using the standard 
graph.  
Breed Age Sex 
CKCS 8 years old Male 
Mixed breed CKCS 10 years old Female 
Mixed breed Terrier 14 years old female 




The assay of collagen based on hydroxyproline measurement is summarised in table 
4.1. The mean values for collagen content based on dry tissue were found to be 
416.15 ,g/mg   ± 9.21 (SD) and 370.06 ,g/mg ± 12.76 (SD) in healthy and diseased 
regions, respectively. The mean values for wet tissue were also 37.48 ,g/mg and 
33.15 ,g/mg in healthy and diseased regions respectively. Analysis of all triplicate 
results for healthy and diseased regions using two sample un-paired t-test showed 
that the quantity of collagen diminished approximately by 10% in the affected valves 
compared to that of normal valves (P + 0.05). Comparing the amount of collagen in 
mitral valve leaflets (irrespective of their disease status) to that of collagen content in 
tail tendon, (especially wet tissue measurement) reveals a big difference. This may 
indicate the difference in hydration state between tail tendon and mitral valve 
leaflets. As the tissues were degreased during the preparation procedure, it may also 





 ,g/mg  dried tissue ,g/mg wet tissue 
Normal 416.15  ± 9.21 37.48 
Affected  370.06  ± 12.76 33.15 
Tail tendon 467.17 ± 8.05 172.15 
Table 4.2: Collagen content of dog tail tendon, normal dog mitral valves leaflets and valve 
leaflets from dogs affected by MMVD, determined by quantitative analysis of hydroxyproline 
((g/mg) using an adapted form of Bergman and Loxley method (Hurtig et al., 2001).   
Discussion 
Hydroxyproline assay is an established method of measuring the collagen content of 
different tissues and of the body as whole. Many diseases, including cardiac 
conditions, are associated with the depletion or restructuring of collagen. 
Determination of changes in the amount of collagen in certain diseases can provide 
valuable information about the pathogenesis. For example, in one form of mouse 
model of osteogenesis imperfecta (oim) where the pro-#2(I) chain of collagen is 
faulty, there is about 60% less collagen in tail tendon and a 40% reduction in tensile 
strength to that of wild type mice (Weis et al., 2000). Electron microscopy studies 
have also shown areas of depleted and disorganised collagen in the affected leaflets 
in MMVD (Tamura et al., 1995; Black et al., 2005). However, there has not yet been 
any study of the amount of this depletion. The current study has shown that there is a 
depletion of about 10% in the mild and moderately affected leaflets (grade I and II). 
The amount of collagen in the tendon samples, per dried tissue mass (approximately 
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50%), according to the hydroxyproline assay, was in close agreement with an earlier 
study of the collagen content of equine superficial digital flexor tendon (Lin et al., 
2005) and it validates the measurements in the dog valves. The depletion of collagen 
would certainly affect the general properties of the leaflets making them weaker and 
less able to resist blood pressure, thereby contributing to the clinical malfunction of 
the leaflets. However, it should be mentioned that depletion of collagen alone cannot 
be the only reason for the leaflet dysfunction, as the previous chapters have shown 
that the structure of the fibrils and their orientation must be of considerable 
importance as well. 
The reason for the depletion of collagen in MMVD or primary mitral valve prolapse 
remains unknown. In diseases such as osteogenesis imperfecta, it seems that 
production of faulty collagen fibrils renders the collagen liable to be removed faster 
than normal. However, in MMVD, the genes that encode collagen seem to display no 
abnormalities (Pedersen and Häggstrom, 2000). The question is then, why do these 
apparently properly encoded collagen molecules start to deplete faster than the 
normal rate? One possible explanation may lie in extensive post-translational 
modifications that collagen undergoes after its primary formation. Another possible 
explanation relates to the context of the micro-milieu of the leaflets. Changes in this 
micro-milieu, such as excessive deposition of glycosaminoglycans and an increased 
activity in the pathways that may suppress collagen synthesis or enhance its 
degradation, can also play a part in this process. In this aspect, the role of cytokines 
needs to be taken into account. Several studies have shown that transforming growth 
factor-!1 (TGF-!1) in human patients is responsible for deposition of extracellular 
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matrix in hypertensive blood vessels or fibrosis in aortic valve disease (Grande et al., 
1997; Lin et al., 2008). However, a study showed that there was not any connection 
between TGF-!1 and human mitral valve prolapse in a population of Taiwanese 
patients (Chou et al., 2002). Other cytokines, such as tumour necrosis factor-# and 
interferon-" can also suppress collagen synthesis. Interleukin-6 also strongly inhibits 
the growth of the fibroblasts (Ihlberg et al., 1993). Injuries and remodelling 
processes are often accompanied by an increase of hydroxyproline concentration in 
the most tissues, but it seems in MMVD this remodelling in response to the disease is 
somehow different. Rabkin et al. (2001) have shown that there is no increase in 
collagen mRNA in the remodelling of connective tissue in myxomatous mitral valve 
disease, while at the same time there is strong expression of the matrix 
metalloproteinases, cathepsins and interleukin-1!. 
One potentially important area of investigation is the biology of advanced glycation 
end products (AGEs) as they might also play a role in collagen depletion. It seems 
that AGEs can affect the matrix-cell interactions, such as migration, growth, 
proliferation and also gene expression. It has been shown that the cells grown in 
matrices with high concentration of AGEs have different characteristics in terms of 
differentiation, response to cytokines, motility, etc. The relation between AGEs and 
apoptosis has also been studied. In two recent studies, Takahashi et al. (2008) have 
shown that methylglyoxal (MG) (one of the precursors of AGEs) is responsible for 
apoptosis in endothelial cells of bovine aorta, while Niu et al (2008) have shown that 
AGEs can induce cell arrest and apoptosis in the cultured dermal fibroblast. It has 
already been shown that receptors of AGEs accumulate during the course of diseases 
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such as diabetes, Alzheimer disease and also during aging. In vitro studies have 
demonstrated that binding the AGE to its receptor triggers the activation of the 
transcription factor NF-kB (nuclear factor-kappa B) via p21ras/MAP. NF-kB is a 
transcriptional factor responsible for gene modulation of endothelin-1, VCAM-1 
(vascular cell adhesion molecule-1), tissue factor and thrombomodulin. It is also 
related to the generation of some cytokines, such as IL-1#, IL-6 and TNF-# (Singh et 
al., 2001). Research projects targeting AGEs, in order to reduce their formation and 
possible detrimental effects, are many and on-going. Several AGE inhibitors have 
been studied. Of these, some have attracted more interest than others, including 
aminoguanidine, aspirin, antioxidants (vitamin C and E), metal ion chelators 
(desferoxamine and ALT-946,N-(2-acetamidoethyl)hydrazinecarboximidamide 
hydrochloride),  penicillamine, pyridoxamine (vitamin B6), and enzymes that cause 
deglycation of Amadori products (amadoriases) (Reddy and Beyaz, 2006; Desai and 
Wu, 2007). Aminoguanidine (AG) and aspirin are potentially promising agents. AG 
mainly acts by sequestrating 1,2-dicarbonyl compounds (which arise from oxidation 
of free sugars or Amadori products) through the formation of their corresponding 
adducts, 1,2,4-triazines, which are relatively non-toxic compounds. Aminoguanidine 
is also structurally similar to that of L-arginine, which is the precursor in the 
formation of nitric oxide (NO). It has been shown that AG is capable of inhibiting 
NO synthase (NOS) (Singh et al., 2001; Wilkinson-Berka et al., 2002; Reddy and 
Beyaz, 2006). NO and its potential relation to MMVD was discussed in Chapter one. 
Aspirin acts in a concentration-dependent manner and two mechanisms may be 
involved: scavenging of oxygen radicals and acetylating lysine residues which then 
blocks glycation, though some have questioned the importance of the latter 
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mechanism (Hadley et al., 2001; Urios et al., 2007). More research is needed to shed 
light on the role of AGEs in MMVD and the possible amelioratory or therapeutic 
effects of AGEs-inhibitors.  
The exact factors which trigger the primary causes of collagen depletion are still 
unknown. However, it is now well documented that the depletion of collagen in some 
tissues, especially those that are under repeated stress such as muscle, can lower the 
threshold of micro-injury level making them more prone to a form of self-





Differential scanning calorimetry 
(DSC) and thermal stability of 
collagen in MMVD 
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Differential scanning calorimetry 
Differential scanning calorimetry (DSC) is a technique that belongs to a group of 
techniques called “thermal analysis”. The objective behind any thermal analysis is 
simply to obtain information about thermal changes in a sample by heating or 
cooling it. In DSC, this is done in comparison to a reference sample. Depending on 
the specific heat of a given sample any thermal energy supplied to a sample would 
increase its enthalpy and temperature. The energy supplied to the sample not only 
increases the temperature and enthalpy, but it can also change the physical and 
chemical status of the material, leading to melting, denaturation, decomposition etc. 
DSC and differential thermal analysis (DTA) are two major thermal analysis 
methods employed in biology. The term “differential” reveals an important feature of 
the techniques: two identical sensors are connected to the sample and reference and 
the output signal from the instrument is directly related to the difference between 
these two samples. The two techniques are often used for solid materials though 
using them for suspensions or solutions, such as various lipid solutions is not 
uncommon (Davies et al., 1998). The requirement for a very small amount of the 
sample and rapidity of the methods, have increased the popularity of these thermal 
techniques. However, differential scanning calorimetry is fundamentally different 
from differential thermal analysis. In DTA the temperature difference between a 
sample and reference material is monitored while they are subjected to the same 
environment of the heating or cooling. Then the plot of DTA is drawn as -T 
(function of temperature) on the y-axis against the time or temperature on the x-axis. 
In the case of DSC, on the other hand, while the sample and reference are in exactly 
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similar environments, using a predetermined programme, the temperature for the 
sample and reference are maintained equal throughout the experiment even when the 
thermal events occur in the sample. The energy which has to be supplied or 
withdrawn from the sample to yield a zero temperature difference between the 
sample and the reference is recorded. Therefore, the DSC plots record energy (heat) 
in the y-axis against temperature or time on the x-axis. Any changes in the sample 
which are associated with absorption or releasing of heat are recorded as a peak 
whose area is proportional to the enthalpy changes and direction (whether negative 
or positive) indicates the type of the thermal event, namely endothermic or 
exothermic. 
DSC often falls into two major categories: Power Compensated DSC and Heat Flux 
DSC. In case of Power Compensated DSC, there are separate micro-heaters and 
temperature sensors for the sample and sensor. In the event of temperature difference 
between the sample and reference, energy is supplied or withdrawn in order to keep 
the difference at zero. The differential energy is the source of the instrument signal. 
In Heat Flux DSC the sample and reference are heated in the same furnace and the 
temperature difference (-T) is measured by thermocouples. -T is then converted 
into differential energy by the use of instrument software. Additionally, in Heat flux 
DSC (like DTA), an endothermic event produces a negative peak and exothermic 
event would give rise to a positive peak, which is the opposite of the thermal plots 
from Power Compensated DSC. A typical thermal analysis curve for Power 
Compensated DSC is shown in Figure 5.1. Of particular interest of this curve is the 
extrapolated peak onset temperature (Te) which is the intersection of the extrapolated 
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baseline and the tangent line of linear section of main peak. This is more reliable 
than the maximum temperature of the peak, as it is less affected by the heating rate. 
The initial peak temperature and the final peak temperature are difficult to pinpoint 
so they are seldom used (Höhne et al., 1996; Laye, 2002; Ramachandran et al., 
2003). 
 
Figure 5.1: Characteristic features of the thermal analysis curve. Initial peak (Ti), 
extrapolated peak onset temperature (Te), maximum peak (Tp), extrapolated peak 





Proteins, including collagen, in their natural tertiary structures are thermally stable 
compounds with a lower state of energy. The thermal properties of proteins are 
affected by hydration, hydrogen bonds, environmental conditions (such as pH), 
cross-links, mechanical loading of proteins etc. An understanding of the 
physicochemical principles of thermal properties of proteins can help us to 
understand the functions of proteins. This DSC study was, therefore, designed to 
investigate changes in the thermal properties of collagen molecules occurring in 
MMVD. Different aspects of changes which collagen molecules undergo in MMVD 
have been shown in this thesis and the DSC results are interpreted accordingly in the 
light of those findings. 
Materials and methods 
In the current study a Power Compensated Perkin Elmer Pyris I differential scanning 
calorimeter was used (Norwalk, CT USA). A schematic set up for the experiments 




Figure 5.2: A schematic of set up of the Power Compensated DSC used in the current study 
(Nicula, 2002).  
Tissue samples were chosen and excised from the affected grade I MMVD freshly 
thawed leaflets and also from normal leaflets. Overall, 10 diseased and 7 unaffected 
samples (from 4 different leaflets of grade I and II) were analysed (Table 5.1). They 
were cut into small pieces and   blotted with a soft tissue and then weighed. They 
were sealed in aluminium pans (8 mm in diameter) and placed in the DSC 
instrument. An empty pan was used as a reference.  Heating was carried out from 10 
to 80°C at a rate of 5°C/min after initially holding at 10°C for 2 minutes. The onset 
temperature and enthalpy (!H) were calculated from thermograms for each process. 
The enthalpy was determined from the area under the curve between the extrapolated 
peak onset and the extrapolated peak completion. Rat  and dog tail tendons were also 
run to ensure reproducibility of the data and for comparison, respectively. After 
completion of the measurements the sample pans were punctured and placed under 
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vacuum for 3 hours to desiccate the samples before they were re-weighed. The DSC 
instrument was calibrated with indium and water as standards, prior to the 
commencement of the measurements. Statistical analysis was performed using a two 
sample un-paired t-test with significant differences taken at P + 0.05. 
Breed Age Sex 
German shepherd 14 years old Male  
Beagle 3 years old Male  
Grey hound 9 years old Male  
Collie 10 years old Male  
Table 5.1: The details of the dogs used in DSC experiment. All of them demonstrated grade 
I and II mitral valve involvement. 
Results  
Table 5.1 gives the thermometric parameters determined by DSC for samples of 
myxomatous and healthy leaflets and dog tail tendon. The data reveal a reduction in 
the enthalpy of denaturation in affected regions of the leaflets compared to that of 
normal ones (P + 0.05). The onset temperature of the main endothermic peak was 
slightly lower in affected areas compared to the normal group, but this was not 
statistically significant. Comparing the leaflets with dog tail tendon (Figure 5.3) a 
noticeable difference in the enthalpy of denaturation was found for both normal and 
diseased tissue. However, the endothermic peak in tail samples was at the same 
temperature position as those of the leaflets.   
137 
 
 Onset Temp mean Peak Temp mean Enthalpy(-H) mean 
Dog tail tendon 64.56 °C  ± 0.23 65.75 °C 8.52 J/g   ±  0.19 
Healthy sample  65.10 °C  ± 0.35 66.37 °C 1.75 J/g   ±  0.07 
Affected sample  64.60 °C  ± 0.30 65.45 °C 1.40 J/g   ±  0.05 
Table 5.2: Comparison of thermal parameters for collagen denaturation in dog tail tendon   
(n = 5), healthy sample (n = 7) and affected sample (n = 10). Measurements were performed 
on a Perkin Elmer Pyris 1 differential scanning calorimeter.  
 
Figure 5.3: A thermogram of differential scanning calorimetry. From top to bottom:  dog tail 
tendon, diseased and normal valve leaflets. The weights of the samples used were: dog 
tendon 35.2 mg; healthy valve 36.0 mg; diseased valve 36.2 mg. The weights have been 




Measurements of the melting process by differential scanning calorimetry give 
insight into the structural alteration that occurs with myxomatous degeneration of the 
mitral valve. In general, the thermal stability of collagen depends upon the level of 
hydration of the collagen, the number of hydrogen bonds and the number and the 
nature of covalent cross-links (Sionkowska, 2005; Trebacz and Wójtowicz, 2005). 
The mechanism of denaturation is based on an irreversible process beginning with 
the rupture of hydrogen bonds coupling the three #-chains followed by breakage of 
the cross-link bonds (Miles, 1993; Miles et al., 1995). Miles and Ghelashvili 
proposed that dehydration reduces the free-volume available for denaturation of the 
#-chains in the presence of thermally stable cross-links in the collagen fibres (Miles 
and Ghelashvili, 1999). Moreover, this dehydrated collagen could be confined in a 
spatial arrangement within the lattice of the fibre decreasing the entropy and 
subsequently raising the thermal stability of collagen (polymer-in-a-box theory). 
Alternatively, simultaneous with rearrangements in the molecular packing of 
collagen in the fibre, water molecules that are connected via hydrogen bonds to the 
triple helix itself would be gradually stripped away, as the fibre is further and further 
dehydrated. Some of these molecules are involved in water bridge structures that 
connect one #-chain to another. These hydrogen bonds would need to be broken on 
denaturation. Thus stripping away of water bridge molecules has several effects, of 
which the most important one is the reduction of enthalpy of denaturation because 
fewer hydrogen bonds need to be broken to separate the #-chains and reduce them to 
random coils.  Finally, once the #-chains are uncoupled, the whole molecule 
becomes unstable, rapidly unzips, and collapses to form random coils. 
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In the measurements from this study, the enthalpy of denaturation of collagen in both 
groups of valve leaflets showed distinct differences compared to the tail tendon. 
Comparison of the affected and normal leaflets also revealed that, in the affected 
leaflets, the enthalpy of denaturation was decreased by 20% or, in other words, 20% 
less intact collagen fibrils. To validate the current DSC data experiment, the 
reanalyses of the x-ray diffraction data was performed on the summed meridional 
diffraction intensities, normalised using readings taken from ion chambers (in a SRS 
set-up, ion chambers are often placed after and before the sample. They convert the 
intensity of beam into number of x-ray photons, providing a useful tool for 
normalising data and monitoring the incident beam). This produced a value that is 
proportional to the fibrillar collagen content per unit mass of tissue without taking 
into account the presence of non-fibrillar collagen. The results also confirmed a 20% 
decrease of intact collagen fibrils in the diseased areas (two-sample un-paired t-test; 
P + 0.05). 
This decline in fibrillar collagen cannot simply have been caused by a depletion of 
collagen in the diseased samples as the hydroxyproline assay has revealed that there 
was only about 10% depletion of collagen in the affected tissue (Chapter 4).These 
findings imply qualitative, as well as quantitative, changes in the collagen of affected 
valve leaflets. However, there was no significant difference in the onset temperature 
of denaturation between diseased and normal leaflets. The underlying cause must 
only be affecting the enthalpy of denaturation and not the onset temperature. It is 
already known that a change in pH or concentration of ions around the collagen 
molecules only influences the temperature but not enthalpy of denaturation (Miles et 
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al., 1994). Changes in amino acid composition would also impact on both the 
temperature and the enthalpy. It was Gustavson (1955) who drew the attention of 
composition of amino acids and collagen thermal stability and highlighted the 
importance of hydroxyproline residues in forming hydrogen bonds between its 
hydroxyl group and carbonyl oxygen of adjacent peptide.  Although there are long 
standing reports determining the thermal stability of collagen on the basis of 
combined content of proline and hydroxyproline, new studies have shown that in the 
typical collagen motif of Gly-X-Y (which X and Y are proline and hydroxyproline 
respectively), hydroxyproline stabilises collagen in the Y position independently 
from the X position, while stabilisation occurs in the X position only if the residue in 
the Y position can form stabilisation interactions with X (Berisio et al., 2004). It 
seems that this is the reason why in vertebrates, hydroxylation only happens in the Y 
residue. Other research into the stabilisation effect of hydroxyproline has been 
carried out by substituting of hydroxyproline with 4-trans-fluoroproline. This has 
yielded interesting results. 4-trans-fluoroproline can form hydrogen bonds but the 
resultant collagen is very stable. It has been concluded that hydroxyproline is pivotal 
in the conformational transformation of imino peptide bonds to the “trans” mode. As 
in native collagen triple helix all bonds are in “trans” mode, the collective “trans” 
plays a more important role in the thermal stability of collagen than hydrogen bonds 
(Bann et al., 2000). Moreover, glycine’s role in determining the thermal stability of 
the helix needs to be taken into account. It has been shown that in osteogenesis 
imperfecta, substitution of glycine with another amino acid can affect the thermal 
stability of the collagen, but not all substitutions of glycine residues are equally 
important and the effect varies according to the molecular region (Bächinger and 
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Davis, 1991). However, a change in thermal stability does not necessarily reflect the 
clinical manifestation of a collagen-relevant disease. In one form of osteogenesis 
imperfecta, where there was a glycine to tryptophan substitution with associated 
severe clinical signs, there was only a very slight decrease in the thermal stability of 
the affected collagens (Nuytinck et al., 2000). All these changes in amino acid 
sequences can also affect the onset temperature and enthalpy. While the current view 
is that collagen genes are not affected in MMVD the extensive post-translational 
modification of collagen during its biosynthesis, especially regarding hydroxylation 
of proline and its importance in the thermal properties of the tissue, makes amino 
acid sequence change worth investigating. 
The most probable explanation for the observed decrease in enthalpy of denaturation 
in MMVD collagen is that not all of the collagen molecules are in the form of intact 
and regularly-structured triple-helix and/or fibrils.  This is known by the data from x-
ray diffraction study since only the regularly ordered and intact fibrils would 
contribute to the diffraction pattern (Chapter 2) (Hadian et al., 2007). By comparing 
affected and normal leaflets, it is clear that there is a 20% decrease in intact collagen 
fibrils. This non-fibrillous collagen can arise from failure of incorporation of the 
molecules into fibrils, an uncoupling of the #-chains as a result of enzymatic 
depolymerisation and subsequent denaturation, or from an alteration in the nature 
and number of the cross-links responsible for strengthening the collagen helices. 
Consequently, the onset temperature of denaturation remains unchanged for these 
molecules, but the enthalpy undergoes some changes. This is consistent with the 
findings of a study carried out on the superficial digital flexor tendon degeneration in 
142 
 
the horse which showed that the enthalpy of denaturation of degenerated tendon was 
less than that of normal tendon whereas the temperature characteristics were the 
same (Miles et al., 1994). Interestingly, although the two diseases are very different, 
both appear in advanced age and the cause has been suggested for both to include a 
repeated injury mechanism. However, one may question the underlying source for 
this non-fibrillous collagen. There are reports that the mechanical rupture of tendons 
makes them more susceptible to denaturation and also proteolysis (Miles et al., 
1994). The implication of the “polymer-in- a box” theory is that restriction of the 
collagen molecules in this way can close or cover thermally labile domains (TLD) 
where the triple helices lack hydroxyproline. This restriction of freedom of the 
molecules would prevent molecular gyration and therefore promote thermal stability. 
This suggests that factors such as mechanical or tensile over-load can disrupt this 
structure rendering it more susceptible to denaturation and proteolysis.  In an 
experimental model of tendon overload, it has been shown that the enthalpy of 
denaturation was unchanged while the temperature of denaturation changed (Willett 
et al., 2008). Although these results are in contrast to Miles et al. (1994) and the 
mitral valve results, where the temperature characteristics remained the same, there is 
the interesting point of mechanical impact as a possible contributor to MMVD. The 
leaflets undergo a continuous load during a complete lifespan and this tensile over-
load might play a role in disruption of fibrillous collagen from its original ordered 
structure (especially in older age) resulting in more configurational entropy. 
However, whether this tensile stress can also change the temperature of denaturation 




Neutron scattering and collagen 




Neutron scattering has a use in tissue imaging and can elucidate in great detail the 
structure of biological systems. Neutrons are the subatomic particles first discovered 
by the English physicist James Chadwick in 1932. The unique property of the 
neutrons is that they (unlike electrons or protons) do not carrying any electrical 
charge. Neutrons posses a slightly higher mass than protons i.e. 1.008 amu (atomic 
mass units) based on the C12 scale or 1.675 &  10-27 Kg. Neutrons also have a large 
magnetic dipole moment. The overall charge of neutron is a zero but the distribution 
of the charge is not uniform and, if the electric charge in one end happens to be 
greater than the other side, then a neutron is said to have an electric dipole moment 
(EDM). The half life of a neutron (when they are not in a given stable nucleus) is 886 
± 2 seconds, after which it decays to a proton; an electron and an antineutrino. 
Neutrons display behaviour characteristic of both light and particles. It was Lewis de 
Broglie who combined the wave-particle duality of neutrons via combining Einstein 
and Planck equation to a new equation: 
(=h/mv          (6.1) 
Where h is Planck’s constant, ( is the wavelength, m is the particle mass and v is the 
velocity. As h and m are fixed, one can see that changing the velocity also changes 
the wavelengths (Dobrzynski and Blinowski, 1994). 
Being forms of electromagnetic radiation, light scattering and x-ray diffraction both 
are based on their wave properties. Neutron scattering, however, is based on particle 
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scattering. Neutrons interact with the nucleus of the atoms rather than electron 
clouds. Consequently, there is a relationship between atomic number and an atom’s 
ability to scatter neutrons, a property called the neutron scattering length (see below). 
Neutron scattering length can show large variations among the different isotopes of a 
single element. This makes neutrons a very useful tool for studying isotopes. This 
effect has wide application, especially for distinguishing between the isotopes of 
hydrogen. The scattering lengths of hydrogen and deuterium have opposite signs, 
namely -0.374 and 0.667 m. Furthermore, through their magnetic dipole 
characteristic they interact with unpaired spins (one electron occupying one orbital) 
of a molecule.  
There are 4 possible outcomes when a neutron interacts with a nucleus, namely: 
scattering, transmutation, fission and radiative capture. The type of the scattering is 
mostly depended on the incident wave frequency to that of scattered one. They are 
the same in coherent neutron scattering. If, however, there is a frequency change 
during the scattering process, then it is classified as either elastic or inelastic 
scattering. In elastic scattering, a neutron collides with the nucleus and bounces off 
without any change in energy. In inelastic scattering, the collided neutron is 
temporarily absorbed by the nucleus forming a transient compound before emitting 
another neutron with lower energy together with a gamma particle which accounts 
for the rest of the energy. Alternatively if there is small change in the amount of 
energy combined with a frequency shift, the scattering would be quasielastic (Friedli, 
1996). Therefore, there are 6 types of neutron scattering: coherently elastic 
scattering, incoherently elastic scattering, coherently inelastic scattering, 
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incoherently inelastic scattering, coherently quasielastic scattering and incoherently 
quasielastic scattering. 
There are two important factors which determine the strength of the scattering from 
an atomic nucleus: scattering length and scattering cross-section. The scattering 
length (b) has the dimension of length and is the ability of a single atom to scatter a 
neutron. It is a real and constant value for a given atom or an isotope. The neutron 
scattering cross section of a system is defined by its ability to scatter neutrons, in 
other words it is an effective area which the target nucleus presents to an incident 
beam. The neutron scattering cross-section has the dimension of area and is 
measured in barns (1 barn = 10-28 square metre) and mathematically is defined as:  
. = 1//          (6.2) 
where        
Additionally, the relationship between the cross section and scattering length is 
defined as . = 4"b2        (6.3)         
Taking into account the above equations results in several important conclusions. By 
combining the kinetic energy of neutrons (as they have a finite mass) with the 
Broglie equation, one can deduce that an x-ray photon at the given wavelength has 
about 200,000 times more the energy than a neutron at the same wavelength. 
Deposition of this much x-ray energy in sensitive biological samples causes radiation 
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damage, leading to molecular degradation of the samples. On the other hand, having 
a small neutron cross-section means that if neutrons hit this area, they would scatter 
isotropically (equal probability in any directions). This happens as the area of 
nucleus compared to neutron wavelength is very small and the nucleus acts as a 
“point of scatter”. In case of x-rays, however, they interact with electron clouds 
which are comparable in size to the incident beam. Consequently, the scattered beam 
is not isotropic. Furthermore, the interaction and absorption of neutrons by most 
materials are weak, and this characteristic makes neutron beams much more 
penetrating than x-rays.  
Aim 
The cross-links of collagen provide tensile strength and structural stability to 
collagen molecules and connective tissues. The majority of cross-links in collagen 
arise from an enzymatic pathway mediated by lysyl oxidase. They are first produced 
as immature cross-links before transformation into mature cross-links. It has been 
shown that any abnormality in cross-links can affect functional properties of collagen 
molecules. The pathways of cross-links production and their significance in disease 
and health states have been detailed in Chapter 1. The purpose of this neutron 
scattering study was to investigate whether MMVD could affect immature cross-
links. The result could give an insight into the pathogenesis of the disease and could 




Instrumentation and methods 
Neutrons can be produced in two different ways, namely fission (in research 
reactors) and spallation (in accelerator-driven spallation neutron sources). In the 
research reactors, neutrons are produced as the result of chain reactions caused by 
bombarding heavy atoms such as uranium or plutonium. The heavy atoms then break 
up into some nuclear fragments, produce energy and emit neutrons. These neutrons 
are then responsible for self-sustained reactions. Thus, the reactor is a continuous 
source of neutrons. After moderation (see below) a neutron beam should be 
converted to a monochromatic beam. This is performed by applying Bragg’s Law (n( 
= 2d sin)) to a single crystal which is often made of pyrolytic graphite, germanium 
or copper. Although the beam has many wave-lengths, spacing between the layers 
(2d) and scattering angle (2)) are chosen in a way that only neutrons that satisfy 
Bragg’s Law are directed towards the sample. One example of such reactors is the 
High Flux Reactor at the Institut Laue-Langevin in Grenoble (France). This reactor 
was used in the current study. In the spallation method, high energy photons, 
produced in an accelerator, hit heavy metal targets like uranium or tungsten 
separating the neutrons. The neutrons from a spallation source are not in continuous 
flux, but are emitted in pulses. However, spallation produces 20-30 neutrons per 
photon while in reactors only one neutron is produced per single fission reaction. 
Primary neutrons produced by either of the two methods are called thermal neutrons 
and are literally “too hot to handle”.  If they were used for scattering measurements, 
they would disturb the atomic positions of the sample materials. Moderation is a 
process in which the thermal neutrons are directed towards a moderator such as 
beryllium or graphite. Possessing a large neutron cross-section, these materials cause 
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thermal neutrons to undergo several inelastic collisions, thereby producing slow and 
cold neutrons with energy between 0.1 and 10 meV suitable for investigational 
purposes (Dilip, 2004; Harroun et al., 2006).  
The instrument D22 (Figure 6.1), at the Institut Laue-Langevin (Grenoble, France), 
was used to collect small angle scattering data with 7 Å wavelength neutrons. Using 
this instrument a well-established technique called isomorphous replacement was 
applied, which involves replacing hydrogen atoms in the sample molecules with the 
stronger-scattering deuterium. The ability of sodium borohydride (NaBH4) to react 
and reduce the keto-amine and Schiff base groups of mostly aldehyde-based cross-
links has been reported previously (Robins and Bailey, 1977). The introduction of 
deuterons into an ordered structure will alter the neutron scattering density profile 
and therefore its diffraction pattern. Therefore, sodium borodeuteride (NaB2H4, 98% 
atom of deuterium) was used to target the reducible cross-links specifically, using the 
method of Wess et al. (1993). The reducing solution was made by dissolving 70 mg 
of sodium borodeuteride in 5 ml phosphate buffered saline (PBS) at pH 7.5. Each 
fresh sample (approx 1 g in weight) was immersed separately for 20 minutes 
followed by washing with phosphate-buffered saline at pH 7.4 to stop the reaction.   
 The 96 x 96 cm detector was placed at two positions, 2.5 and 11.2 metres, to collect 
data spanning the range from the 1st to the 7th order of meridional diffraction. Neutron 
scattering data were collected from each mitral valve leaflet sample at each detector 
position, and then the same samples were treated with sodium borodeuteride and re-
measured. Due to constraints on the allocated instrument time, it was only possible to 
run one unaffected and one diseased (grade I and II) sample obtained from two 
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different mitral valve leaflets and one dog tail tendon (Table 6.1).  An empty cell and 
detector-calibration (water cell) measurements were also performed, for use in 
correcting and analysing the data.  
Breed Age Sex 
German shepherd  10 years old  Male 
Jack Russell 8 years old Male 
Table 6.1: The details of the dogs used for neutron diffraction experiment. 
151 
 
     
 
Figure 6.1: The layout of D22 instrument at ILL. The incoming neutrons are monochromized 
by a mechanical velocity selector and the beam is collimated using collimators and neutron 
guides before they hit the sample. The detector is inside an evacuated tube and its distance 
from the sample can be adjusted accordingly (diagram courtesy of ILL official website). 
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The LAMP program (Large Array Manipulation Program, ILL) was used to 
normalize the data to water with all corrections (transmissions and background) 
carried out on radially-averaged data. Diffraction spectra were obtained by sector 
summation and ratios of diffracted intensity were calculated for each of the seven 
orders of meridional diffraction by dividing the diffracted intensity of treated tissue 
by the corresponding intensity of untreated tissue. The data sets have been scaled to 
give a first order ratio of 1.0. For comparison corresponding data from an earlier 
study of rat tail tendon, by Wess and co-workers (1990), was analysed in the same 
way. 
Results 
Table 6.2 shows the effect of NaB2H4 treatment on the three different types of tissue. 
The results are expressed as ratios of Bragg peak intensity, before and after reduction 
of the cross-links. There were clear differences in the pattern of altered intensities 
between tail tendon and healthy heart valve. The intensity changes are larger in tail 
tendon, suggesting that all mitral leaflets, irrespective of their pathological status 
(healthy or diseased), have only a small number of reducible cross-links. However, 
there are also clear differences between the systematic changes of healthy and 
diseased valves, with the pattern of diseased valves lying closer to that of the dog 
tendon implying an increase in the amount of reducible cross-links in the leaflets 
affected by MMVD. 
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Diffraction order Dog tail tendon  Healthy leaflet  Diseased leaflet Rat tail tendon 
1 1.00 1.00 1.00 1.00 
2 1.05 0.94 0.94 0.90 
3 0.95 0.91 0.93 0.93 
4 1.14 0.96 0.99 0.80 
5 1.22 1.01 1.01 1.15 
6 1.27 1.01 1.03 1.37 
Table 6.2: The effect of sodium borodeuteride treatment on the meridional diffraction pattern 
of collagen from dog tail tendon, normal dog mitral valves leaflet and valve leaflet from dog 
affected by MMVD: The data were calculated by dividing the diffracted intensity of treated 
tissue by the corresponding intensity of untreated tissue. The data sets have been scaled to 
give a first order ratio of 1.0. Also shown are corresponding ratios from rat tail tendon, 
calculated from Wess et al., (1993). 
Discussion 
In previous reports, the study of deuterated tendon using neutron diffraction for 
collagen molecule has provided reliable results (Wess et al., 1990; Wess et al., 
1996). The neutron diffraction data from dog tail shows systematic changes that are 
comparable to those of reported by Wess et al. (1990 & 1993), indicating the 
presence of a high number of reducible cross-links in the tail tendon. There is a 
marked difference in the number of reducible cross-links between tail tendon and 
valve leaflets, irrespective of the pathological status of the valves. However, 
according to the same sets of neutron data there are more reducible cross-links in the 
diseased leaflets than in the healthy leaflets. As mentioned before, the cross-links are 
formed enzymatically through the intermolecular reactions of aldehyde residues 
catalyzed by lysyl oxidase. Initially, there are two pathways based on the precursor, 
namely lysine aldehyde and hydroxylysine aldehyde. The latter is the predominant 
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form in most connective tissues. Both of these pathways lead to the production of 
cross-links which are primary borohydride-reducible giving the opportunity to 
investigate them by neutron diffraction, in a non-destructively and highly sensitivity 
manner. However, as the tissues mature these reducible cross-links tend to transform 
to mature and non-reducible cross-links. 
Although the qualitative state of this approach and low number of sample pose a 
limiting factor, the observed changes in the qualitative state of reducible cross-links 
have a number of implications. It is known that MMVD in the dog and human is an 
age associated condition. Studies of other systems have shown that, with advancing 
age, the activity of lysyl oxidase decreases. This indicates that collagen from older 
patients will tend to have fewer cross-links than those found in younger patients 
(Eyre et al., 1988). Other studies have shown that the increased deposition of 
proteoglycans (PGs), which is a proven histopathological aspect of MMVD, might 
interfere with the formation of cross-links (Scott and Orford, 1981). Accumulation of 
advanced glycation end products (AGEs) which are non-enzymatic cross-links, 
derived from prolonged exposure of proteins to reducing sugars, has been also 
reported to have detrimental effects on mechanical properties of a tissue and might 
also interfere with the formation of enzymatic cross-links. Increasing importance is 
being given to the role of AGEs in the process of aging and has been discussed 
earlier (Haus et al., 2007; Shiraki et al., 2008).  Another interesting finding comes 
from the studies done by Akeson et al. (1977) and Harwood and Amiel (1992) in 
which they reported increased reducible collagen cross-links in periarticular collagen 
of rabbits after some weeks of immobilization. They have described it as a secondary 
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increase due to the lack of stress and motion. Although in some tissues motion and 
tonic neuronal input is essential for the remodelling of the connective tissue and 
collagen, which otherwise would result in atrophy, these studies have not explained 
clearly how the reducible cross-links can increase while a given organ and its 
surrounding connective tissue is immobilised.   
Nevertheless, in the neutron diffraction study, the increase in reducible cross-links 
can be explained in a different way, namely collagen depletion and an altered 
population of collagen-secreting cells (Rabkin et al., 2001; Black et al., 2005, 
Disatian et al., Han et al., 2008). Collagen depletion had been observed before and 
has been quantified by the current study (Chapter 4). In terms of cell population, the 
transition from quiescent fibroblasts to activated myofibroblasts, and finally to 
smooth muscle-like cell phonotype, has been documented for myxomatous mitral 
valves (Rabkin et al., 2001; Black et al., 2005). On the other hand, the presence of 
reducible cross-links is an indicator of collagen synthesis and shows that the integrity 
of the pathways for formation of the cross-links is almost intact. This suggests that 
the products of recently-activated myofibroblasts or smooth muscle-like cells are 
likely to be young and immature collagen molecules. As turn-over increases there 
would not be enough time for the transformation of immature reducible cross-links 
into mature ones. Consequently, with more reducible cross-links, the mitral leaflets 
will be rendered less strong. One of the roles of the cross-links in mitral valve 
collagen would be to provide enough tensile strength in order to withstand pressure 
of ventricular systole.  It is known that prolapse (bulging) of affected leaflets towards 
the atrium during the systole, which is one of the manifestations of MMVD in dogs 
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and MVP in humans (Pederson, 2000; Hayek et al., 2005, Hyun, 2005), can be 
caused by hyper-extensibility of affected leaflets. All in all although reducible 
immature cross-links lack the properties of mature cross-links, their synthesis is an 
important step towards the formation of the mature cross-links and as discussed 





High performance liquid 
chromatography (HPLC) for the 
measurement of mature collagen 
cross-links in MMVD 
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High performance liquid chromatography 
High performance liquid chromatography is a separation technique in which solutes 
migrate through a column or are held back in a stationary phase at rates that depend 
upon their distribution ratios. The distribution ratio or D is determined by the relative 
affinity of solutes for the two phases and is described as the ratio of total solute 
concentration (CS) in the stationary phase to that of it in the mobile phase (CM): 
D = CS / CM          (7.1) 
Therefore, the larger the D value, the longer the migration time we would expect and 
vice versa. As the interaction of the solutes with the stationary phase slows down the 
migration of the solutes, the process is called retention or retardation. Column 
separation describes the time that solutes take to pass through the column, while 
retention time (tR) and retention factor (K) are directly proportional to D. The 
equation for this is: 
tR = tM (1+K)          (7.2) 
In the above equation tM is known as the dead time and is the time required by non-
retained solutes to go through the column. These non-retained solutes migrate at the 
same velocity as the mobile phase, so their K value is zero, leading to   tR = tM. 
Solutes with values of K and D are greater than zero are often retarded 
proportionately in the column. To keep the retention time in an acceptable range in 
chromatographic conditions, the K values should be less than 20. The elution order is 
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dependent on the chemical nature of the solutes and the overall polarity of the two 
phases (Kealey and Haines, 2002). Moreover, size of the particles and pore size of 
the column, and type of the material in the stationary phase are essential 
determinants for the efficient elution of the solutes. The solutes eluted from the end 
of the column pass through a detector (often of ultraviolet light or fluorescence) so 
that a sequence of peaks, differing in absorption or intensity, can be detected and 
identified. There are several modes of HPLC which are mostly classified according 
to the type of stationary phase and the sorption mechanism. Sorption is a process in 
which solutes are transferred from mobile phases into the stationary phase. 
Desorption is the reverse process. In this scheme, almost 90% of all HPLC modes 
can be classified into the following groups:   
Adsorption chromatography, in which the stationary phase is adsorbent and 
separation is based on differing degrees of adsorption and desorption.  
Ion-exchange chromatography, the stationary phase is an ionically charged material 
with a charge that is opposite to that of the sample. 
Size-exclusion chromatography, the stationary phase comprises precisely controlled 
microparticles, and separation is based simply on molecular weights. 
Normal phase chromatography, the stationary phase is made of strongly polar 
material and the mobile phases are non-polar such as n-hexane or tetrahydrofuran. 
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Reverse phase chromatography, the stationary phase is a non-polar material; and the 







Figure 7.1: A simplified diagram depicting the main parts of a typical HPLC set-up. The 
pump provides a steady high pressure with no pulsation, and can be programmed to vary the 
composition of the mobile phase during the course of the separation. While mobile phases 
are running, sample is injected into the loop and upon turning the valve it will be included in 
the circuit directed towards the column. The detector will monitor the mobile phases while it 
emerges from the column and will respond to the physical properties of the solutes which are 
not exhibited by the pure mobile phase (in this case UV absorbance). After passing through 


















In Chapter 6, immature cross-links were studied qualitatively. However, due to the 
nature of neutron scattering experiment, measurement of the mature cross-links was 
not feasible. So evaluation of the cross-linked state of collagen in MMVD was not 
complete because it only studied immature cross-links. In a fully developed tissue, 
most of the attributes of cross-links results from mature type (see Chapter 1). The 
following study was designed to investigate quantitatively the state of mature cross-
links in MMVD using reverse phase HPLC. 
Materials and methods 
In the current study, reverse phase chromatography was used, with the following 
materials and instruments: acetonitrile (HPLC gradient grade), methanol 
(chromasolve), sodium dihydrogen orthophosphate (NaH2PO4), boric acid and o-
phthalaldehyde (OPA-complete solution) (Sigma-Aldrich, UK). Sample mature 
cross-links standard, pyridinoline (PYD) and deoxypyridinoline (DPD) were kindly 
supplied by the Rowett Research Institute (Aberdeen, UK). A standard single amino 
acids collection was from VWR International (UK). The conditions used for 
chromatography were generally in accordance with the Bartolomeo and Maisano 
methods (2006). Chromatography was performed on a Pharmacia LKB.VWM 2141 
HPLC system at room temperature using Phenomenex Luna 5µm C18 (2), reverse 
phase column (150 * 4.6 mm) with UV detection at (=338 nm. Mobile phases were  
NaH2PO4 40 mM adjusted to pH 7.8 with 2 M NaOH (buffer A) and  
acetonitrile/methanol/water (45/45/10) (buffer B), and the below gradient was 
followed for the runs at 2 mL/min. 
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Table 7.1: Gradient used in HPLC experiments. Mobile phases were NaH2PO4 40 mM 





The samples were injected via an external sample loop directly into the pressurised 
flowing mobile phase just ahead of the column, using a round tip Hamilton micro-
syringe pipette. The loop was filled with the sample while the mobile phase flowed 
directly to the column. By turning the handle of the loop’s valve, the mobile phase 
was diverted into the loop, injecting the sample into the column without any flow 
stoppage (Figure7.2). The valve injection was computer automated, so the 
chromatogram recording started as soon as the injections had been completed. 
A      B 
           
Figure 7.2: Sample injection valve and loop. Sample loading position (a); sample injection 




The separation and quantification of amino acids, or their derivatives can provide an 
invaluable insight into the structure and characteristic of proteins. Often, there is only 
a very low concentration of the target substance in a given sample. Most amino acids 
and their derivatives also lack chromophores and fluorophores. These amino acids 
must therefore be quantified in the presence of other substances which might 
interfere with their detection. Considering this there has always been a high demand 
for a chromatography system which possessed high sensitivity and specificity. The 
introduction of ion-exchange chromatography, followed by the post-column 
derivatisation seemed to have resolved these problems. However, ion-exchange 
chromatography is of low resolution and requires a longer run time. Furthermore, 
post column derivatisation not only increases the time, but the addition of an extra 
pump in the post column system adds to the complexity of the system. Additionally, 
reactions of background contaminants contribute to an increase in baseline noise. 
The development of the pre-column derivatisation offers a technique with better 
sensitivities and shorter analysis times. 
 The two major approaches for pre-column derivatisation of amino acids use dansyl 
chloride and o-phthalaldehyde (OPA). Dansyl chloride (1-dimethylaminonaphtalene-
5-sulphonyl chloride) is very useful for determining the N-terminal of the residues 
and the derivative is highly fluorescent and also stable to acid hydrolysis (Jones, 
1986).The reaction of OPA with primary amines is the result of the formation of an 
OPA2/2-mercaptoethanol adduct which then reacts with a primary amine of the 
amino acid to form a highly fluorescent and UV absorbent thio-substitute isoindole. 
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However, some amino acids cannot be detected by OPA. Proline possesses a 
secondary amine group and is unable to react with OPA, and cysteine also has a low 
response (Jarret et al., 1986). Otherwise, the reaction is rapid and proceeds at room 
temperature as shown in Figure 7.3: 
 
Figure 7.3: The reaction of o-phthalaldehyde complete solution (with 2-mercaptoethanol) 
with a primary amine on a peptide. 
To establish the least required and appropriate concentration ratio of OPA with the 
given sample in terms of standard amino acids and standard mature cross-links, a 
total of about 100 runs of HPLC were performed. The following approach proved to 
be optimal. The best results for single primary amino acids required thoroughly 
mixing 7.5 nM of OPA with 1nM of the amino acid in 0.4 M borate (pH = 10.4) and 
0.1 M sodium acetate (pH = 7.2) and incubation for one minute at room temperature 
before injection. 
There are no reports of derivatisation and detection of standard mature cross-links 
under UV as these compounds are naturally fluorescent and are often detected by 
HPLC fluorescence. However, their chemical structures contain three primary amine 





Figure 7.4: Mature cross-links of collagen, top pyridinoline and below deoxypyridinoline with 
three primary amines. 
A series of runs revealed that at the ratio of 37.5 nM of OPA to 1.0 nM of DPD or 
PYD, there was an optimum reaction. The increased amount of OPA might be 
explained by the fact that the molecules of the cross-links contain three primary 
amine groups. Nonetheless, this increase is not proportional when it is compared 
with molar concentration of OPA used for determining standard profile single amino 
acids.   
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Collagen extraction  
Rat tails were frozen immediately after removal from donor rats. During the 
processing, each sample was placed in a Petri dish containing 70% ethanol for 20 
minutes. The tip of the tail was cut crosswise with scissors. The skin was pulled back 
about 0.5 cm to expose the tendons and then each tendon was pulled out with blunt 
tip forceps. After that, samples were washed with PBS buffer and cut into small 
pieces (approximately 5 * 5 mm). In the case of the mitral valves, freshly frozen 
mitral valves were left to thaw at room temperature and then the same procedure was 
repeated, with the only difference being that, after cutting them into the pieces, they 
were homogenised. Tissue was selected from visually diseased and normal areas 
within each valve towards the free edge. Collagen was isolated from the rat tail 
tendons and mitral leaflet samples according to O’Leary et al. (2004), by dissolving 
in 0.017 M acetic acid at 4 g/L. The solution was gently agitated by stirring for 48 
hours at 4°C. In order to purify the collagen solution, they were centrifuged at high 
speed (10000 * g) at 4°C for one hour in a fixed angle rotor (JA-20; Beckman 
Coulter) using a Beckman Coulter high-speed centrifuge (Collier et al., 2006). 
Supernatants were separated and dried using lyophilizer at -40 °C for 12 hours. They 
were weighed into 5mg groups and were hydrolysed in 200 ,L of 6 N HCl under 
vacuum for 12 hours. The hydrolysates were dried and resuspended in 700 ,L 1mM 
HCl and centrifuged at 15000 rpm for 15 minutes. Supernatants were filtered and 
used for HPLC purposes. In total four diseased and four healthy collagen samples 
obtained from two dogs with mxomatous mitral valve (grade I-II) were prepared in 
duplicates. The same number of runs was performed with collagen obtained from rat 
tail tendon.  
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Breed Age Sex 
Yorkshire Terrier 9 years old Male 
Mixed Setter 8 years old ------ 
Table 7.2: The details of dogs used in HPLC experiment. 
Results 
A series of different runs was completed using various concentrations of standard 
mature cross-links in order to characterise the exact appearance of the related peaks 
in the chromatogram and to produce a standard graph. Figure 7.5 shows a typical 
chromatogram of mature cross-links. As the figure shows, pyridinoline and 
deoxypyridinoline appeared at 12 and 12.4 minutes, respectively. Taking into 
account the pattern of chromatogram of amino acids, another series of HPLC runs 
was conducted using standard amino acids in order to calibrate the machine and also 
to see whether there would be any possible peak interference with those of standard 
mature cross links (Figure 7.6). HPLC was also run for the samples (diseased and 
healthy leaflets and rat tail) (Figure 7.7). From this figure (7.7) it is apparent that in 
all sample-runs (in the rat tail and mitral valve collagen samples, irrespective of their 
disease status) only one type of mature cross-link, namely pyridinoline, was 
detectable. The analytical areas for the respective peaks were determined and the 
amount of pyridinoline cross-links was calculated in picomoles (Figure 7.8). 
Statistical analysis was carried out using Kruskal-Wallis for analysis of variance. It 
showed a statistically significant difference in pyridinoline content between the three 
170 
 
groups with 25% reduction of  pyridinoline content in the affected areas comparing 




Figure 7:5:  Chromatogram of mature standard cross-links at 1 nM concentration each. 
Pyridinoline (A) and Deoxypyridinoline (B). 
 







Figure 7.7: A chromatogram of mature pyridinoline cross-links of (from top to bottom) 




Figure 7.8: The amount of the pyridinoline cross-links in 20 (g of collagen sample. The 
error-bars are derived from standard deviation and for healthy, diseased and rat tail are 1.53, 
1.16 and 4.37, respectively. 
Discussion 
The study of the reducible cross-links using the neutron diffraction has a very high 
sensitivity compared to other methods, such as chemical and chromatographic ones. 
However, it lacks the capacity to provide quantitative data about the cross-links. The 
study and quantification of collagen cross-links dates back to decades when Verzar 
(1964) reported a form of binding among collagen fibrils without knowing the exact 
nature of this binding. Reducible cross-links were then quantified and isolated by 
chemical reduction with radioactive sodium bromide (Baily and Lister, 1968) and 
Bailey and Shimokomaki (1971) compared the amount of reducible cross-links in 
different tissues of rat, bovine and human highlighting the issue of temporal age and 
physiological maturation of tissues. We now know that reducible cross-links are 
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intermediate compounds that are substituted with mature collagen cross-links as the 
tissue matures. Quantification of mature collagen cross-links is a good marker to 
assess the current status of collagen in a given tissue. They are almost trivalent (or 
sometimes tetravalent) with more than one amino acid side chain. Mature residues of 
the hydroxyallysine pathway (see Chapter one) are deoxypyridinoline and 
pyridinoline. Both compounds are naturally fluorescent (Saito et al., 1997) and are 
widely distributed in different tissues. However, deoxypyridinoline is found 
exclusively in bone and dentin, while pyridinoline is found in other tissues such as 
tendons, cartilage, and skin (Rosen, 1996). Pyridinoline can also found in the bone, 
where the ratio of pyridinoline to that of deoxypyridinoline is approximately 2:3. 
During collagen turn-over and remodelling, mature collagen cross-links are released 
into the blood circulation and excreted in the urine. Considering the high turn-over of 
bone in the healthy animal, almost all of these circulating mature cross-links are 
considered to originate from bone (Gerrits et al., 1995). Consequently, circulating 
mature cross-links can be used as a diagnostic or prognostic tool in various 
connective tissue disorders such as bone metastasis and fibromyalgia (Fontana and 
Delmas, 2000; Ribel-Madsen et al., 2007). However, considering the total mass of 
the mitral valve leaflets, it is unlikely that the changes in the mitral valve leaflets 
would be reflected by changes in circulating mature cross-links, except when mitral 
valve alteration forms part of a generalised disease, such as Marfan syndrome.  
As mentioned earlier these mature cross-links are naturally fluorescent and several 
chromatographic methods have been used for their detection, using a fluorescent 
detector. Saito et al. (1997) used cation-exchange column HPLC to measure the both 
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the reducible and mature cross-links in human articular cartilage, skin and the 
diaphysial femur. They applied the postcolumn derivatisation technique using o-
phthalaldehyde to measure the reducible cross-links, as these cross-links are not 
naturally fluorescent. They quantified mature pyridinoline and deoxypyridinoline on 
the basis of their natural fluorescent characteristic. Reversed phase HPLC has also 
been used by Chen et al. (2000) to study pyridinoline and deoxypyridinoline in 
human yellow ligament. To our knowledge, there are no reports of the use of pre 
column reversed phase HPLC combined with a UV detector to detect pyridinoline 
and deoxypyridinoline. Derivatisation, using o-phthalaldehyde, was successfully 
applied and pyridinoline and deoxypyridinoline were detected in the standard 
solutions. The same procedure was used in the samples and, as the results show, in 
the leaflets and the rat tail tendon there was only one type of mature cross-links was 
detected, namely pyridinoline. This finding is in agreement with the fact that while 
there are two mature cross-links derived from the hydroxyallysine pathway, 
deoxypyridinoline is almost exclusive to bone connective tissues (Rosen, 1996). 
Comparing the quantity of pyridinoline in the different groups clearly shows that rat 
tail has a considerably high amount of pyridinoline content than mitral valve leaflets. 
The difference may be explained by the collagen type. Rat tail tendon is almost 
exclusively made of type I collagen, which is necessary for the toughness and 
strength of the tail tendon. However, mitral leaflets in dogs might contain different 
types of the collagen molecules. This has been indeed shown in human mitral valves 
where normal human leaflets contain approximately 74% of type I, 24% of type III 
and 2% of type V. Even in diseased human valves, this changes to 67%, 31% and 2% 
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respectively (James et al., 1991). The current study has shown that there is a 
statistically significant decrease in the amount of pyridinoline in diseased valves 
compared to normal valves. This decrease may be related to a possible change in the 
ratio of collagen types in the normal and affected leaflets of dogs (see above). 
Therefore, the proportion of different collagen types in the dog mitral valve needs to 
be clarified with further studies. However, it is reasonable to argue that without 
alteration of the ratio of collagen types, in the dog valve the decrease in pyridinoline 
reflects a reduction in the synthesis of mature cross-links associated with disease. 
A further explanation of this finding might be that, since, pyridinoline and other 
mature cross-links are the result of transformation of immature cross-links as the 
tissue matures, the neutron diffraction results in the current study reflect higher 
reducible immature cross-links. Therefore, one may explain the decrease in mature 
cross-links in the context of increased immature cross-links. It has also been shown 
during the remodelling of connective tissue in the granulation stage of wound healing 
in skin that there is an increase in the production of type III collagen (Haukipuro et 
al., 1997). After deposition of the collagen strengthening of the tissue continues with 
the development of mature cross-links. This is also in agreement with other studies 
which showed that the high degree of collagen turn-over at this stage in skin 
corresponds with that found in embryonic tissues (Paul et al., 1997). So on the one 
hand, it seems that changing the proportions of the collagen type I and III in the 
disease state may be a part of a general process of the remodelling of collagen and on 
the other hand this increase in turn-over and remodelling gives rise to young collagen 
molecules with the bivalent or immature cross-links. A final consideration is, as the 
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underlying process of myxomatous degeneration continues there would be no time 





Coherent anti-Stokes Raman 
scattering spectroscopy (CARS) 
study of canine mitral valve 
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History of spectroscopy 
The science of spectroscopy started with Isaac Newton when he let the sunlight pass 
though a prism and produced a spectrum. In 1801, the dark lines in the solar 
spectrum were discovered by the English scientist William Wollaston. It was not 
until 1814 that Joseph Fraunhofer reproduced the Wollaston work and concluded that 
the dark lines were the result of the absorption of certain wavelengths. Then, in 1859 
a German physicist called “Gusatv Kirchhoff” demonstrated that each pure substance 
causes a unique light spectrum. 
Generally, there are 3 types of spectroscopy used today; emission, absorption and 
scattering spectroscopy. Absorption spectroscopy, such as infrared or ultraviolet 
spectroscopy, measures the wavelengths which a given matter absorbs. Fluorescent 
and laser spectroscopy measure the emitted light. Scattering spectroscopy measures 
the amount of light that a substance reflects at a given excitation wavelengths 
(Lambert et al., 2006).  
Raman spectroscopy 
Raman spectroscopy, which is a type of scattering spectroscopy, takes its name from 
the Indian scientist Chandrasekhara Venkata Raman. In 1930, he and his colleagues 
found that, when a certain wavelength passed through a transparent chemical 
compound, there was a small fraction of beam emitted at a right-angle that possessed 
a different wavelength.  
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When an incident light hits a molecule it interacts with the electrons of the molecules 
causing existing covalent molecules to bend, stretch and rotate. Bonds in the 
molecule then become polarized, producing dipoles called induced dipole moments 
(P) which are directly related to the electrical field (E), produced by the incident 
light. The equation for this effect is: 
P = 0E    where 0 is electric susceptibility constant    (8.1) 
During the interaction of a molecule with the incident light or electrical field the 
dipoles in the bonds oscillate at the same frequency of the incident light and emit 
wavelengths of almost the same frequency as the incoming beam when they are 
returning to the ground state. However, each and every bond in any molecule has its 
own resonant frequency, which is independent of the applied oscillation and 
excitation caused by the light beam. As molecules have different covalent bonds so 
they posses multiple and various resonant frequencies which are unique for each 
substance. These different patterns of resonant frequency are often plotted as 
intensity of the emitted beam against the energy or frequency of the vibration and are 
called Raman spectra. 
When a molecule is hit by frequencies which equal their resonant frequencies, the 
dipoles resonate with greater amplitude, resulting in a significant absorption of the 
energy and the molecule releases a wavelength whose energy is less than the 
incoming beam. The molecule is then left in a lower energy state, in terms of 
vibrational energy, which is, however, still above the ground state. This phenomenon 
is called Stokes shift Raman. On the other hand, the opposite might also occur which 
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is called anti-Stokes shift Raman. A molecule which is already in a vibrational state 
releases a wavelength with a higher energy than the wavelength it absorbs (Figure 
8.1). The ratio of the higher energy to the lower one can be calculated to give the 
Raman signal, which can then be compared with reference spectra (Cheng et al., 
2002; Potma and Xie, 2004; Lambert et al., 2006; Rodriguez et al., 2006). Date was 
correct and the reference was added. 
 
Figure 8.1: Stokes and anti-Stokes phenomena in a given molecule. In Stokes (a) the 
released photons are in a lower energy state and in anti-Stokes (b) the released photons are 
in higher energy state. Note that the new state of the energy is called virtual as the energy is 




Introducing laser beams, with their ability of focusing high intensity beams on very 
small areas opened a new chapter in Raman spectroscopy. Before this, Raman 
spectroscopy had relied upon weak spontaneous, incoherent signals. Even with 
intense laser beams, biological samples were very difficult to measure. Coherent 
anti-Stokes Raman spectroscopy (CARS) was designed to deal with these problems. 
CARS is a method of acquiring Raman signals  in which a molecule is stimulated 
until it achieves its vibrational state and then the same molecule is again stimulated 
to emit an anti-Stokes emission. The final emission (anti-Stokes) is achieved using 
two different laser frequencies. Higher frequency (pump) and lower frequency 
(Stokes) are combined together to form a modulated coherent sinusoidal wave with a 
high frequency beat (1p + 1s) and a low frequency beat (1p – 1s). When the lower 
frequency beat equals the vibrational frequency of the bond, the bonds begins to 
excite resonantly. In the second step, the already excited bond is hit by second higher 
frequency pump photons, resulting in the emission of an anti-Stokes photon that has 
a higher energy than the incoming photons. The equation for this anti-Stokes 
emission can be stated as follows: 
1AS = 21p – 1s         (8.2) 
Where 1p is two combined beams and 1s is the wavelength of the Stokes beam and 
1AS is the final anti-Stokes emission.  Since there are 4 photons involved in the 
CARS process, namely 2 incoming photons, one Stokes and one anti-Stokes, this 
process is also called “four mixing process”. CARS imaging is a non-linear process 
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so the anti-Stokes photons travel in the same direction as the incident beam in a 
coherent way and are in phase with each other. This imaging approach provides 
some advantages for visualising biological samples, such as; offering chemical 
selectivity without the need for labelling; the near-infrared excitation beams scatter 
little and allow deeper penetration; due to the anti-Stokes effect, CARS signals have 
shorter wavelengths and higher energy making their detection feasible in the 
presence of the fluorescent background; coherent addition of the beam provides a 
very strong signal; non-linear pattern excitation intensities produces 3D-resolution; 
and, finally the non-invasive characteristic of approach presents an opportunity to 
even examine a live sample without any damage.  
Aim 
CARS imaging allows the identification of different types of chemical bonds. It also 
offers a unique chemical selectivity for compounds (see above). This experiment was 
designed to follow on in the investigating of collagen changes in MMVD in the 
previous chapters. Considering the structural changes in MMVD leaflets (Chapter 2 
and 3) and changes  in cross-links (Chapter 6 and 7), it was felt that not only could 
these changes be reflected in CARS images, but also the unique potential of CARS 
imaging would add new information to the understanding of MMVD. 
Materials and methods 
The set-up used in the current study is shown in Figure 8.2, which was similar to that 
of Evans et al, (2005). For CARS imaging the system was tuned in such a way that 
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the difference between the “pump” and the “Stokes” wavelengths equals about          
2840 cm-1, which corresponds to the symmetry of the CH2 (bond) stretch vibration 
(Wang et al., 2005). CARS imaging of CH2 stretch has been intensively investigated 
in recent years in different tissues. It has been shown that it can be used to visualise 
endothelial cells, smooth muscles, axonal myelin, lipid bilayers, and fibrous protein 
structures such as elastin and collagen where CH2 stretches are especially abundant 
around cross-link areas (Wang et al., 2005; Wang et al., 2008). The latter has 
recently been of a particular interest for identification of most tumour masses, where 
the surrounding tissues are abundant in collagen unlike the tumour itself (Cheng et 
al., 2007).The CARS imaging facility at the University of Edinburgh has been 
established very recently and, due to time constraints and hardware problems with 
the instrument, it was only possible to run two samples obtained from a male beagle 
(5 years old) with MMVD grade I. They had been kept in -70°C and before 
experiment they were let to thaw in room tempreture. Each sample was collected 
from obviously diseased areas and measured 2 * 2 mm and was sandwiched between 
2 cover-slips. The sample was scanned in 0.4 µm thick slices of an area 0.2 * 0.2 mm 
covering the entire depth of the leaflet. Images were taken with phosphate buffer 





Figure 8:2: The setup for CARS imaging used in the experiment at the Institute of Materials 
and Processes at the University of Edinburgh. The system employs a Nd:YVO4 laser as 
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“pump” beam. Delay online or stage is responsible for the temporal overlap of the pump and 
Stokes pulses. The sample was staged on a confocal laser scanning microscope (Nikon BV 
‘C1’, Amsterdam, Netherlands). Various wavelengths of custom-made long pass dichroic 
mirrors (Chroma, Rockingham, USA) are required within the scan unit, in order to separate 
the anti-Stokes (CARS signal) from the longer wavelength pump and Stokes (inputs). 
Results and discussion 
Figure 8.3 shows a series of CARS images obtained from grade I MMVD sample, 
based on CH2 stretches. The extracellular matrix of the mitral leaflets, especially the 
fibrosa layer, is mainly composed of collagen. The network-like pattern of the image 
is mostly compatible with the collagen structure. These slices show  how pattern and 
structure of the fibrils change in different depths of leaflets. Lipid droplet and lipid 
accumulation in the extracellular matrix can also give rise to very rich and strong 
CARS imaging, such as one can observe in the extracellular matrix of an atheroma 
(Le et al., 2007). However, it is very unlikely that lipid accumulation can produce the 
network pattern observed in the MMVD samples and lipid accumulation has not 
been reported in MMVD.  
 
Figure 8.3 (following pages): CARS images (from A-L) of CH2 stretches of a diseased mitral 
leaflet. A series of 0.4 µm thick slices of an area 0.2 x 0.2 mm and 4.4 µm deep. Given the 
pattern of the image and considering that the main ingredient of extracellular matrix of the 
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In the current CARS imaging, images were recorded from two affected areas 
(MMVD grade I) obtained from the same leaflet and due to the time and technical 
problems the running of more samples in order to draw a comparison between 
diseased and healthy leaflets was not possible.     
It is possible to distinguish between collagen and elastin using the technique of 
second harmonic imaging (SHI). The unusual structure of collagen 
(noncentrosymmetric) and its high degree of crystallinity are able to convert the light 
to its second harmonic. To date, this is the strongest SH signal that has ever been 
obtained from a biological material (Williams et al., 2005; Cox and Kable, 2006). 
Elastin can also be imaged by using two-photon excitation fluorescence (TPEF) 
(Cheng et al., 2007). However, in CARS imaging, the best way to distinguish 
between collagen and elastin fibrils is based on their specific Raman spectra. 
Although the first experimental images of CARS were obtained in 1982 (Duncan et 
al., 1982), measurement of the Raman spectrum of collagen dates back to the 70s 
(Frushour and Koenig, 1975). Attempts to obtain specific collagen Raman spectra 
(Figure 8.5) from mitral leaflets were unsuccessful. The Stokes beams had very low 
intensities at the frequencies that were suggested for collagen and this may explain 
my failure. This may be resolved by technical modification of the equipment, and 






Figure 8.5: Raman spectrum of collagen (Achilles tendon of bovine) adapted from Frushour 
and Koenig (1975). 













To conclude this section, it should be mentioned that, although imaging of CH2 
stretches has been carried out in different tissues, to the best of my knowledge, this 
was the first time that the technique has been applied, in a limited fashion, to the 
structure of heart valve leaflets. It demonstrates an interesting pattern of the fibril 
structure at different depths of the leaflets. Although further studies using a large 
number of both diseased and healthy leaflets are required to validate the current 
results, these changes in lay-out of the fibrils may shed more light into pathogenesis 
of the disease. It may also be useful in designing and engineering artificial valves. 
CARS imaging offers several advantages for biology and medicine. CARS imaging 
is a non-destructive approach that can even be applied to living cells. CARS signals 
are much stronger than spontaneous Raman scattering. This makes it possible to 
acquire images in a time scale of less than one second, compared to confocal Raman 
images that may take several hours. By the use of specific vibrational frequencies of 
different bonds in a certain molecule, it uniquely provides a chemically-selective tool 
to differentiate between bio-materials and bio-molecules, without the need for 
labelling. As CARS depends upon the non-linear excitation intensity, it produces a 
signal only in the focal centre, giving rise to a 3 dimensional spatial resolution. 
Moreover, the use of the infrared lasers with long wavelength of excitation produces 
a deep penetrative beam which also reduces the amount of the scattered light in the 
tissue. As well as the considerable set-up costs for CARS instruments, another major 
disadvantage of CARS results from the non-resonant background. This interferes 
with weak Raman bands and reduces the sensitivity of the method (Rodriguez et al., 
2006; Cheng et al., 2007; Djaker et al., 2007). All in all, it seems CARS imaging has 
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This study has markedly improved our understanding of the structural changes that 
occur at the molecular level in MMVD, and has demonstrated the applicability of 
various techniques to further understanding of the disease.  Important findings of this 
study with respect to mild or moderate MMVD can be summarised as follows:  
1. The orientation, the degree ofalignment and density of collagen fibrils are 
altered in diseased areas of the affected leaflets in MMVD; 
2. A 10% depletion of collagen in the affected areas was demonstrated 
compared to the healthy regions; 
3. The affected regions have 20% less fibrillar collagen; 
4. The diseased regions have increased numbers of immature reducible cross-
links in comparison to the healthy areas; 
5. The diseased regions contain 25% fewer mature cross-links (pyridinoline) 
compared to the healthy zones; 
Much is known about MMVD its natural history, diagnosis, clinical development, 
therapy and outcome. However, the exact pathophysiology of the disease still 
remains unclear. Work to date, in our laboratory and others, has identified 
ultrastructural changes, endothelial alteration and changes to the proteome in 
195 
 
diseased dog mitral valves, and many of those finding match those reported for 
mitral valve disease in humans. The matrix of leaflets and one of its major 
components (collagen fibrils) have central roles in the function of mitral valves. By 
selecting mild and moderate grades of MMVD, I was able to investigate the events 
mid-way through development of the condition, before it advances to end-stage and a 
completely dysfunctional and insufficient valve. The information revealed gives 
clues about the origin and progression of the disease.  
Collagen molecules cannot be stretched and contracted to the same extent as elastin 
fibrils, so the orientation of collagen fibrils (Chapter 1) reveals how the mitral valve 
leaflet responds to mechanical load during the heart cycle. The x-ray experiments 
provided detailed maps of collagen fibrils in affected regions and differentiated 
between fibrillar and non-fibrillar collagen. They also provided strong confirmation 
that the changes in collagen fibrils only occurred in the free margins of the leaflets. 
The question of why free margins are more prone to injury than other regions 
remains to be answered. The DSC experiments gave important information about the 
thermal characteristics of collagen molecules, and showed that not just tertiary 
structure is important in determining the thermal characteristics of a molecule, but 
also the microenvironment in which the molecule lies. The DSC and x-ray data 
showed that there was 20% depletion of fibrillar collagen while hydroxyproline assay 
showed that there was only 10% depletion of collagen molecules. 
Affected regions also had 25% fewer mature cross-links. Some of this reduction may 
result from depletion of mature collagen, while increased levels of non-fibrillous 
collagen may also contribute to this sequel. However, the neutron scattering 
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experiment found more reducible cross-links in these affected regions. This increase 
in reducible cross-links may be explained by increased production of new collagen in 
which the cross-links are yet to mature. Conversely, the higher level of non-fibrillous 
collagen may be explained either by disruption of fibrils, or by the production of 
collagen molecules that have not yet assembled into fibrils. Increased collagen 
synthesis in response to injury has been reported in human MVP (Cole et al., 1984) 
but has not yet been clearly demonstrated in the dog. Recent work by our group and 
others (Disatian et al., 2008; Han et al., 2008) has shown increased numbers of 
activated-myofibroblasts close to the valve surface and reduced numbers of inactive-
myofibroblasts in the valve spongiosa of dogs with MMVD. The valvular interstitial 
cells in mitral valve leaflets have also been shown to undergo changes with age and 
environmental condition (they are even suspected to change under mechanical stress) 
(Schoen, 2008). MMVD has been closely linked with ageing in the dog. Considering 
the age-association changes in collagen such as the change in the nature of cross-
links and alteration of the lysyl oxidase activity, the reported cellular changes might 
be associated with MMVD. The increase in reducible cross-links may be explained 
by increased collagen synthesis, which may also be related to the activity of lysyl 
oxidase. Numerous factors have been associated with MMVD, including aging, 
repeated stress, involvement of various cytokines, involvement of advance glycation 
end (AGEs), endothelial cell breakage followed by neovascularisation etc. However, 
it may be postulated that endothelial damage initiates a stromal interstitial 
transformation from quiescent fibroblasts to activated myofibroblasts. These cells 
migrate towards the site of endothelial damage and as a part of their activation 
increase production of proteolytic enzymes (MMPs) which destroys the mature 
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collagen present in the leaflet, while at the same time increase production of 
immature collagen. However, this collagen fails to mature and what should proceed 
as a reparative process turns into a dyscollagenesis with collagen loss and reduced 
mechanical strength of the remaining collagen. Coupled with this is an increase in 
GAG expression from the activated myofibroblasts which further compromises 
collagen organisation and maturation and itself reduces valve mechanical strength. 
This loss of mechanical integrity increases the chance of appositional trauma of the 
leaflet edges and results in further endothelial damage. The process continues in this 
fashion until the whole free edge of the leaflet is severely damaged. However, 
whether the procedure is exactly similar to that of repair and what triggers these 
events in the first place is still not known.  
The DEI imaging demonstrated the potential of this technique for the studying of 
structural changes in extracellular matrix. MMVD starts with small macroscopic 
nodules resulted from disruption of matrix structure and as disease progresses this 
disruption become more marked (Chapter 1). In the current study, the DEI was able 
to highlight associated features of lesions and healthy areas and differentiating 
boundaries between them. The similarities found between MMVD and human breast 
cancer images were interesting, considering the pathological changes that occur in 
MMVD, such as destruction and production of collagen, activation and potential 
apoptosis of vascular interstitial cells.  
The CARS imaging experiment demonstrated how effectively this approach can be 
applied to mitral valve leaflets. The observation of different patterns of collagen 
network at different depths gave an insight into the pathogenesis of the disease. The 
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specificity and selectivity of CARS that result from the unique Raman spectrum of 
each type of molecule can also be exploited to differentiate changes that are 
happening in MMVD. 
To conclude, the present study bridges the knowledge gap and helps to provide better 
understanding about collagen changes in the pathogenesis of MMVD. The 
consequences of these collagen changes can be readily appreciated, in terms of 
significant mitral valve regurgitation and eventual left sided heart failure. 
Furthermore, as MMVD bears considerable similarities to human valvular disease 
(especially mitral valve prolapse) and given the importance of this disease in 
humans, the finding in this thesis can be equally taken into account in human studies 
as well. However, the current study was limited by some factors such as the 
qualitative state of the neutron diffraction study and low number of samples in the 
same study. These factors and others (see below) should be taken into account when 
interpreting the results of this thesis. 
Future studies in this area could include investigation of collagen structure in severe 
forms of disease and in different breeds. This work can also be expanded to embrace 
specific age groups as a recent study by our lab (unpublished data) has shown that 
beagles as young as one year old were suffering from MMVD. Cytoskeletal proteins 
such as vimentin through multi-adhesive matrix proteins such as fibronectin interact 
with other matrix proteins such as collagen and elastin. Although cells are 
responsible for secreting and remodelling the matrix, but matrix also plays an 
important role in maturation, differentiation and migration of its cellular content. 
Thus, understanding of the function of multi-adhesive and cytoskeletal proteins and 
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their relation with collagen fibrils seems imperative. Moreover, identifying of exact 
composition of collagen in mitral valve leaflets can shed more light on the 
pathogenesis of the disease. Although type I and III are the major types, it has shown 
that in some tissues two quantitatively minor fibrillar collagen type V and type XI 
coassemble with type I collagen regulating the structure and properties of the fibres 
(Lodish et al., 2008). In cartilage proteoglycans through collagen type IX are cross-
linked to collagen type II and contribute to the mechanical properties of the matrix. 
Therefore, study of proteoglycans and their relation with matrix proteins can also be 
considered in future studies.  
 Finally advanced glycation end products (AGEs) are opening a new field of study 
and are currently receiving considerable attention. It has been shown that high level 
of pentosidine, one of the advanced glycation end products (AGE), can be considered 
as a risk factor in patients suffering from heart conditions (reference).Given their 
importance, more studies can be directed to elucidate AGEs and receptors of AGEs 
(RAGE) roles in MMVD. More recently an experiment has been recently designed 
by the author and funded by Small Project Grant scheme (University of Edinburgh) 
in order to investigate plasma concentration of carboxymethyllysine (CML), an AGE 
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